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Chapter 1 
INTRODUCTION 
1.1 General 
The idea that changes in the chemical composition of body fluids could be of 
significance in revealing the presence of disease was first recognized by 
Robert Boyle at the end of the 17th century. (1) 
Since that time, particularly in the 20th century, the knowledge about the 
chemical composition of body fluids increased, and in todays practice of 
medicine, chemical analysis results are indispensable tools in the medical 
decision making process. 
Basically laboratory data are used to measure, in body fluids and tissues of 
individual patients, those substances which are relevant for the understanding, 
prevention, diagnosis, or treatment of disease. 
Some measure of the increasing demand for chemical analyses may be derived 
from the growth in the number of investigations performed by clinical chemical 
laboratories. A rule of thumb which was valid for most laboratories in the 
period 1960 - 1972 was an annual growth rate of approximately 20%. (2, 3, 4) 
This increase is composed of an increase in the test results generally 
available for a particular patient and an increase in the kinds of determina-
tions one might request to be performed. The fact that in the diagnostic 
armamentarium of the medical profession 30% of all information comes from 
laboratory data, may also illustrate the importance of chemical investiga-
tions. (5) 
The recognition that subtle variation in the levels of certain constituents 
in body fluids may be of significance in revealing the presence of disease, or 
in differentiating one population of individuals from an other, has placed 
increasing demands on clinical laboratories for reliable analysis results. 
Reliable thereby implies that accuracy and precision of these results are of 
such a standard that their information is not lost against a background of 
experimental error. 
The progress in analytical technology and the development of new analytical 
techniques have made the detection of these subtle variations possible. 
The introduction of quality control programs in clinical chemistry laboratories 
provided the mechanisms to document, evaluate and improve their performance in 
matters of accuracy and precision. 
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The need for such programs and the complexity of the quality control problem 
may be illustrated by the fact that the introduction of work-simplifying 
techniques and automatic methods of analysis in clinical chemistry laboratories 
has not improved the reliability of the chemical analysis results as much as 
might have been expected (2). The capability of clinical laboratories to 
provide analysis results of a better standard than at present should be aimed 
for since conversely this could create new opportunities for improved use of 
clinical chemical analysis results in medical practice. 
1.2 Quality control in clinical chemistry 
Statistical quality control of industrial goods originated with the work of 
Shewhart (6), who introduced the basic principles of industrial quality control 
in 1931. 
The extension of these techniques to the field of clinical chemistry followed 
in 1947 by Belk and Sunderman (7). This apparently became evident with the 
recognition that clinical chemistry laboratories are in many ways similar to a 
manufacturing plant. Reagents and specimens (the raw materials) are received 
and subjected to a variety of manipulations using specialized tools or instru­
ments, and the final product, the analytical results, are produced. 
The findings of Belk and Sunderman (7) during their pioneer survey were later 
confirmed by the results of similar studies (8, 9, 10, 11, 12). Λ11 revealed 
a wide range of reported values for the analysis of identical specimens among a 
group of laboratories. Of more importance however was the recognition that the 
analysis of a conmon specimen either in several or in a single laboratory could 
evaluate laboratory performance. This concept was soon applied in two major 
ways 1) for intralaboratory monitoring of accuracy and precision and 2) for 
the interlaboratory comparison or proficiency testing surveys. 
Both fields of application have proven thejr usefulness over the years and are 
now properly considered aspects of quality assurance in clinical chemistry. 
1.2.1 Intralaboratory quality control 
In their provisional recommendation of quality control in clinical chemistry, 
the International Federation of Clinical Chemistry (IFCC) defines quality 
control as 'The study of those errors which are the responsibility of the labo­
ratory and the procedures used to recognize and minimize them. This study there­
by includes all errors arising within the laboratory between the receipt of the 
specimen and the despatch of the report' (13). The term 'error' thereby 
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signifies a deviation of the result from some 'true' value, which is considered 
to have a self evident meaning requiring no definition. Since this value is 
never really known, we can only consider estimates of the errors inherent in 
the experiment. These errors are generally classified according to the way in 
which they affect the result as random, systematic or gross errors. 
Random errors are errors which originate due to unattnbuted causes, and 
systematic errors or bias are of constant character which make the results 
different from the 'true' or most probable value with reproducible discrepancies 
to either high or low values. Gross errors or illegible errors are time 
isolated errors, the magnitude of which identifies them at first sight as errors 
far exceeding the random errors in size. However according to the gaussian law 
of random error distribution, it is strictly speaking impossible to regard even 
the largest error as non random, although such error will occur only very 
occasionally. True gross errors however occurring for example as a consequence 
of mistakes, may occur at any time and their occurrence cannot very well be 
explained by the validity of the gaussian law of random error distribution but 
moreover as a deviation from this law. Gross errors also differ from systematic 
errors mainly in magnitude, irregularity and isolation of occurrence. In 
practice use is made of the fact that an analytical result subject to a gross 
error differs greatly from the other results. Such result is then referred to 
as an outlier. Statistical literature includes quite a number of objective 
criteria to detect such outlying observations (14, 14), but little use is made 
of them in clinical chemistry where such outliers are often eliminated on 
rather subjective criteria. (16) 
Causes of gross errors are those originating during specimen collection and 
transportation (17, 18), resulting from interchange of samples and errors of 
transcription, and laboratory bench errors. The latter include items as dirty 
or damaged glassware, use of wrong pipets and faulty reagents and fatique and 
boredom (19, 20) of analysts. Mc Swiney and Woodrow (21) and Grannis et al. 
(22, 23) estimated the frequency of these gross errors at approximately 3Í.. 
Errors of this category are of concern to a laboratory and should be part of 
an extended quality control system. 
Most intralaboratory quality control systems however work in a narrower sense 
than indicated by the earlier definition of quality control. At present these 
systems are mainly focussed on the monitoring of precision and accuracy of 
analytical procedures. 
Precision is defined as the agreement among repeat measurements made under the 
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г"ame conditions without reference to any 'true' value, and is a measure of 
random error. 
Accuracy is defined as the closeness of an observed result to the 'true' or 
most probable value of the quantity studied, and is a measure of systematic 
error or bias. 
Two kinds of mtralaboratory quality control systems can be distinguished i.e. 
those which are based on the routine analysis of patient specimens and those 
based on the analysis of quality control specimens which simulate the chemical 
composition and the physical characteristics of the patient specimens. 
The monitoring of analytical procedures with the aid of so called quality 
control specimens is based on the implicit assumption and intent, that these 
specimens behave and are treated in the same way as patient specimens. Control 
specimens are thereby included in a series of patient specimens and the results 
of these control specimens are regarded to be representative for the analytical 
performance during the analysis of such a series of patient specimens. There­
after the control results are subjected to statistical analysis which is 
intended to show whether or not the analytical procedure was under control in 
the time span the series was analyzed. 
The first to describe a formal mtralaboratory quality control system according 
to this concept were Levey and Jennings in 1950 (24). Their so called reference 
sample method combined the use of control specimens with the application of the 
control charts which Shewhart (6) developed for industrial quality control. 
(Shewhart actually introduced two charts, one for plotting the mean of a group 
of observations and the other for plotting the range of the observations; in 
clinical chemistry often only a single control measurement is made and therefore 
only one control chart is needed). 
The Levey and Jennings system was later modified by Henry (25), and his single 
reference sample method has become a mainstay in mtralaboratory quality control. 
Although there are limitations in sensitivity of the method (26, 27), it has 
been shown to be more sensitive to error than methods based on the use of 
patient specimens (28). Other specialized applications of Henry's system have 
been described but the modifications are minor and mainly concerned with the 
frequency of including control specimens (27) and the setting of warning and 
action limits in the control charts (29). Other statistical techniques used to 
evaluate mtralaboratory quality control data are the cummulative sum method 
(30), which Griffin (31) adapted to clinical data, the Trigg's test for trend 
analysis (32, 33) and the analysis of variance technique (34, 35). Recently 
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Westgard et al. (36) and Berger and Hirsch (37) described the decision limit 
cumulative sum method, which provides equivent information to that of the 
commonly used cumulative sum method, but makes use of a numerical limit in 
stead of the V-mask, thus facilitating calculation and manual application. 
The control specimens used in clinical laboratories include aqueous solutions 
of single compounds or mixtures of compounds, and a wide variety of protein-
con taming preparations. (38, 39) 
For monitoring the analytical performance during plasma or serum analyses, 
protein-containing controls, referred to as control sera, should be included 
among the patient specimens. 
Most control sera preparation methods are based on the collection of large 
volumes of human or animal serum. The selection of desired analyte concentra­
tions in these control sera should be dependent on various factors. In general, 
clinical chemical determinations should be most accurate and precise at those 
concentration levels at which clinical decisions are made. Control sera should 
hava analyte concentrations near these decision levels. The choise should also 
be considered with respect to the distribution pattern of results obtained with 
routine clinical specimens. Once the desired characteristics of the control 
serum are decided, a source of the specimens must be selected. 
Most commercially available control sera preparations are supplied as a 
lyophilized product. A large serum pool is prepared, the analyte concentrations 
adjusted to desired levels and aliquots are dispensed and lyophilized. These 
products are thereafter purchable as unassayed or assayed control sera. 
A control serum is referred to as an 'assayed' serum when the manufacturer 
includes mean values of the various constituents with the serum. 'Unassayed' 
control sera are sera whereby a laboratory itself or a collective of labora­
tories determine the various analyte concentrations which consequently are 
used as assay values. 
The other source from which control sera are obtained are the laboratories 
themselves. The excess serum left from the daily routine chemistry is collected 
and stored at approximately - 20 C. When enough serum has been collected, this 
is allowed to thaw at room temperature, mixed and centnfuged. The clear 
supernatant is again thoroughly mixed, distributed in aliquots of 5 - 15 ml 
and stored at - 20 С prior to use. 
General basic requirements for control sera preparations are that they simulate 
both chemically and physically the patient specimens and do not deteriorate due 
to bacterial contamination. Furthermore they are to be protected from exposure 
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to light, evaporation or losses of gaseous compounds and should pass un-
recognized through the same analytical steps as the patient specimens. 
Other factors which influence the reliability of the concept of control sera/ 
to monitor accuracy and precision of analytical procedures have been described 
and are for example concerned with their position in the series of patient 
specimens (40), prior knowledge of this position to the analyst (41) and 
inbomogeneity of the control sera aliquots. (42) 
The second category of intralaboratory quality control systems are those which 
are based on the results of analyzed patient specimens. 
Advantages of such systems are: a) there are no additional expenses, b) there 
is no extra workload, c) there is no so called analyst bias i.e. it is prevented 
that analysts work towards a 'known' value of the constituent considered and 
d) these data could give an indication of the sources of error which might 
affect the specimens before they arrive m the laboratory i.e. at the time of 
specimen collection on the wards, during transportation, and reception at the 
laboratory. 
The basic premise underlying this concept is, that if a significant change 
occurs in a test procedure, that change should also be reflected in the clinical 
data routinely generated by the laboratory. 
Hoffman and Waid have proposed several such methods (43, 44, 45). Their 'daily-
mean' (43), 'number-plus' (44) and 'average of normals' method (45) were 
conceptually attractive, but have not been widely adopted because of unfavorable 
appraisals of their usefulness (28, 46, 47, 48, 49). Kilgariff and Owen (49) for 
example found that the average of normals method failed to detect simulated 
systematic errors as great as 30°o. Amador et al. (28) showed that the 
sensitivity of the reference sample method to systematic errors is much better 
than that of either number-plus or average of normals method. 
All three methods, 'daily-mean', 'number-plus' and 'average of normals', are 
based on the assumption that day to day changes in the sets of specimens 
received for analysis, are negligible in their effect on the mean value of all 
(daily-mean) or categorized results (number-plus and average of normals). 
Another premise was that the frequency distribution of patient data for the 
various constituents were approximately gaussian. 
Both assumptions have been in conflict with findings of for example Stamm (50) 
and Elveback. (51) 
At present most applications of patient data for intralaboratory quality control 
purpose are concerned with deriving within batch and between batch precision 
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estimates. For that purpose analysis results obtained on one patient specimen 
either placed in the same series or in the subsequent series are compared. 
Another development started with the introduction of computerized data handling 
systems in clinical chemistry laboratories. Lmdberg et al. (52, 53) for 
example described a computer program which scans the routine laboratory data 
of patient specimens to detect unlikely combinations of test results. Similarly 
Ladenson (54) developed a system to detect unlikely changes in serial values 
obtained on particular patients. Both systems are however mainly designed to 
detect 'gross' errors rather than analytical methodologie errors. 
From the foregoing it will be clear that presently, intralaboratory quality 
control systems based on the use of control specimens cannot be replaced by 
systems employing routinely generated patient data. The usefulness of the 
latter lies mainly in their ability to provide precision estimates of within 
batch and between batch error. With the introduction of computerized data 
handling systems m clinical laboratories their possibilities to detect gross 
errors can also be a valuable adjunct to intralaboratory quality control 
programs, although it has to be realized that such facilities are not within 
reach of every laboratory. 
1.2.2 Interlaboratory quality control 
With the increasing interchange of patients between hospitals and the wish to 
establish uniformity in chemical analysis results, medical, clinical and 
governmental authorities have stressed the need for interlaboratory quality 
control programs of clinical chemistry activities. Such programs have been 
initiated in clinical chemistry and are defined as procedures which utilize 
for quality control purpose, the results of several laboratories which analyze 
the same specimen. (13) 
The conventional procedure for obtaining information from a large number of 
laboratories, is to conduct a collaborative study. These studies involve 
sending to each laboratory one or more 'unknown' specimens with each laboratory 
receiving one or more specimens of identical composition. The analysis results 
of all participants are thereafter collected along with other information about 
the laboratories and subjected to statistical analysis. Consequently the 
resulting information provides a summary of the ability of the participants to 
test the 'unknown' specimens. 
The various sources of error contained in the obtained data are: a) the random 
error, b) the inherent systematic error in the analytical procedure and c) the 
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modification in this systematic error that is a consequence of any particular 
laboratory's environment, equipment and specific way of using the analytical 
procedure. 
In order to assess insight in these sources of error, it has to be realized 
that the information derived from an interlaboratory study is rather dependent 
on such items as: a) the number of samples each laboratory receives and the 
number of analyses performed on each, b) the number of participating labora­
tories and c) the statistical techniques used to evaluate the survey data. 
The purpose of the study is also to be clearly stated. Is it for example meant 
to evaluate the performance of analytical procedures under actual working 
conditions in a group of laboratories or does it have to establish the maximum 
possible accuracy and precision estimates of analytical procedures? 
Presently most interlaboratory surveys conducted in clinical chemistry are 
mainly focussed on the evaluation of analytical procedure performance under 
actual day to day routine working conditions in a group of laboratories, and 
involve testing of mostly commercially obtained control specimens of pooled 
serum. 
Two interlaboratory survey systems can be distinghuised i.e. those in which 
specimens are periodically distributed, often referred to as proficiency 
testing surveys, and those in which a group of laboratories use the same control 
material(s) over a prolonged period of time. The latter are mostly organized 
on a regional level an allow participants to compare their results continuously 
(55). The proficiency testing programs are mainly organized on interregional, 
national and international level. 
Belk and Sunderman (7) initiated the interlaboratory comparison studies m 
clinical chemistry. Their findings showed a wide variation between the labora­
tories when reporting results for analysis of identical constituents m 
identical control specimens. This pattern of interlaboratory disagreement has 
since been shown to be a problem in many countries. (Θ, 9, 10, 11, 12, 56) 
Statistical techniques to evaluate the results of interlaboratory surveys are 
presently the Youden-plot (57), ranking test (57) and analysis of variance 
technique. (58) 
More frequently adopted analysis concepts are those in which the survey results 
of laboratories with comparative analytical methods for the determination of a 
certain constituent are grouped. The precision and accuracy performance within 
and between such groups are evaluated wxth Fisher's F-test and Student's 
t-test (58). This comparison is also practised with reference to the consensus 
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mean result of all survey results for the various specimen constituents. This 
currently is for example the case in the Netherlands (59). Other systems do not 
use the consensus mean result but evaluate the survey results in comparison 
with target or reference values for the various constituents, which values have 
been established by reference laboratories. (12) 
After the evaluation of the survey results, these are reported to the partici-
pants. For the survey information to be of use to the participants, this 
information should be presented in a concise, relevant and easily to be read 
and interpreted report format. It should be avoided that participants are 
overwhelmd with irrelevant details and different report formats in order to 
prevent that the really significant survey information is lost. 
For example the classification of a laboratories' performance as compared to 
'his group' as the best or seventh best and in comparison with the performance 
of all survey participants as seventeenth best is irrelevant and of no use to 
a participant at all. 
It should also be realized that the results of intralaboratory surveys only 
indicate the performance of a participant as compared to the survey group. 
Consequently participating in the same survey can then only indicate 
improvements of the survey population as a whole or of a participant as compared 
with this population. Only participating in regional trials, with mostly a 
limited number of participants, may then obscure the actual problems. Regularly 
participating in interregional, national and international proficiency testing 
surveys therefore is essential. It are these surveys which best can indicate the 
present state of the art of accuracy and precision standards in day to day 
clinical chemistry activities. 
The state of the art presently indicates that since the survey of Belk and 
Sunderman (7), an improvement in consistency between reported results has been 
noticed. But as Whitby (2) stated: 'It is perhaps disappointing that standards 
of accuracy and precision have not increased more since the publication of the 
first interlaboratory survey in clinical chemistry'. 
A factor which undoubtedly contributed to Whitby's observation is the confusion 
about which accuracy and precision requirements are required for clinical 
chemistry investigations. 
1.3 The degree of accuracy and precision required for clinical chemical 
investigations 
If a measurement process is to be meaningfull, then the data obtained should 
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be both precise and free of systematic error within agreed upon end-use 
requirements. 
In the field of industrial quality control, these end-use requirements of 
measurements are set by consumer needs. 
In clinical chemistry these consumer needs are more difficult to establish: 
a) Biological differences between individuals exist and apparent identical 
physiological conditions occur together with constituent levels which 
differ from individual to individual. 
b) Physiological variations within an individual may occur which are without 
significance for the health state of that individual or for conclusions to 
be drawn from the measurement. 
c) In the medical decision making process, the degree of importance of the 
chemical analysis result as compared to other series of observations 
obtained from the same individual, varies from cast to case. 
d) The variability in the total process from the sampling action until the 
analytical result becomes available, is for many constituents not 
negligible as compared to intra- or inter individual biological variation 
or clinically important differences. (60) 
If a measurement system is accurate, the numerical value obtained for the 
properties being measured are 'true values' (13) within the uncertainty of the 
measurement process being used. 
A pragmatic operational definition of the 'true value' of a property, is the 
value determined by precise measurement methods that are free of systematic 
error, i.e. an accurate method. 
The fundamental basis for accuracy in chemical analysis is provided by 
definitive methods i.e. methods that have a valid and well described 
theoretical foundation, have been experimentally evaluated, so that reported 
results have negligible systematic error, and have high levels of precision. (6) 
The findings of mterlaboratory surveys in clinical chemistry of accuracy 
compatibility, have stressed the need for improvements. 
Different mechanisms for achieving accuracy compatibility throughout large 
measurement networks in clinical chemistry are for example, the use of reference 
materials and reference methods. 
Reference materials in clinical chemistry laboratories are for example 
homogeneous, stable calibration standards, with known amounts of analyte. It is 
through the use of these reference materials that accuracy compatability between 
chemical analyses can be most easily achieved. That is to say when these 
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materials in turn form a component of a compatible measurement system, which 
utilizes accurate methods and a good measurement quality control throughout. 
Reference methods provide an additional mechanism for achieving measurement 
compatibility. 
A reference method of analysis is a method that has had its accuracy performance 
ngourously demonstrated through experimental validation by direct comparison 
with a definitive method or primary standard materials. (61) 
Since reference methods, like definitive methods, may also be moderately 
sophisticated, they however are not always acceptable for routine field use. 
Ultimately accuracy standards for clinical chemistry investigations should be 
of such order that systematic errors are no longer significantly present in 
comparison with the random errors of measurement processes. 
Initial precision requirements for measurement processes in clinical chemistry 
laboratories to assure medical usefulness of laboratory data however is a 
debatable subject. 
Several attempts have been undertaken to define precision requirements for 
clinical chemistry measurements in relation to medical usefulness. 
Tonks (10) for example suggested 'allowable limits of error' based on the 
assumption that analytical variability should not exeed a certain proportion of 
the human biological variation. Cotlove and co-workers (62) suggested that an 
analytical procedure should be at least as stable as the subject measured. They 
propose that analytical variability should be based on variations within the 
individual rather than on biological variation between individuals. Steel et al. 
(63) adopted this approach and reported 'requirements for analytical perfor-
mance'. Campbell and Owen (64) reported 'acceptable analytical limits' in view 
of a number of clinicians. Barnett (65) proposed 'medically significant values' 
derived from opinions of clinicians and laboratory specialists. Later Gilbert 
(66) derived 'analytical goals' from Barnett's data, which best approximated 
the 'average medically significant changes in a patient', reported by Elion-
Gerritzen. (67) 
The International Federation of Clinical Chemistry (68) states to this issue: 
'Health requirements as determined by benefit to patients, clinical practice 
and cost to the community, must be taken into account, in order to avoid wrong 
management decisions which might result from reliance on intralaboratory 
criteria alone'. 
In view of the ever increasing costs in clinical chemistry, indeed cost-
benifit analyses will have to be considered when precision requirements for 
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clinical chemistry measurement processes are to be established. 
Up to now cost-bemfit analysis have had little attention in clinical chemistry 
literature. Apparently Lindberg et al. (69) were one of the first to discuss 
this aspect. They used a mathematical model to study the effect of lack of 
precision in measurements upon the diagnostic process, and the influence upon 
these two of importance of diagnosis and prevalence of disease in view of costs 
to society. 
If the medical profession were also able to agree on which criteria their 
medical decisions are based, which presently certainly is not the case (70, 
71, 72), the present confusion around the issue of which precision criteria 
are needed for clinical chemistry measurement processes would be less confusing 
and could be more systematically approached. 
1.4 Objectives and design of the investigation 
The mtralaboratory quality control systems used m clinical chemistry today, 
start from the assumption of the independency of successive quality control 
measurements representative of a sampled analytical process. 
The analytical processes that are used for the various clinical chemical 
determinations are considered to be time invariant, suggesting total un-
predictability of the process fluctuations in time. 
In this report the dynamics of analytical processes are of concern. It is 
investigated whether analytical processes are time invariant or time variant. 
Knowledge with regard to this aspect is important when considering that new 
potentials for mtralaboratory quality control could be in prospect if 
analytical processes were to be time variant. Application of industrial process 
control methods in clinical chemistry laboratories, based on the predictability 
of orocess fluctuations m time, could be pursued, wmch possibly could create 
new opportunities for improved use of chemical analysis results m medical 
practice. 
In the investigation 25 Dutch clinical chemistry laboratories participated. 
The data and information for the investigation, that were acquired from each 
participant, concerned the routinely generated mtralaboratory quality control 
data pertaining to the serum calcium and urea determination in 1974 - 1975, 
and a detailed description of the mtralaboratory quality control programs that 
were used in each of the laboratories at that time. 
In the course of this study investigating quality control in clinical chemistry 
and dynamics of analytical processes, the following subjects were dealt with, 
12 
and are discussed in this report: 
- Chapter 2. 
The state of the art of intralaboratory quality control and related aspects in 
a group of Dutch clinical chemistry laboratories in 1974 - 1975. 
- Chapter 3. 
Autocorrelation analysis of time series consisting of quality control obser-
vations, which time series are considered to be representative of a sampled 
analytical process. 
Encountered practical problems, inherent to the design of the investigation, 
hampering the direct application of the autocorrelation technique are dealt 
with, and solutions are given to overcome these. 
A relationship between the analysis of variance technique, which already is 
used for intralaboratory quality control purpose in clinical chemistry, and the 
autocorrelation technique in time series analysis of first order stationary 
stochastic processes is derived. 
- Chapter 4. 
The dynamics of analytical processes. After defining the analytical process it 
is investigated whether analytical processes are time invariant or time variant. 
Results pertaining to analytical processes that were used for the serum calcium 
and urea determination are shown and discussed. 
- Chapter 5. 
Based on the time variant behaviour of analytical processes a dynamic system of 
process deviation control could be in prospect. Here, first incentives are given. 
- Chapter 6. 
Presentation of an external quality control program to evaluate accuracy and 
precision of clinical chemical determinations. 
This program has in the mean time been adopted by the Foundation on Quality 
Control in Clinical Chemistry Hospitallaboratones (Sec. 1.5) and several trials 
have been organized. 
Motives accounting for the design of the investigation. 
The calcium and urea determination were selected in view of the results and 
data of the external quality control program of the Foundation which indicated 
for calcium a good mutual agreement between the laboratories whereas for urea 
this was less satisfactory. Secondly this choise allowed to consider analytical 
processes involving a non enzymatic (calcium and urea) respectively an enzymatic 
chemical reaction step (urea), as well as manual, semi-automated and automated 
methods of analysis. The investigation restricted to two serum constituents to 
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prevent it from becoming too large. Moreover measurement of these constituents 
may be considered sufficient representative for the entire clinical chemistry 
area. 
For the investigation intralaboratory quality control data that had already 
been routinely generated in each of the laboratories were used. This was done 
for the following reasons. 
a a data base covering a large time period could be created in a relative 
short time. 
b the investigation could start at short notice. 
с the data would not be affected by any 'special attention'. 
d in this way insight in some of the daily problems which possibly could 
hamper the introduction of techniques and theories presented m this report, 
could be obtained and solutions to overcome and/or prevent these could be 
given or looked for. 
e the participants were not exposed to too great a workload, time investment 
and possible expense. 
The motives why several clinical chemical laboratories were asked to participate 
in the investigation were. 
a the fact that m this way various analytical processes would be involved 
in the study ranging from manual, semi-automated and automated determination 
methods in both small and larger laboratories. 
b the reason stated earlier under d. 
c: the consideration that a specific laboratory organization and surrounding 
affects the possibilities or impossibilities of the techniques and theories 
dealt with in this investigation. 
d the circumstance that we wished to verify the state of the art of intra­
laboratory quality control and related aspects in the Netherlands. 
The disadvanges of this design were that not all submitted data were suited for 
autocorrelation analysis, a lot of administrational work had to be done, a 
coding concept for the data had to be develloped in order to be able to identify 
each quality control result as a unique i^em pertaining to a certain quality 
control serum preparation in time, and the fact that a questionnaire had to be 
designed to obtain the necessary information from each participant, whereby it 
was impossible to design it in such a way that it could be processed on a 
computer. 
The investigation was organised in co-operation with the Foundation on Quality 
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Control in Clinical Chemistry Hospitallaboratories. (Stichting Kwaliteitsbewa-
king in Klinisch Chemische Ziekenhuislaboratona) . 
In the following some background information about this Foundation is given. 
1.5 Organization of cooperating clinical chemistry laboratories in the Nether-
lands 
In the Netherlands no legal regulations do exist for intralaboratory or inter-
laboratory quality control. 
In 1959 (9) the Dutch Institute of Public Health (Rijksinstituut voor de Volks-
gezondheid) started its activities on quality control in clinical chomibtry. 
These activities of the governmental institute in this field ceased some 10 
years ago and the Dutch Society for Clinical Chemistry (Mederlandse Vereniging 
voor Klinische Chemie) took over the initiative. 
To promote the activities on quality control, the Dutch Society for Clinical 
Chemistry raised a foundation, the Foundation for Quality Control of Clinical 
Chemistry Hospitallaboratories (Stichting Kwaliteitsbewaking Klinisch Chemische 
Ziekenhuislaboratona) . 
The participating laboratories, approximately 200, are mainly hospital labora-
tories,- approximately 10 are non hospital laboratories. Participation is on a 
voluntary base. 
The anonymity of the participants is guaranteed by the foundation. Only the 
organizer of the surveys is acquainted with the results of each participant. 
The organization distributes 6 times a year 2 lyophilized control sera samples 
to the participants. Commercially available sera of different firms are used, 
and include human as well as bovine and horse sera preparations. 
Presently 24 components are included in the surveys. 
The samples contain different analyte concentrations and are to be considered 
as routine samples, and should not receive special attention. 
The results must be reported on special forms and returned within 2 week^. 
Results of the statistical analysis are returned to the participants within 
two weeks. Each survey is concluded with a (regional) meeting of the partici-
pants on which the results are evaluated and discussed. 
The scheme is financed by the participating laboratories by a registration -
and contribution fee. 
For the present investigation 26 laboratories, all member of the foundation 
were approached. 
25 laboratories agreed to cooperate and supplied the data and information for 
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the btudy investigating quality control in clinical chemistry and dynamics of 
analytical processes. 
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Chapter 2 
INVENTORY INQUIRY 
2.1 Introduction 
To get the necessary information a questionnaire was set up and distributed 
among the participants concerning the analytical methods that were used for 
the serum calcium and urea determination and the installed intralaboratory 
quality control systems. Apart from information concerning these aspects for 
each participant, in this way also the whole group could be considered. The 
findings pertaining to the various intralaboratory quality control systems 
and related aspects, consequently indicate the state of the art on quality 
control in a group of clinical chemistry laboratories in the Netherlands in 
1974 - 1975. 
Along with the questionnaires, one concerning calcium, the other urea, a 
detailled description of what information should be filled m , was given to 
each participant. 
To be able to place the relevance of the questions, a summary of the objectives 
of the investigation and of the theoretical background of autocorrelation 
analysis and measurability and controllability rules, which had previously 
been presented during a meeting of all participants, was included. 
The data for the investigation concerned the routinely generated intralabora­
tory serum calcium and urea quality control data in 1974 - 1975. To facilitate 
the data-acquisition, the participants were given a 'code-book'. Thus each 
quality control result could be characterized as a unique item. 
In the following, the questionnaire, code-book and the results derived from 
the questionnaires are dealt with and discussed. 
2.1.1. Questionnaire 
AnalyfLoal procedure 
1. On which literature referenee(o), is the enptenjed саліуіггаі procedure base'? 
!'. Accor^Lrvj to which laboratory manual are the patient anc, quality control 
specimens analyzed? 
o. lirm, model, type and year of assernhlinj of the various apparatus глзеіі in 
the ar^aLytical procedure 
4. Vfliich reagents were used, and from which firmisi were these purchased? 
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Calibration standards 
5. Aqueous and/or protein containing solutionis)? 
6. rou) are these prepared? 
7. What are the concentration levels of either calcium or urea? 
8. hau are these stored, prior to use? 
Control sera 
9. ¡•fhirih control sera were used? 
10. During which pein-odis) were these control sera employed to surveil the 
ana ly ti cal pe rformance ? 
11. Were these control sera, commercial control sera, or were bhey prepared 
within the laboratory? 
12. If prepared within the laboratory, how was this done? 
13. If it were commercial control sera, please state: 
a) origin i.e. human, horse or bovine pooled serum 
b) firm 
c) batchnumber 
14. Codenumber you assigned to the various control sera for the present 
investigation. (Section 2.1.2) 
lb. For each control serum, please state: 
a) the assay values for calcium respectively urea i.e. x, the mean analyte 
concentration and standard deviation s, with which χ was established, 
for both components. 
b) Were χ and s determined within the laboratory (denote with E) or were 
the assay values of the firm who supplied the control serum preparation 
(denote with Γ)? 
c) If determined within the laboratory i.e. E, haw were χ and s established 
for the vaious control serum constituents? 
If this is a standard procedure in the laboratory, followed for all 
control serum preparations, please state so. 
d) Were χ and s consequently used for setting target values, warding and 
action limits in the control charts? 
Analytical run 
Definition according to the International Federation of Clinical Chemistry 
(IFCC) of run i.e. 'a set of consecutive assays performed without interruption' 
and for which 'the results are usually calculated from the same set of 
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calibration readings'. 
Whenever within such an analytical run, groups of patient and quality control 
sera samples, some times proceeded by additional calibration standard(s) can be 
distinghuished, these will be referred to as analysis series. 
16. How папу patient and quality control specimens are usually contained in an 
analysis series? 
17. What is the composition of an analytical run? 
Denote analysis series by brackets with subscript η i.e. ( ) . 
Example 
5 different calibration standards - 5 patient specimens - ( 1 calibration 
standard - 2 different quality control specimens - 10 patient specimens ) 
18. How many replicate determinations are performed per calibration standard, 
quality control and patient specimen? 
19. The average time required to analyze: 
a) one patient or quality control specimen 
b) one complete analysis serieSj including the time delay introduced by 
inserting aqueous solutions in the series in order prevent 'carry-over1 
or for intermediate base-line corrections in continuous flew analysis. 
c) The total daily number of determinations performed for the specific 
bloodserum component, calcium or urea, excluding cito determinations. 
Intralaboratory quality control 
20. W-iich intralaboratory quality control systems based on the use of quality 
control specimens are currently incorporated in the laboratory? 
21. If, in any way, the routinely generated patient data, are used for quality 
control purpose, please state haw. 
22. When are controlling/intervening actions performed i.e. which criteria 
govern these actions? 
23. At which Lime are these actions performed. As soon as the result becomes 
available or are quality control data accumulated during ihe day and are 
intervening actions thereafter performed? 
24. If the analytical procedure is out of control, what is done with the 
obtained results for the analyzed patient specimens? 
Reporting System 
25. Are all quality control data documented, as well large deviations i.e. 
outliers, as well as the data obtained after an intervention has been 
21 
performed or only the lat top? 
УС. 'лЪіак о/ these data vere вЛті! Led d0? the preseni. insesti^.atior'. 
H?. I]' the analytical procedure or the intra laboratory quality control system 
was modified during the реггои 1974 - U97U, please state these 
modifications here. 
28. J look foruard to receive any additional information which could be of 
relevance for the presenz investigation. 
2.1.2 Data coding 
In order to characterLze each quality control result as a unique item, 
following descriptors were used: 
1) day number 
2) serial number 
3) control serum number 
4) nummencal value of the analysis result of the control specimen 
Apart from that, also the number of patient and quality control specimens 
analyzed each day was registered. 
In the following the coding concept is dealt with in detail. 
To facilitate the use of this concept, an example (A) is given at the end of 
the description. 
Points requiring special attention, dealt with in the text, are included in 
this example. They are referred to in the text as A:l, A:2, etc., to indicate 
where these points can be found in the example. 
Day nvribcr 
Per definiliof' nonday January the seventh 19/4 is assigned day vwiber 0001. 
All days thereafter are numbered consecutively till 0 ¡64 ( = January 5lh, 197b) 
Monday January the sixth 19/5 again is assigned day number 0001 and so forth. 
Serial number 
The analysis series (defined in 2.1.1), seqaentially analyzed each day in a 
laboratory, arc numbered consecvtioely. To thai purpose these analysis series 
are given a serial number beginning each day with 01 till k, with к indicating 
the number of analjalr scries deal ζ with on thai day. 
Control serum number 
'ihis number is needed to be able to identify each of the quality contro! sere, 
used for the suroeillancc of the analytical proce Jure i.e. calcium or urea. 
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Γον Lhat purpose to each o? these seva a control serum number is adjudged 
between 01-99, which can be chosen freely. 
¡Ivnerical value of analysis result 
Here thr analysis re.ulv of a a ¡ality cortrol specimen specified accordiruj 
to day, serial and control seru/'i number, can be filled in. 
These values are to be reported in the number of decimals they are ¿eriercted 
by the laboratory. 
Nurbev of analyzed specimens 
here the number of patient and quality control specimens analyzed each day is 
to be filled in. 
This value is filled in once a day along with the first generated quality 
control result. 
Additional information 
- Whenever, within an analysis series, several quality control specimens are 
placed, also several lines in the coding concept are to be filled in. 
Ihereby the results are to be listed consecutively in the sequence they were 
analysed, together with day, serial and appropriate control serur" number. (A:l) 
- The n'Mnbeving of the analysis series is independent of the fact if the series 
contained a control specimen or not. This number however is registered only 
when the particular series contains a control specimen. (A:2) 
- In the situation where on a day only patient specimens were analyzed and no 
quality control specimens at all, only day number and number of analyzed 
specimens need to be filled in. (A:3) 
Tiie number of analyzed patient and control specimens else is always denoted 
along with the first generated quality control result that day. (A:/!) 
- If on any occasion no analyses are performed (for example Saturday s/Sundays), 
no lines have to be written. (Л:5) 
The first day thereafter on which analyses were performed, after a weekend 
for ехаітріс, is assigned the appropriate day number in com aria on with the 
last day analyses had been performed, ir. this exemple mostly friday. (A:.) 
Examfile A 
January Gth, is the first monday in 1975 i.e. day nmber 0001. 
When for example data are supplied from January 16th 1975 i.e. day mmber 0011, 
we could have following sequence, when in this laboratory 7 quality control-
sera, control serum numbers 01 - 07, had been used. 
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Important are the positions, the daza are wriibcn. 
Please keep to followiwj scheme. 
Positions 
1 -
5 -
7 -
9 -
(2)—{ 
(2)— 
(5)— 
m-{ 
(J)— 
(V— 
(Ä)— 
(5)—{ 
- 4 : 
- 6 : 
- 8 : 
- 13 : 
day 
number 
ООП 
ООП 
ООП 
ООП 
OOIP 
0012 
0012 
0012 
0015 
0015 
0015 
ООП 
OOIC 
0016 
0016 
0017 
0018 
0018 
0018 
0019 
0022 
002? 
day number 
serial niariber 
aon trol serum number 
nimerical value 
serial 
number 
01 
02 
0¿ 
04 
01 
03 
04 
06 
01 
02 
OZ 
01 
01 
02 
OZ 
01 
02 
03 
01 
04 
05 
(hereby a dot . is 
control serum 
mmber 
01 
01 
0? 
03 
01 
02 
02 
03 
04 
02 
01 
01 
01 
11 
07 
01 
02 
0? 
01 
02 
01 
a separate 
numerical 
vauue 
09.60 
09.50 
08.40 
08./0 
09.35 
08.40 
08.60 
08.95 
08.40 
Oo.CO 
09. С5 
09.65 
09.30 
08.60 
08.65 
09.55 
08.85 
08.65 
10.30 
08.80 
00.60 
position) 
mmber 
analyz * i 3d 
specimens 
040 
0,8 
037 
045 
015 
025 
027 
056 
-(4) 
-(4) 
-(4) 
-(4) 
-(4) 
-(4) 
-(4) 
-(4) 
2.1.3 Analytical methods 
In order to identify the different analytical methods used for the various 
bloodsera component determinations, the Dutch Foundation on Quality Control 
in Clinical Chemistry Hospitallaboratones introduced codes. These codes are 
based ori the chemical reaction principle and on the instrumental methodology 
(manual, continuous flow etc.) 
During the present investigation these codes were adopted. Tables 2.1.a and 
2.1.b summarize the principles of the analytical methods used for the serum 
calcium and urea determination and the corresponding codes. Laboratories 
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which had employed the specific analytical method are listed. To quarantee the 
anonimity of the participants, during the present investigation a separate 
laboratory code was introduced, which will be referred to, from now on. 
Furthermore Tables 2.1.a and 2.1.Ъ show the literature reference(s) and/or 
firm manuals according to which the determinations were performed. 
The laboratory manuals actually used in the daily routine work, were apart from 
minor modifications in some instances, in close agreement with the cited 
references and/or manuals. 
Table 2.1.a 
Analytical methods used for the serum calcium determination 
principle 
analytical 
method code laboratories 
references/manuals 
(quoted in questionnaires) 
manual 
complexometnc 
titration 
021 224 
automatic 
continuous flow system 
colorimetrie 
022 204 
208 
213 
216 
220 
221 
automatic 
complexometnc 
titration 
023 
atomic absorption 
spectroscopy 
024 
202 
203 
206 
207 
209 
211 
212 
215 
216 
219 
222 
225 
201 
205 
210 
217 
5, 6 
5, 6 
5, 7, 8 
5, 8 
5, 6, 7 
5, 6, 9 
5, 8 
5, 8 
7, 8 
7, 8 
6 
5, 8 
10, 11, 12 
10, 11, 12 
10, 11, 12 
10, 11, 12 
manual 
colorimetrie 
026 214 
223 
13 
14 
25 
Table 2.1.b 
Analytical methods used for the serum urea détermination 
principle 
analytical 
method 
code laboratories references/manuals 
(quoted in questionnaires) 
manual 
urease-phenol 
051 
automatic 
continuous flow system 
urease-phenol 
automatic 
continuous flow system 
diacetyl monoxim 
052 
053 
manual 
diacetyl monoxim 
automatic 
discrete 
urease-phenol 
055 
056 
202 
203 
205 
206* 
207 
210* 
215 
224 
225 
201 
212 
213 
214 
222 
204 
208 
209 
210* 
211 
216 
217 
218 
219 
220 
221 
223 
206 
15 
16, 
18 
19 
18 
18 
17 
18 
15, 
18 
15, 
22 
23 
18 
20, 
20, 
20, 
20, 
20, 
20, 
20, 
20, 
24, 
20, 
20, 
17 
17 
18 
21 
21 
21 
21 
21 
21 
21 
21 
25 
21 
21 
26, 27 
19 
"In the period 1974 - 1975, laboratory 206 switched from method 051 to method 
056, and laboratory 210 from method 051 to 053. 
2.2 Number of calcium and urea determinations in patient sera 
The number of participants that responded on the question of calcium and urea 
analyses was too smal to draw conclusions. 
Nevertheless Table 2.2 gives some impression of the workload in 4 laboratories 
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as for as these determinations are concerned. To be able to compare the data 
of 1974 with those of 1975, both within the same laboratory as between 
different laboratories, the average number of daily performed calcium and urea 
determinations in patient sera is coraputed. This was necessary because not all 
data covered a whole year. 
The weekends were omitted from the computations since in most laboratories 
not any or in the ultimate case only a minor number of determinations were 
performed. Also, only those laboratories are contained which were able to 
retrieve the necessary data for both determinations and both years. 
Table 2.2 
Average number of daily performed calcium and urea determinations in patient 
sera. 
Calcium 
laboratory 
202 
212 
220 
224 
Σ 
1974 
15 
8 
63 
6 
92 
1975 
19 
8 
70 
6 
103 
Σ 
34 
16 
133 
12 
195 
Urea 
202 
212 
220 
224 
Σ 
18 
37 
63 
8 
126 
20 
39 
70 
8 
137 
38 
76 
133 
16 
263 
Table 2.2 indicates that there is a tendency towards an increasing number of 
determinations. For all 4 laboratories the number of serum calcium 
determinations increased =? 121 and the urea determinations =r 9 . Altogether 
the number of determinations increased ~ 11°. 
From Table 2.2 also follows that the number of serum urea determinations 
exceeds those of calcium at approximately 35%. 
The distribution of the averacc number of serum calcium and urea determinations 
on the various days of the week, in 1974 and 1975, in the laboratories 
considered in Table 2.1, is visualized in Fig. 2.1.a and 2.1.b. Here the length 
of a bar indicates the average number of determinations on the specific day 
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9 ^ ^ _ ^ ^ _ ^ _ ^ _ ^ ^ ^ ^ ^ ^ ^ ^ ^ _ ^ _ _ ^ ^ ^ ^ ^ ^ ^ _ ^ ^ ^ ^ ^ ^ ^ _ ^ _ _ _ l a b o r a t o r y 212 
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6 Ц 
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laboratory 224 
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Fig. 2.1.a Distribution of the average number of daily performed serum calcium 
determinations on the various days of the week i.e. monday, tuesday, 
Wednesday, thursday, fnday. 
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laboratory 202 
1974 
1975 
laboratory 212 
1У74 
197 
laboratory 220 
1"74 
1^75 
laboratory 224 
1974 
197^ 
Fig. 2.1.b Distribution of the average number of daily performed serum urea 
determinations on the various days of the week i.e. monday, tuesday, 
Wednesday, thursday, fnday. 
29 
(i.e. from the top downwards, the repeating sequence monday, ...., fnday) . 
This number also is explicitely mentioned at the beginning of the bar. 
From Fig. 2.1.a and Fig. 2.1.b it follows that the workload is rather constant 
from day to day. This pattern was characteristic for the other laboratories 
which were considered but which are not contained in the figures. 
2.3 Control sera 
Various subjects related to the use of control serum préparations for intra-
laboratory quality control purpose are investigated; 
1) the origin of the control sera i.e. pooled human, horse or bovine sera, 
2) the source of the control sera i.e. purchased or prepared in the laboratory 
from pooled sera, 
3) the procedures according to which target values for control serum constitu-
ents are established, 
4) the number of control serum specimens in a series of patient specimens. 
2.3.1 Source, origin and procedures for establishing target values 
A summary of the control serum preparations which were used for intralaboratory 
quality control purpose in 1974 - 1975 by the participants, is shown in 
Table 2.3. Here the source and origin of the control sera are indicated 
together with the number of times a preparation with such specifications was 
used in a particular laboratory. 
3 procedures were used for establishment of target values: 
a) the laboratory itself established target values (WL) 
b) target values set by a laboratory were first compared with those of other 
laboratories (WI/CD 
c) target values established by the suppliers of the control sera were 
used (Γ) 
From Table 2.3 following observations can be made: 
- 60 out of 96 employed control serum preparations (=62.5%) were 'commercial1 
(=C) and 36 (=37.5%) were 'non commercial'. (=//6') 
- 351 of the 'commercial' control sera were prepared from pooled human sera 
(=№) , 43°.. from pooled horse (=rO) and 22% from pooled bovine sera (=B0) . 
- 72% of the 'non commercial' sera were of human, 6% of horse and 22% of 
bovine origin. 
A comparison of 'commercial' and 'non commercial' sera learns that the latter 
are prepared mainly from human sera (=72%) and for 28% from pooled horse or 
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Table 2.3. Characteristics of employed control serum preparations 
control sera specifications 
laboratory 
NC 
origin 
HU HO BO 
source where target 
values for constituents 
arc established 
WL WL/CL 
number of times 
a control serum 
with these 
characteristics 
was used 
201 
202 
203 
204 
205 
206 
208 
20'J 
210 
211 
212 
213 
214 
215 
216 
217 
218 
219 
220 
221 
222 
223 
224 
225 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
Abbrevations used: 
С : commercial 
NC: non commercial 
HU: human 
HO: horse 
BO: bovine 
F : firm 
WL: within the 
own laboratory 
WL/GL: within the own laboratory 
after comparison of the own 
results with those of other 
laboratories 
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bovine sera. The distribution for the 'commercial' sera is the inverse i.e. 
65% is prepared from pooled horse or bovine sera and 75% is of human origin. 
- Looking at all 96 used control serum preparations both 'commercial' and 'non 
commercial', it is seen that 49% is of human and 51% of bovine or horse 
origin. 
- 4 laboratories only used 'non commercial' sera. 14 laboratories relied 
strictly on 'commercial' sera. 
A factor which undoubtedly contributed to this observation is the fact that 
when the number of patient specimens analyzed in the laboratory is limited, 
the preparation of control sera from pooled human sera in that laboratory 
is hampered. 6 laboratories take intermediate positions and use both 
'commercial' and 'non commercial' sera. 
One of the advantages of pooling patient specimens and preparing a control 
serum from these sera, is that no additional expenses are involved. Besides 
that, the control specimens from such batches remain unaffected by 
reconstitution errors, by which errors the 'commercial' control specimens 
can be affected since these are generally supplied as lyophilized preparations 
which have to be reconstituted prior to use. 
- The mean values of the various control serum constituents which are used as 
target values for the control charts, are mainly established by the partici-
pants themselves. 
In 2 laboratories the firm specifications are adopted. 
In 6 laboratories the firm specifications are adopted when these are confirmed 
by the own observations. When these observations are in conflict with the firm 
specifications, the latter are often rejected. 
In 3 laboratories the target values for the control serum constituents are 
established in co-operation with other laboratories. 
The impact on the performance of an intralaboratory quality control system 
of these observations is different. 
Strictly relying on observations of the own laboratory has two disadvantages. 
In the first place a possible systematic method error may be overlooked and 
secondly the target values are established from a rather limited number of 
observations. 
In absence of definitive analytical methods (28) for the determination of 
most blood serum components, the first disadvantage can partially be overcome 
when the target values for control serum constituents are established in 
cooperation with other laboratories. Then comparison of the own results with 
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those of the group offers the possibility to verify a possible systematic 
error of the own analytical method. 
However this is only meamngfull when a large number of observations is 
involved when target values for serum constituents are computed from such 
a survey. When this is not the case, ontlying observations or a bad 
performance of one of the participants may have a large negative effect on 
the computed overall mean values for the various constituents. 
Similar considerations hold for the situation where own laboratory results 
are compared with firm specifications for 'commercial' sera. 
Table 2.4 summarizes the procedures according to which target values for control 
serum constituents are established. The procedures listed are those the parti­
cipants described in the questionnaires. Whenever the procedures for uroa and 
calcium differed, this is indicated. In general however, for both these 
constituents the same procedure is used. 
From Table 2.4 follows that on first sight the procedures are quite similar 
i.e. one or more analyzed control specimens per day during a certain time 
period, whereby each specimen is analyzed one single time or in duplicate, 
from which results mean values of analyte concentrations (x) and standard 
deviations (s) are computed. 
The impact of the various procedures on the setting of target value (χ), 
warning (x ± 2.5s) and action limits (x ± 3.0s) in the average control charts, 
which all participants used as part of their intralaboratory quality control 
system, could be different. 
For example when several control specimens are daily analyzed, an appropriately 
designed analysis of variance scheme offers the possibility to obtain estimates 
of the within-day and between-day variability. Using the withm-day variance 
estmate for the setting of warning and action limits in the average control 
charts, consequently could lead to narrower limits, when there is a significant 
between-day variability. The possibility of detecting an out of control 
situation of the analytical procedure would increase. However no participant 
makes use of this possibility. 
Analyzing a control specimen in duplicate each day during a certain time period 
and consequently computing χ and s from the daily computed mean values leads 
to a standard deviation estimate which is a factor /2 smaller in comparison 
with the one that would have been obtained when the control specimens had been 
analyzed one single time. 
An advantages of duplicate analyses is that partially the variability due to 
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Table 2.4 
Procedures according to which target value, warning and action limits in the 
average control charts for the control serum constituents, calcium and urea, 
are established. 
lahora-
Lurv 
POI 
204 
¿li 
2 l ì 
¿ld 
21 ; 
г uiiijer of d a i l y 
rtndlyzod c o n t r o l 
•specimens 
irKjle d u p l i c a t e 
time per iod 
during winch 
the ano І у и ь 
a r e perf-orrreù 
(day,) 
addiLiondl intornatiob 
205 
20b 
¿OO 
209 
1 
1 
¿ 
1 
¿l'J sûvcrdL 
?Л) several 
221 1 
221 
¿0 
20 
30 
40 
10 
Π 
JO 
20 
10 
10 
10 
5 
20 
¿0 
ry іс it со mont ily dfLer ^І-ісЬ *^ and are 
acl-justed if considered пссрььагу. 
. is fir^t compared v^ ith Die rc^ultb of 
other la bord tones, after v^nach the vJiolr 
procedure іь repoatcd hor another month. 
Tlirn the target values arc ebtaJilished. 
After 40 days the procrdure is repeated. 
From dll re ,ultb, the final target аіиеь 
aie (.sLiblibhcfl. 
Tor urea tJie апаіуьеь art ±n dujilicate. 
Before Ine target value i^ r"tdLlibhf-d, 
the own results are first compared with 
the results other laboratories obtdined 
on analyzing the marrie '-oiotitje t in tf e 
control ^erum. 
This ι s repeated for another month. 
From the monthly obta ined r e s u l t s the 
f i na 1 ta rqe t va lue i s е^ t a b i ι ьііесі, 
when the monthly obta ined mean value-, 
ai e α,,ιμί oximatel > cqu« I 
t o r c a l c i ш the "ridi ses a r e in d u p l i c a t e . 
For calcium tlie ana lyses ari m d u p l i c a t e 
The mean value.-· c a l c u l a t e d m tlic l a b o r a t o ­
ry i s compdred with tue firm s p e c i f i c a t i o n 
for t h a t p a r t i c u l a r c o n t r o l serum 
c o n s t i t u e n t Wnen botri aro in сіочс 
agrcLiiient, the f ι mi s j^ci F icat ion i s 
adopted When both a r e m c o n f l i c t tlif 
firm speci I i c a t i o n i s disfjardea and a new 
s e t of c o n t r o l speciTiiLns i s analyzed from 
which the t a r g e t value i s c a l c u l a t e d . 
After compiri '.on of the u\ ^ r e s u l t s with 
those obta ined in l'i o l h e r l a b o r a t o r i e s , 
which a l l used the same a n a l y t i c a l proce­
dure for tne *erum calcium d e t c r m i i a t i o n , 
the f i n a l t a r g e t value i s computed from 
a l l r e s u l t , . For urea the sdme procedure 
ι
ι
 followed only here dailv. r)-(> coi i trol 
sjiecimenb a r e analyzed one ^ i r g l e time 
After 40 days thi 1 " uroeednrt i_ n-pe iteti 
From a l l r e s u l t s IT агю к a r e c i l c u l a t e d . 
S imi lar hold ' for urea where the cont ro l 
specimens a r e annlvzod one « m g l e time 
F i r s t o u t l y i n g o b s e r v a t i o n s a ie omitted 
This p r o c e d a l e ι > ie t>e-itcd and a
+ t ( r - 0 
dav- the l i n a i tarciot valw i s o<-1 » h l i ' h ' d . 
Laboratory 
210 
211 
215 
errors by which the control serum itself is affected, is reduced. 
Some of the described procedures in Table 2.4 show lack of detail, for 
example: 
It is not stated how the results are compared and what the 
consequences of such a comparison are. 
The interpretation of 'approximately equal' is not further described 
When the own value confirms the specification of the firm, the 
latter is adopted, 'confirm' is not further described. 
In the situation where both specifications are in conflict, the 
firm specification is rejected and a new set of control specimens 
is analyzed to establish the target value for the specific 
constituent. This is not a very consequent approach. 
From Table 2.4 it is seen that only in laboratory 219 strongly deviating 
observations (outliers) are removed before a target value is established. 
In non of the other laboratories this seems to be doneÍ 
How these outliers are detected however was not further described. 
2.3.2 Frequency of implementation in a series of patient soecimens 
After the target values for the various control serum constituents have been 
established, the control serum is used for the daily surveillance of the 
analytical performance in a laboratory. In the following the number of control 
serum specimens that are placed in a series of patient specimens is of concern. 
Also the time lag during which a quality control result is considered to supply 
enough information about the performance of the analytical procedure to be 
able to prevent the analytical procedure to run out of control, is dealt with. 
In Table 2.5 the results pertaining to the laboratories which were able to 
supply the necessary information and data, are summarized. 
From Table 2.5 it follows that approximately \r>% of the activ analysis capacity 
of the laboraties for both listed determinations is used for the analysis of 
control serum specimens. (Column 5) 
Assuming that the control specimens are regularly spread over the analytical 
run, this means that in general one control specimen is used for the 
surveillance of the analytical procedure during the analysis of approximately 
5-6 patient specimens. 
35 
Table 2.5. 
Frequency of control sera specimen implementation in a series of patient 
specimens. 
results 
pertaining 
to 
calcium 
1974 
calcium 
1975 
urea 
1974 
urea 
1975 
laboratory 
202* 
203 
212 
216° 
220 
224 
202V 
203 
205 
211 
212 
213 
215 
216' 
220 
224 
202 
212 
216° 
220 
224 
202 
211 
212 
216 T 
220 
224 
average 
number 
of daily 
analyzed 
patient 
specimens 
(3) 
15 
6 
8 
59 
63 
6 
19 
5 
3 
3 
8 
15 
8 
195 
71 
6 
18 
37 
59 
63 
8 
20 
20 
39 
195 
71 
8 
average 
number 
of daily 
analyzed 
control 
specimens 
(4) 
2 
1 
1 
6 
7 
2 
2 
2 
1 
2 
1 
3 
1 
23 
8 
2 
2 
2 
6 
6 
2 
2 
4 
3 
23 
8 
2 
(4) 
(3) + (4) 
(%) 
12 
14 
11 
9 
10 
25 
10 
29 
25 
40 
11 
17 
11 
11 
10 
25 
10 
5 
9 
9 
20 
9 
17 
7 
11 
10 
20 
* Calcium titrator, M a n u s Utrecht 
V Corning Calcium Analyzer model 940, Laméris Utrecht 
0 SMA 12/60, Techmcon 
Τ SMAC, Techmcon 
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For the listed laboratories this implied that approximately every 1 5 - 3 0 
minutes a control specimen was analyzed. 
However as will be seen in section 2.5 (Table 2.7.a), not always are the control 
specimens regularly spread over the analytical run. Repeating the computations 
after having omitted these laboratories (for calcium, laboratories 211, 213, 
214, and for urea 202, 211, 212, 224) however has no influence on foregoing 
conclusions. 
2.4 Calibration standards 
Calibration standards are used in an analytical process to assign numerical 
values to specimens by relating the readings or analytical responses obtained, 
to the concentration or other quantities present. (29) 
The International Federation of Clinical Chemistry (IFCC) states that primary 
calibration standards i.e. those prepared from pure solute and pure solvent 
with concentration values established by preparation, have significant 
operational advantages over those materials whose values must be established 
by analysis (i.e. secondary calibration standards), and they should be used 
wherever possible. (29) 
The uncertainty level of primary calibration standards is only that associated 
with the operation of weighing and volume measurement and the limitation of 
purity evaluation. With secondary calibration standards, the uncertainty level 
is larger than that of primary calibration standards, as it depends on the 
precision and accuracy of the method used to establish the value. (29) 
A summary of the calibration standards that were used in the laboratories is 
shown in Table 2.6. 
From Table 2.6 following observations can be made: 
- In all but 5 laboratories for calcium and 7 for urea, where secondary protein 
containing calibration standards were used, primary aqueous calibration 
standards were used for calibrating purposes 
- For calcium 20 laboratories establish the calibration curve from only 
1 calibration standard next to the blank which both for the serum calcium 
and urea determination always formed a point of reference. 
For urea this procedure is followed in 10 laboratories. 
- Two or more calibration standards are used in 5 laboratories for calcium and 
15 laboratories for urea. 
- In general the calibration curve for urea is established from more calibration 
standards than for calcium. The only exceptions are laboratories 201 and 217. 
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Table 2.6 
Calibration Standards 
labora-
tory 
201 
202 
203 
204 
205 
206 
207 
208 
209 
210 
211 
212 
213 
214 
215 
216 
217 
218 
219 
220 
221 
222 
223 
224 
225 
number of calibration standards used for establishing the 
calibration curve and approximate calcium respectively urea 
concentration levels in mmol/l 
calcium urea 
1.0 - 1.5 - 2.0 - 2.5 - 3.0 2.5 - 5.0 - 7.5 - 10.0 
2.5 8.4 
2.5 8.0 - 16.0 
2.5 10.0 - 20.0 
2.5 - 5.0 5.0 - 10.0 
2.5 10.0 - 20.0 - 30.0 
2.5 10.0 
Techmcon reference serum Techmcon reference serum 
2.5 3.0 - 6.0 - 9.0 - 12.0 - 16.0 - 25.0 
2.5 5.0 - 10.0 
2.5 5.0 - 10.0 - 20.0 
2.5 5.0 - 10.0 - 15.0 - 20.0 
0.5 - 1.0 - 2.0 - 3.0 - 4.0 2.0 - 4.0 - 6.0 - 8.0 - 10.0 - 12.0 
2.5 3.0 - 6.0 - 9.0 - 12.0 - 15.0 
Welcome II (assayed serum) Welcome II (assayed serum) 
Techmcon reference serum Techmcon reference serum 
1.25 - 2.50 - 3.75 Techmcon reference serum (23.0) 
2.5 3.0 - 5.0 - 7.0 - 10.0 - 15.0 - 20.0 
2.5 1.5 - 4.5 - 7.5 - 10.5 - 13.5 - 15.0 
Techmcon reference serum Techmcon reference serum 
'Home made' poolserum 'Home made' poolserum 
2.5 - 3.0 2 Momtrol sera (5.0 - 12.0) 
2.5 10.0 
2.5 8.4 
2.5 5.0 - 10.0 - 15.0 
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- Technicon reference sera are used for calibrating purposes in 3 laboratories 
for the serum calcium determination and in 4 laboratories for urea. 
The name 'reference' serum implies that analyte concentrations have been 
assigned reference method values, which are defined as (28): 'The best 
available estimates of the true values i.e. the most probable values ia'ived 
from a set с f results obtained by most reliable reference methods available'. 
Being a secundary calibration standard, the name 'reference serum' is somewhat 
ambiguous as may be doubted whether these sera are analyzed with reference 
methodology. The use of primary calibration standards is however always to 
be preferred. (29) 
- 3 laboratories of which 222 only for urea, use control serum preparations for 
calibrating purposes. This is not correct since the function of a quality 
control serum preparation is quite different from that of a calibration 
standard. (28) 
From these observations it follows that discrepancies between the participants 
concerning the calibration of analytical methods, exist. These differences 
concern both the source, origin and number of used calibration standards 
as well as the range of the concentration levels of the calcium respectively 
urea component. 
The laboratories where only 1 calibration standard result next to the blank 
is used, are more quickly subject and more sensitive to errors in comparison 
with the laboratories where several calibration standards covering a wide 
concentration range, are used for establishing the same calibration curve. 
2.5. Composition of analytical runs 
In the following the place of calibration standards, quality control and 
patient specimens in an analytical run is of concern. The term 'analytical run' 
adopted here, is consistent with the IFCC definition (28), given in section 
2.1.1. 
In Table 2.7.a the composition of the various analytical runs for the serum 
calcium and urea determination in the laboratories participating in the present 
investigation in 1974/1975, is shown. 
The abbrevations used are: 
BD : blank 
Ξ : calibration standard 
С : quality control specimen 
Ρ : patient specimen 
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If not stated otherwise the determinations are performed once. The subscripts 
d, t or χ· indicate that determinations are performed respectively in duplicate, 
triplicate or nore replicates i.e. Sd, St, or Sr and Cd, Fd etc. A number is 
added to the symbols S and С to be able to verify if several different cali­
bration standards or quality control specimens with varying concentration 
levels of the constituents were used or not i.e. Sl,S2,Cl,C2 etc. The sequence 
Siti, S2d, S3d consequently indicates that 3 different calibration standards are 
used, each of which is analyzed in duplicate. The number preceeding symbol Ρ 
indicates the approximate number of analyzed patient specimens i.e. 10F, 20V etc. 
Analysis series (dealt with in Sec. 2.1.1) are indicated in the analytical run 
by brackets with subscript n, to illustrate the repeating character of such a 
sequence. 
The blank (BD), although used in all laboratories, in the description of the 
analytical run in the questionnaires by only few participants. 
From Table 2.7.a following observations can be made. 
Generally all analytical runs begin with the sequence 'calibration standardis) -
control specimens - patient specimens'. 
The composition of the analysis series in the various analytical runs differs. 
Laboratories 206, 208, 217, 219, and 221 for the calcium determination, and 
206, 208, 211, 212, 217, and 221 for urea, have analysis series composed of 
'calibration standard(s) - patient specimens'. 
Of these laboratories only 217 and 221 for both determinations and 211 for 
urea place random i.e. not m every analysis series, one or more control 
specimens between the patient specimens. In the other laboratories, the 
analysis series do not contain any control specimen at all. 
Laboratories 201, 202, 204, 215, 216, 218, 220 and 225 for the calcium 
determination, and 201, 204, 213, 215, 216, 220, 222 and 223 for urea, have 
analysis series with a repeating sequence 'calibration standard(s) - control 
specimens - ра гепі specimens'. 
Laboratories 210 and 216 for the calcium determination and 205, 210, 216 and 
219 for urea, have analysis series with composition 'conlrol siPcimcns — 
1
 alti η'. s' ccimens '. 
The composition of the analysis series within the analytical runs of course 
has impact on the possibilities and impossibilities of an intralaboratory 
quality control system to actually detect and control an 'out of control' 
situation in the analytical procedure. 
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Table 2.7.a 
Composition of analytical runs for the serum calcium and urea determination. 
labora- analytical run labora- analytical run 
tory (calcium) tory (urea) 
201 (Sld-S2d-S3d-S4d-SSd-Cld-llFd) 201* ( Slii-S2d-S3d-S4d-BD-6P-Cl-7P) 
η η 
202 (Sld-Cld-6Pá) 202 Slc¿-Cld-19P-C2¿ 
η 
203* ^.li'^A'^î 203 Slcí-S2d-Cld-14Pd-Cld 
Sld-Cld-6Pd 
204 (S1-C1-C2-32P-C1-C2) 204 ( S1-S2-C1-C2-14P-S1-(S2 or C2)-
C1-14P-S2-C2) 
Π 
205 S1-S2-C1-3P 205 S1-S2-(C1-10P) 
η 
206 Sld-Cld-lOPd-(Sld-lOPd) 206 Sl-S2-S3-Cld-7Pd-(Sl-VPd) 
η η 
207 Slr-Cld-12Pd 207 BDt-Slt-S2t-Clt-46Pd 
208 Sld-Cld-8P-(Sl-9P) 208 Sld-Cl-8P-(S1-9P) 
η η 
209* Sld-Cld-16Pd 209 S1-S2-S3-S4-S5-S6-C1-70P-S1-S2 
S3-S4-S5-S6 
210 Sld-4P-Cld-(8P-Cld) 210 Sld-S2d-4Pd-Cld-(8Pd-Cld) 
η η 
211 Sld-Cld-C2d-5Pd 211* Slt-S2d-S3d-Cld-(S1-BD-8P) -Cid 
η 
212 Sld-Cld-8Pd 212* Sl-S2-S3-S4-Sx-Cl-C2-C3-6P-
(SX-9P) -Sl-S2-S3-S4 
η 
213 Sld-S2d-S3d-S4d-S5d-BD-Cl-C2-C3- 213 Sld-S2d-S3d-S4d-S5d-S6d-Cl-C2 
15P-Sld-S2d-S3d-S4d-S5d C3-C4-C5-(BD-Sld-S2d-S3d-S4d-
S5d-S6d-BD-15P) 
η 
214 Sld-Cld-C2d-4Pd 214 S1-S2-S3-S4-S5-11P-C1-12P-C2 
215 (Sld-Cld-8Pd) 215 (Slt-Cld-22Pd) 
η η 
216* (Slí-Cl-12P-Cl)n , 
зи-(С1-10Р)
и
 SU-(Cl-lOP) 
217* Sld-S2d-S3d-6Pd-(S2d-6Pd) 217* (S1-8P) 
η η 
218 ( Sld-Cld-C2d-8Pd) 218 S1-S2-S3-S4-S5-S6-C1-C2-38P 
η 
219 Sl-Cl-C2-20P-(S1-20P) 219 S1-S2-S3-S4-S5-S6-2P-(C1-C2-
17P,„ 
220 ( Slr-Cld-20P) 220 ( Slr-Cld-20P) 
η η 
221* BD-Slt-16P-{ (BD-S1-18P)- 221* BD-SU-16P-{ (BD-S1-18P)-
(BDt-Sl-16P) } -Ci (BDt-Sl-16P)} -CI 
η η 
222* S1-S2-C1-C2-20P-20P 222 ( S1-2S2-C1-8P-S1-11P-S1-12P-
Sl-Cl)
n 
223 BD-Sld-Cld-c2d-7Pd 223 ( BD-Sld-Cld-9Pd) 
η 
224 Sld-Cld-6Pd-c2d 224 sld-Cld-12Pd-c2d 
225 (Sld-6P-Cl-Sl) 225 Sld-S2d-S3d-6Pd-Cld 
η 
: additional information in Table 2.7.b 
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Table 2.7.b 
Additional information about the laboratories marked (*) in Table 2.1.a. 
laboratory additional remarks 
201 One control specimen CI is placed at random between every 
13 patient specimens. 
203 Changed from apparatus i.e. Manus Calcium Titrator to 
Corning Calcium Analyzer. 
209 CI is placed random between the 16 patient specimens 
211 Apart from Cl, a second control specimen СУ is placed at 
random between the patient specimens by replacing one of the 
patient specimens by C2. 
212 ¡Jx is one of the calibration standards SI-CJ" which is 
repeatedly placed in the analytical run. 
Within one analytical run it is the same calibration 
standard each time. 
216 Changed from apparatus i.e. SMA 12/60 to S4AC. 
When the SMAC was installed the calibration procedure was 
repeated after every 48 analyzed specimens. 
217 Calcium 
Among the first 30 patient specimens at random 2 control 
specimens CI and C2 are placed. 
Urea 
Among the first 20 patient specimens at random 1 control 
specimen CI, is placed and among the first 40 patient 
specimens are always 2 control specimens i.e. CI and ul. 
221 Next to CI, sometimes a second control specimen C2 is placed 
between the patient specimens. 
222 The patient specimens are analyzed m duplicate i.e. patient 
specimens numbered 1 - 2 0 are first analyzed one single 
time each and are thereafter again analyzed in reverse 
order i.e. from number 2 0 - 1 . 
The combination 'calibration standard''s) - patient specimens ' in an analysis 
series allows to adjust periodically for drift. In absence of control specimens 
the events occurring in the analytical process however cannot be measured and 
henceforth intralaboratory variability cannot be controlled. 
With the sequence 'aalibration standaifd(s) - control specimens - patient 
speciretiS ', both features become possible. 
In absence of calibration standards in an anlysis series, the periodical 
adjustment of the analytical procedure for drift becomes impossible. 
A situation as seen in laboratory 209 must be rejected. Here for the urea 
determination, 1 control specimen is placed at the beginning of the analytical 
run. The analysis result of this specimen is supposed to supply enough 
information about the events occurring in the analytical process in order for 
controlling actions to be appropriate during the analysis of the subsequent 
series of approximately 70 patient specimens. 
Similar remarks hold for those laboratories where all the control specimens 
are placed one after the other at the beginning of an analytical run and 
subsequent analysis series. 
In order to get insight in the events occurring in the analytical process it 
would be better to regularly implement control specimens in a series of patient 
specimens. How to choose the intervals between the control specimens is 
discussed in chapter 5. 
From Table 2.7.a it can also be observed that the number of replicate 
determinations performed on each quality control and patient specimen varies 
from laboratory to laboratory. 
For example analyzing a quality control specimen in duplicate has the 
advantage that the between-vial variability of the control serum sanples is 
reduced, when the intralaboratory quality control system is based on the mean 
result of the 2 performed analyses. In howfar this really is an advantage for 
the ability of the quality control system to actually measure the events 
occurring in the analytical process and consequently to control these, is of 
concern in chapter 5. 
From the observations dealt with in this and previous sections, it is seen that 
before adopting a certain intralaboratory quality control system, m advance 
its possibilities and impossibilities can to a certain extent be verified. 
Important features thereby are; the number, place and frequency of implemen-
tation of calibration standards and quality control specimens in the analysis 
series, the characteristics of the calibration standards and the control 
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specimens, and the procedures according to which target values for analyte 
concentrations in quality control sera preparation are established. 
2.6 Intralaboratory quality control 
The intralaboratory quality control procedures for the serum calcium and urea 
determination are now of concern. A summary of the procedures the participants 
adopted for quality control purpose is given, and the procedures in which next 
to control serum preparations, also patient specimens were used, are discussed. 
Thereafter some examples are shown of the criteria on which the participants 
actually intervened m an analytical process trying to prevent the disturbances 
acting upon these processes from accumulating, as a result of which such 
processes would tend to get out of control. 
2.6.1 Procedures and intervention criteria 
The principle of the 'reference-ьатріе method' introduced by Levey and 
Jennings in clinical chemistry (30) was used by all of the participants for 
their intralaboratory quality control. 
However, the average control charts thereby employed were in a number of 
laboratories not very effective m detecting an 'out of control' situation 
of the analytical process. 
Two factors contributed to this observation i.e. warning and action limits 
were not set correctly in the charts and secondly quality control data were 
sometimes rounded-off to an extent that is in severe conflict with the 
rounding-off criterion (0.6 χ standard deviation). (31) 
Figure 2.2 shows the effect of rounding-off quality control data to an extent 
wiiich does not conform the 0.6 χ s criterion. The results shown pertain to the 
calcium quality control data of one of the laboratories. Here the data were 
rounded-off at 1 decimal place, which is incorrect in view of the standard 
deviation of 0.098. 
The implication of this rounding-off error is that warning and action limits 
in the control charts are set at such levels that the control chart is less 
sensitive for the detection of an out of control situation. 
From Fig. 2.2 it can be seen that such a situation hardly occurs. 
Furthermore the application of an average control chart presumes a gaussian 
distribution of the data. The results shown in Fig. 2.2 which are subject to 
a large rounding-off error, in fact hamper the application of the average 
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Fig. 2.2. Average control chart pertaining to the calcium quality control data 
of one of the participants, illustrating the effect of rounding-off 
data to an extent not permitted according to the 0.6 χ с criterion. 
control chart, since the distribution of these data barely copes with the 
gaussian distribution law. 
Another observation hampering the correct application of the average control 
charts was the incorrect setting of warning and action limits in these charts 
in one of the laboratories. In the particular laboratory the calcium analyses 
were all performed in duplicate. However in the average control charts the 
warning and action limits were established as though the analyses had been 
performed only one single time. Since intervening actions in the analytical 
process were performed on the mean result of the in duplicate analyzed control 
specimens, the average control chart was not very effective in detecting and 
out of control situation. Instead of setting the warning and action limits at 
χ ± 2s//2 respectively χ ± 3s//2, these were set at χ ± 2s respectively χ ± 3σ 
i.e. the range of 'tolerated' quality control results is artificially broadend. 
Quite a number of participants employ several control sera preparations, in 
most instances two, with different analyte concentrations for the surveillance 
of their analytical processes during the same time period. The quality control 
data pertaining to the same control serum constituent in each of the control 
specimens separately and together, give insight in the behaviour of the 
analytical process during the analysis of patient specimens. Consequently 
when 2 different control sera are used, for every constituent, 2 average 
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control Charts are constructed and intervening actions are governed on the 
separate or combined quality control results. A 'combined' control chart was 
not used for intralaboratory quality control purpose in any of the laboratories. 
On the urea quality control data of one of the participants the additional 
information obtained when working with the 'combined' chart in comparison with 
the separate average control charts, is illustrated. 
In the particular laboratory daily 2 different quality control specimens 
denoted pool 1 and pool 2 were analyzed during a common prolonged time period. 
The characteristics of these preparations were: 
pool 1 : χ = 17.61 mmol/l, S = 0.691 
г
 jurea 
pool 2 : χ = 7.2 3 mmol/l, s = 0.189 
urea 
The data pertaining to pool 1 and pool 2 were subjected to an analysis of 
variance scheme which Riddick et al (32) proposed for intralaboratory quality 
control purpose. 
In Fig. 2.3 the average control chart of pool 1 (=a), pool 2 (=b) and the 
combined chart i.e. the difference between the daily obtained results of pool 1 
and pool 2 (=c), are shown. In these charts the warning and action limits were 
computed according to Riddick. et al. (32) 
From Fig. 2.3 following observations can be made: 
1) Relying on the separate average control charts (a and b) does not give any 
indication about the within day variability in the laboratory. 
2) An out of control situation i.e. control results outside the action limits 
χ ± 3s is found on 2 occasions for pool 1 (=a) and 1 time for pool 2 (=b) . 
3) From the 'difference' chart (=c) however it is seen that the within day 
variability is quite large with 14 out of control situations. 
The performance of the laboratory is not as good as might be expected from 
the results visualized in the control charts of pool 1 and pool 2 
separately. The results shown in the different chart indicate that all 
effort should concentrate on improving the within-day variability. 
Table 2.8 summarizes the laboratories where next to quality control sera also 
patient specimens are used for intralaboratory quality control purpose. 
From Table 2.8 it follows that the various proposed intralaboratory quality 
control methods based on the use of patient data i.e. 'average of normals' (33), 
'daily mean' (34), and 'number-plus' (35), were hardly adopted by the partici­
pants of this investigation. 
This confirms the observation of Grannis and Caragher (36) who stated that 
these methods have not been widely adopted in clinical chemistry laboratories, 
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Fiçt. 2.3. Average control charts of quality control preparations pool 1 (= a), pool 2 (= b) and difference chart 
i.e. daily results of pool 1 - pool 2 (=0), according to Riddick et. al. (32) 
(О . indicates an observation outside the action limits) 
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Table 2.8 
Intralaboratory quality control procedures based on the use of patient data. 
laboratory intralaboratory quality control procedure based on the use of 
patient data 
201 Ггога every analysis series 1 patient specimen is again analyzed 
in the subsequent series, to control the 'between-series' 
variability. 
202 Pertaining to the urea determination, the 'average of normals' 
method (33) is used. 
204 From the total number of daily analyzed patient specimens at 
random 5 are selected and again analyzed. From the 5 duplicate 
measurements the coefficient of variation is calculated 
which, when the (.V. is 'too large', leads to a controlling 
action. 
209 Each day of the clinical chemist judges the analysis results 
of the patient specimens with his 'laboratory file'. 
213 Whenever 'a great deal' of the patient specimen results are 
outside certain 'reference values' a controlling action is 
performed in the analytical process. The 'reference values' 
were previously established in the laboratory from the 
frequency distribution of a large number of patient results, 
and coincide with the 'steep sides' of this distribution 
equalling in practice the mean value of this distribution plus 
or minus 1.5 times the standard deviation. 
216 The 'daily mean' method. (34) 
219 Every week and once a month a frequency distribution is made 
of all patient results which thereafter are compared with 
previously made frequency distributions. Pertaining to urea 
also 5 times a day α summary is made of 'strongly deviating' 
patient results. After verification of these results with an 
'authorization list' the results are allowed to leave the 
laboratory or not. 
224 With 'strongly deviating' patient results, a random number of 
patient specimens is again analyzed. 
due to unfavorable appraisels of their usefulness in clinical chemistry 
literature. Here, exceptions are laboratories 202 and 216. 
The criteria whether or not patient results lead to controlling actions, were 
most of the time not adequately described in the questionnaires, and showed 
lack of exactness i.e. were vague and not appropriately quantified. 
This holds for laboratories 201, 204, 209, 219 and 224. 
Only laboratory 201 makes use of patient specimens to control the 'between-
s e n e s ' variability. 
In view of the fact that a no additional expenses are involved for the 
'control material', b valuable information is obtained and £ the possibility 
is offered to check similarly obtained results from the analysis of control 
specimens, it is not clear why this procedure is not applied more often. 
After having adopted certain intralaboratory quality control procedures, 
consequently the next question is how the quality control data are used to 
govern possible controlling actions in the analytical procedure. 
In order to illustrate the diversity of these 'intervention criteria' employed 
by some participants, some examples are given. These examples also illustrate 
the different approach towards the use of quality control data in general to 
perform possible controlling actions. 
Example 1 
In laboratory 213 controlling actions are performed in first instance on the 
calibrating aspects of the analytical system: 
1) correct blank setting (absence of drift, correct signal/noise ratio)? 
2) no carry-over (peaks without shoulders); peaks sufficiently separated? 
3) do the calibration standards, analyzed in duplicate give similar results 
i.e. reproducible calibration? 
4) linear calibrationcurve? 
The controlling actions then are governed by the 'reference values' (Table 2.8). 
Quality control data are taken into consideration in last instance as follows: 
a) When the patient results are situated within the 'references values' 
(Table 2.8) and the control results just exceed the warning limits, 
χ ± 1.5s, no action is undertaken on that particular day. Whenever this 
situation would occur on several consecutive days the cause is looked for, 
and possible correcting actions are performed. 
b) When the patient results exceed the 'reference values' (Table 2.8), the 
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control data are considered and when these do not exceed the χ + I.5s 
limits, no action whatsoever is undertaken. 
c) When both the patient results exceed the 'reference values' (Table 2.8) 
and the control data the χ + i.Ss limits, immediately a searching program 
is started to locate the possible source(s) of error. After these have 
been located they are eliminated and all patient specimens are analyzed 
again. 
If the source(s) of error cannot be located, the patient specimens are 
recalculated on the basis of the quality control results. 
Example 2 
In laboratory 215 for both the serum calcium and urea determination, controlling 
actions are undertaken when a the conversion factor for the calibration standard 
differs more than a certain percentage from the usually appropriate factor 
(for urea 10%) and b_ when the quality control data exceed the χ ± 2s limits. 
Example 3 
When a control result in laboratory 219 is 'out of control', the control 
specimen together with the patient specimens in the same series are analyzed 
again. If the result obtained (patient as well as control results) differ 
from the previously obtained results, controlling actions are undertaken. 
However, if only the 'control result' differs, the previously obtained patient 
results are considered to be correct and no further actions are undertaken. 
From these 3 examples it can be seen that intervening or controlling actions 
are governed by different rules. 
In the first example, technical aspects and patient results mainly determine 
these actions. The value of a quality control result in this example is 
somewhat ambiguous. In the situation described under a, the quality results 
are disgarded in first instance. In situation b these same results are 
considered to be appropriate enough to prevent an intervention in the analytical 
process. In situation £ the quality control results take the place of the 
calibration standards and all the patient results are calculated in reference 
to the quality control data. 
In the second example the conversion factor of the calibration standard also 
determines possible controlling actions. 
In the third example the quality control results are only of limited use. 
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Here, in fact, the results of the patient specimens which are again analyzed in 
case of an 'out of control' situation, determine whether or not controlling 
actions are undertaken. 
Similar observations as shown in the 3 examples, were found in some of the other 
laboratories. 
In general however most participants relied in first instance on the quality 
control data when performing controlling actions in analytical processes. 
Such application of quality control data is to be preferred. The situation in 
which the use of quality control data is dependent on the situation one is 
confronted with, is to be disapproved. 
Basic requirement however is always that the control sera preparations them-
selves are of high quality. 
The situation found in the laboratories in 1974/1975 as far as mtralaboratory 
quality control procedures and intervention criteria is concerned, shows that: 
- Apart from the reference sample method and the thereby employed control 
charts, no other statistical techniques were used by most of the participants 
for mtralaboratory quality control. 
The reason for this behaviour is not clear, since at that time, in clinical 
chemistry literature, promissing results with other statistical techniques 
had been reported. (32, 37, 38) 
- The sensitivity of the control charts was in some laboratories negatively 
influenced due to rounding-off error of the quality control data and 
incorrect setting of warning and action limits. 
- Intralaboratory quality control procedures based on the use of routinely 
generated patient results i.e. 'daily-mean', 'average of normals' and 
'number-plus' method were hardly adopted. 
- Controlling actions in the analytical processes, to prevent accumulation of 
the disturbances acting upon these processes, as a result of which these 
processes would tend to get out of control, aro made in the ma3ority of the 
laboratories on the basis of quality control data. 
In some laboratories quality control data are incorrectly applied and a 
variety of intervention criteria are used to inlcrvono in the analytical 
process. 
2.7 Normal range values 
The range of values for a specific constituent observed in healthy individuals 
is referred to as the normal range. 
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In clinical chemistry literature however, the terminology and the concepts 
such as 'normal', 'normal values' and 'healthy' are still debatable subjects. 
(39, 40, 41) 
In view of the fact that a number of participants filled in the normal range 
values for serum calcium and urea on the questionnaires, these values are 
shown m Fig. 2.4. The results illustrate the discrepancy in the range of these 
values. 
Although it was not the scope of the present investigation to explain these 
discrepancies, some possible reasons can be given from clinical chemistry 
literature. 
For example 1) population differences and selection of samples from the 
population (42) of which laboratory 223 is an example (the other participants 
use the stated normal range values as points of reference for all analyzed 
patient specimens) 2) the technique of sample taking, 3) intraindividual 
variation, 4) the adopted definition of 'normal range' and 5) the analytical 
method that is used to establish the normal range values. 
In how far the shown normal range values used by the various laboratories are 
related to those applied by the physicians as 'action levels' was studied by 
Elion - Gerritzen (42). Thereby 'action levels' were defined as the upper or 
lower limit of a constituent level that would prompt to an action of the first 
order in the specific situation of the out-patient with ill-defined complaints 
(for example repeat or additional tests). 
This subject was not of concern during the present investigation. The reason 
for including figures 2.4.a/2.4.b was, to illustrate the discrepancy between 
upper and lower limits of the normal range for serum calcium and urea in a 
number of Dutch Clinical Chemistry laboratories. 
2.8 Conclusions 
The intralaboratory quality control procedures and related aspects in a group 
of clinical chemistry laboratories in the Netherlands in 1974/1975 were dealt 
with, and following observations were made. 
- ± 60% of the control sera were commercially obtained and ± 40% were 'self 
made' pooled preparations. 
ЗБ" of the 'commercial' control sera were human, 43% were horse and 22% were 
bovine pooled sera. For the 'self made' control sera these figures read 
respectively 72, 6 and 22°=. (Sec. 2.3.1) 
- Most of the participants establish target values for control serum 
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Fig. 2.4 Normal range ( I- 4 ) for serum calcium (A) and urea (B), in a 
group of Dutch clinical chemistry laboratories. 
constituents themselves. Some also in cooperation with colleagues, and a 
minority rely on target values given by the manufacturers of the control 
materials. At first sight the procedures that are used to establish these 
target values within each laboratory look quite similar. However, on closer 
study, the impact of the various procedures on the setting of target value, 
warning and action limits m the control charts is different. (Sec. 2.3.1) 
Apart from that, these procedures often were not adequately described i.e. 
show lack of precision and use specifications which are not defined exactly. 
- Approximately 15% of the activ analysis capacity of the laboratories for 
serum calcium and urea determinationb is utilized for analysis of quality 
control specimens. (Sec. 3.2.2) 
- Approximately every 1 5 - 3 0 minutes a control specimen is analyzed during the 
analysis of a series of patient specimens. 
- There are discrepancies between the participants concerning the calibration 
aspects of an analytical method. This not only refers to the number of 
calibration standards, but also to the range of concentration levels. 
In general more calibration standards are used for urea than for calcium 
(Sec. 2.4) 
Most of the employed calibration standards are aqueous solutions. Some 
participants use protein containing solutions and some were seen to be using 
quality control specimens for calibrating purposes. 
- A summary of the composition of the analytical runs which the participants 
used is shown in section 2.5. The impact of the place of calibration 
standard(s) and control specimens in the analytical run is discussed. From 
these considerations some of the possibilities and impossibilities of an 
intralaboratory quality control program to actually measure and control 
deviations from a target value can be verified in advance. 
- Section 2.6 deals with the criteria on the basis of which interventions are 
performed in the analytical process. The examples given there, indicate that 
not always quality control data are applied correctly and that these data not 
only govern intervening/controlling actions. 
- Statistical methods based on the use of patient data for intralaboratory 
quality control were hardly adopted by the participants. (Sec. 2.6.1) 
- The principle of the average control chart, introduced by Levey and Jennings 
in clinical chemistry (30) was used by all participants. 
The sensitivity of these charts in detecting an 'out of control' situation 
was in some instance negatively influenced by rounding-off errors of the 
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quality control data or incorrect setting of warning and action limits. 
An example is included to illustrate the situation in which the use of 
separate control charts for different control serum preparations, instead 
of a combined chart, may actually obscure the problem. (Sec. 2.6.1) 
- In section 2.7 the normal range values used by some of the participants show 
discrepancies between upper and lower limits of the normal range. 
The overall conclusion is that considerable time and effort is spent on 
improving the reliability of clinical chemistry data. In how far this sorts 
the wanted effect and whether the effect is worth the time, effort and expenses, 
can be doubted. 
A more systematic approach in these matters can perhaps refute the following, 
often heard, complaint: 'Although a considerable amount of time and effort is 
put into intralaboratory quality control seldom the results of these efforts 
are seen'. 
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Chapter 3 
AUTOCORRELATION ANALYSIS OF TIME SERIES 
3.1 Introduction 
The statistical methodology used for quality control purpose in clinical 
chemistry laboratories at present, is concerned with models in which the 
observations are assumed to vary independently. 
However, the information drawn from quality control measurements in clinical 
chemistry laboratories is often derived from a sequence of such measurements 
which may very well not vary independently. 
In general a set of observations on the same variable quantity, generated 
sequentially in time, is called a time series, and the techniques available 
to analyze such series is time series analysis. The feature which distinguishes 
time series analysis from other statistical analyses is the explicit recognition 
of the importance of the order in which the observations are made. 
In time series, successive observations may be dependent, and the dependence 
is related to their position m the series. 
Time series may be continuous or discrete and are produced by some kind of 
process. Thereby each time series is regarded to be a sample realization from 
an infinite population of such series, that could have been generated by this 
process. 
An aggregate of such realizations is called an ensemble. 
Two distinct types of time series can be distinguished. 
If future values of a time series are exactly determined by some mathematical 
function, the series is said to be deterministic. Such a model or process will 
enable the calculation of a future value of some time dependent quantity nearly 
exactly, at any instant of time. 
Probably no measured phenomenon is totally deterministic however, because of 
unknown factors that can occur. 
In many problems, time dependent phenomena have to be considered, where there 
are many unknown factors which cannot de described by a deterministic model. 
Nevertheless, it may be possible to derive a model that can be used to caculate 
the probability of a future value to occur. 
A statistical phenomenon that evolves in time according to probability laws 
is called a stochastic model or stochastic process. 
The time series generated by a stochastic process, are called statistical time 
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series, and allow the description of future values only in terms of probability 
distributions 
Time series are used for various purposes. 
(a) The objective may be the prediction of the future, based on the knowledge 
of the past. 
(b) It may give information about the nature of the process from which it is 
a sample realization 
(c) It may serve to control the process generating the series. 
The time series models that are needed for example to achieve optimal control, 
are in fact stochastic models. 
The word 'control' in this context thereby has a different meaning in comparison 
with 'control' usually referred to m the field of quality control m clinical 
chemistry. 
In the latter 'control' refers to the statistical methodology, based on the 
premise of independency between the observations. 
Placed in the context of feedback and feedforward control (1), 'control' 
refers to control schemes which are appropriate for the periodic, optimal 
adjustment of a manipulated variable so as to minimize the variation of that 
quality characteristic about some target or mean value. 
Such stabilizing control schemes require knowledge of both static and dynamic 
behaviour of the underlying process. 
A technique which provides information about the time variant or dynamic 
behaviour of processes is the autocorrelation technique. 
Subjecting time series to autocorrelation analysis is a means to reveal the 
coherence or correlation between any two observations of the series in relation 
to their separation. 
In the following, the autocorrelation analysis of discrete time series is 
discussed. 
Problems encountered during the present investigation concerned missing values 
in time series and rounding-off errors of the measurements. 
The solutions derived to overcome the problems related to these missing values 
in time series are described. 
Monte Carlo simulations were performed to test the validity and applicability 
of the procedures for various time series models. 
The effect of rounding-off errors on the magnitude of the time constant of a 
process is demonstrated. 
Ä relationship between the autocorrelation technique and an analysis of variance 
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scheme in time series analysis of first order stationary stochastic process is 
derived. 
Monte Carlo simulations were performed to test the validity and applicability 
of this relationship. A practical example is included. 
3.1.1 Time series and stationary stochastic processes 
A stochastic process is a process where process values χ at time t, are defined 
in terms of probability distributions ρ (χ ) . 
When these probability distributions Ό(χ ) are time independent and may be 
written ρ (X), the stochastic process is said to be stationary. 
Hence, a stationary stochastic process is a stochastic process which is in a 
particular state of statistical equilibrium. This implies that its properties 
are independent of the starting time of the observation period i.e. it has a 
constant mean value μ and fluctuates about this level with a constant 
variance a2. 
χ 
According to Box and Jenkins (2), μ and α of stationary stochastic processes 
aare defined: 
+ o° 
y = E [a·] = ƒ r pu-) χ (3.1) 
— CO 
and 
+ °° 
σ^ = E [ ( x - μ )•'] = ƒ ( . - μ ) 2 ί><~) ix (3.2) 
- co 
From a limited series of measurements however only estimates of μ and a2 can 
χ 
be obtained. 
Consequently, from a discrete time series of ,J successive observations i.e. 
x. , x , , x , the process mean μ is estimated by the mean 
1 
V t = l 
- · Σ a:t (3.3) 
of the series, and the variance of the process, σ , by the variance 
s¿ = -Γ ( x - χ ) 2 (3.4) 
χ
 N-l ,=ι t 
of the series. 
In situations where the process exhibits a non stationary behaviour, the course 
of t and s can be determined by segregating the process in several stationary 
parts. (2) 
59 
Such segregation of the process is of course only possible when the transition 
times between the stationary parts are known. 
During the present investigation this was sometimes very well possible. 
The description of a process merely in terms of χ and s however is not 
sufficient. 
The statistical description of a process is only complete when apart from X 
and s of the time series generated by the process, also the coherence or 
correlation between any two observations in the series in dependence of their 
separation, is taken into consideration. Subjecting the time series to an 
autocorrelation analysis yields this information. 
3.1.2 Autocorrelation estimates and autocorrelation function 
The information about the coherence or correlation between any two observations 
of a process, is obtained from the joint probability distribution of χ and 
Xt+T i.e. p(xt, xt+T). 
As discussed in the previous section, a stochastic process is said to be 
stationary, when the probability distribution of ж , f [χ ), is time independent 
and could be written ρ(x). Stationanty in this context is referred to be of 
the first order. (2) 
A process is said to be stationary of the second order, when also the joint 
probability distribution of X and χ , ρ( χ , X ) only depends on the time 
interval τ between t and t+τ for every set of integers {t) and for every 
integer τ, and not on the absolute values of t and ί+τ. (2) 
The covanance matrix, by definition, is a function only of the distance or 
lag τ, between observations. (3) 
That is, the covanance of χ and χ , depends only on τ and is defined 
t t+τ 
cov \ixt, xt+j J = E [j a; - μ ) · ( x t + : - μ f] = Ύ(τ) (3.5) 
Since γ (Τ) is the covanance of observations belonging to the same process, 
γ (T) is called autocovanance at lag τ. μ is the mean value of the process. 
(Eqn. 3.1) 
To compare the basic properties of processes, it is often useful to have a 
property that is independent of the scale of measurement of the time series. 
To this end, the autocorrelation ρ(τ) at lag τ between χ and χ is defined (2) 
E [( xt - μ ) · ( xt+^ - μ )] 
Ρ(τ) = • (З.б) 
E[( a;t - μ )
2] 
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hence, ρ (τ) is defined as the autocovanance at lag τ, γ (τ) , normalized to the 
autocovanance at lag Τ = 0, γ(0) : 
Υ (τ) 
ρ (τ) = (3.7) 
γ(0) 
Since for a stationary stochastic process the process variance о , (Eqn. 3.2), 
equals γ(0), (Eqn. 3.5 for r = 0), the autocorrelation at lag τ reads 
γ(τ) 
Ρ(τ) = (3.8) 
The plot of γ ( r) versus τ is called the autocovanance function. 
Similarly the plot of ρ(τ) versus τ is called the autocorrelation function. 
In practice however only estimates of γ(τ) and ρ(τ) can be obtained from a 
limited discrete time series of il successive observations. The estimate of 
the τ - th lag autocovanance γ(τ) , ψ (τ) , is defined (2) . 
1 //-τ 
Ψ (i) = · I ( χ - χ ) • ( £ - „ . ) (3.9) 
Ν-τ-1 t=l 
with τ : time interval between observations expressed in units of sampling 
interval 
il : the length of the series in the same units 
x : mean value of the series. (Eqn. 3.3) 
The estimate of the τ - th lag autocorrelation ρ(τ), φ(τ), is defined (2): 
ψ([) 
φ(τ) = (3.10) 
ψ(0) 
where ψ(0) equals s7, the estimate of the process variance, following Eqn. 3.4, 
leading to 
ψ(τ) 
φ(ι) = — < З Л 1 > 
0
χ 
the plot of ψ (τ) versus τ is called the autocovanance function and (J (τ) versus 
Τ is called the autocorrelation function. 
In general, the autocorrelation function of a stationary process has a limiting 
value for τ -> "> : 
lim 4 (т) - 0 
Ι у со 
Consequently when the autocorrelation function of a discrete time series of N 
successive observations, being a sample realization of that process, exhibits 
such behaviour, this series pertains to a stationary process. This again implies 
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that such a time series suffices for the description of the process. 
Summarizing, a stationary stochastic process is completely described from a 
finite discrete time series of <V successive observations, by its mean value 
X (Eqn. 3.3), variance s 2 (Eqn. 3.4) and autocorrelation function φ(Τ), 
(Eqn. 3.11), or by ar and the autocovanance function ψ(ΐ). (Eqn. 3.9) 
For many processes occurring in nature, the autocorrelation function decreases 
with increasing time interval or lag τ, according to an exponential 
function (1,4): 
PO) - τ Λ" e ' ' χ (3.12) 
Processes exhibiting such a behaviour can be described by a linear differential 
equation of the first order and are called first order stationary stochastic 
processes or autoregressive processes of the first order. Ί is the correlation 
time or time constant of the process quantity studied, and is a measure of the 
velocity with which this quantity fluctuates in time. A high value of Τ 
indicates that the fluctuations are slow in contrast to a low value of I 
χ 
which indicates a fast fluctuating pattern of the process quantity. 
Figure 3.1 illustrates both features. 
Both τ and Τ are expressed in units of interval at which the process is sampled. 
φ(τ) 
Τ So ν ^ кнг" "Tso "— гъъ- -_!Iä 
Fig. 3.1 Autocorrelogram of an uncorrelated (A) and correlated series of 
measurements (В). 
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Figure 3.2 illustrates the various methods to determine ΐ from the auto­
correlation function or autocorrelogram. 
Fig. 3.2 Various methods to determine Τ from an autocorrelogram 
χ 
3.1.3 Standard errors of autocorrelation estimates 
Since the theoretical autocorrelations ρ(τ) are in fact never known but only 
their estimates Φ(Ό, it is important to have some indication of how far an 
estimated autocorrelation at lag τ, φ(τ), differs from the corresponding 
theoretical autocorrelation value at that lag τ. To that purpose the following 
procedure is used. 
After calculating the autocorrelation function φ(τ) of a time series consisting 
of / successive observations, the time constant Τ is approximated according 
to one of the procedures shown in Fig. 3.2. Supposing that the time series is 
a sample realization of a first order stationary stochastic process, the 
standard errors of the autocorrelation estimates at lag τ, ο 2 (φ(τ)), may be 
derived from Bartlett's formula (5): 
σ'(φ(τ)) 1 
Ν-τ 
( 1+е- 2 / Гх)-( 1-е-2Т/Гх 
( 1-е- 2 / У
Х
 , 
2те χ (3.13) 
From Eqn. 3.13 it is seen that for τ = 0: σ (φ(0)) = 0. 
In order to test whether the time series considered indeed can be regarded to 
be a sample realization of a first order stationary stochastic process it is 
thereafter verified if the autocorrelations ρ(T) at various lags τ, computed 
according to Eqn. 3.12, are situated within the confidence interval (6) : 
φ(τ) - >ί(ρ)·σ(φ(τ)) < ρ (τ) < φ(τ) + ^(ρ)·σ(φ(τ)) 
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Where σ(φ(τ)) is multiplied by the gaussian coefficient nip), to obtain 
the desired confidence region related to a certain probability, p(%), of the 
gaussian distribution (7). This is allowed since the autocorrelation estimates 
φ(τ), are approximately normally distributed. (3,8) 
When the autocorrelations ρ(τ) are situated within this interval the assumption, 
that the time series stems from a first order stationary stochastic process, 
is accepted. If not, the assumption is rejected and another model for the time 
series has to be considered, for example a deterministic model. 
3.2 Missing values in time series and the implications on autocorrelation 
analysis * 
A problem rarely dealt with in statistical literature is that of missing values 
in time series analysis and in particular its implication on autocorrelation 
analysis. Often, however, data cannot be collected in an ideal way. Part of the 
investigation concerning dynamic aspects of analytical processes involved this 
problem. Consider the situation in which a process is sampled at regular time 
intervals At. The discrete time series x,, a;_, . . . . χ of N successive observa-
1 2 N 
tions is then regarded as a sample realization from an infinite population of 
such series, representative of the process. 
Now suppose that, for some reason, not all N measurements are available but 
merely Ν , during the same total realization period. Denoting the structure of 
the known and unknown terms by χ and ?, there could raise, for example the 
following sequence of observations. 
ideal situation : χ Χ χ X 
1 2 3 ' 
with missing values : χ ? ? χ 
1 -
In the case of a single gap of one or more observations, with long unbroken 
sequences immediately before and after the gap, interpolation is possible. (9) 
Several gaps, provided they are well separated, can also be filled or interpolated 
separately. Calculating the autocorrelation function need not be a problem sub­
sequently. In the situation with a lot of missing data and no long unbroken 
sequences before and after the gap, as conbidored above, interpolation is 
difficult, if possible at all. 
Let a process of realization length /i be sampled at equidistant time intervals 
At. When the sequence is undisturbed, <. successive measurements form the 
discrete time series χ,, a\, ..., x„, Now assume that the series is filled 1 2 N 
*Limonard, C.B.G., Anal. Chim. Acta, Computer Techniques and Optimization, 
103, 133, 1978. 
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XS X6 Xl ~8 X9 X\Q 
•
 Xb Xl X8 
with gaps and consists of /V1 observations during the same realization period R. 
To compute the autocorrelation function of this series, fill all gaps with an 
arbitrary, recognizable value (AV) not already present in the series. This 
guarantees the equidistancy of all observations, a necessity for autocorrelation 
analysis. Calculate the average process value from the observations, having 
omitted all arbitrary values by 
- 1 N 
χ = — Ζ χ w i t h χ. φ AV 
N1 t = l t t 
and reduce a l l N observat ions by x, as a r e s u l t of which the s e r i e s W , W , 
. . .W i s formed. Suppose the sequence (Л) t o be 
{A) Wl WzAVAVUs AVW7AVAVW10 Wn AVWU У1Ч У1Ъ W^ AV W1B W^ Л 
Autocovanance e s t i ma tes are then computed from 
1 Ν-Ί 
ψ ( τ ) = · Σ W · W (3 .14) 
0(τ)-l t = l t t+τ 
m which multiplications involving an arbitrary value (AV) are omitted (i.e. IS 
Í AV and Ü/ / AV) , and where 6 (τ) denotes the number of multiplications in 
which no arbitrary value is involved, for the various time lags τ. 
The usual procedure would be to replace the missing values by the overall 
mean x. In the series, however, some observations may actually equal x. 
Replacing a missing value by χ thus makes a true observation of the series 
indistinguishable from a missing value. In the first case, Q(T) would remain 
unchanged, but in the latter situation ο(τ) should be decreased by 1 each time, 
in the multiplication of Eqn. 3.14, where an arbitrary value is involved. 
Therefore, for strictly computational reasons, all missing values are replaced 
by a value which can be chosen freely, that is recognizable by the computer. 
For the example (/1) 
τ 0 1 2 3 
η
Λ\) 12 б 5 7 
With no gaps in the sequence Ç(T) running from 20 - 17. In general, 
Q{t) = U - τ - L (τ) where ff is the realization length /Δι, τ the time lag, and 
¿(T) the number of multiplications involving an arbitrary value. The auto-
correlation estimates φ(τ) are then computed from Eqn. 3.10. 
From Eqn. 3.13 it follows that in a sequence with no missing values, var (ψ(τ)) 
is always computed with constant number of observations ü if τ << /7. 
With missing values in the time series, the number of observations varies with 
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each autocorrelation estimate. The variance m these estimates were calculated 
by replacing N - τ in Eqn. 3.13 by ζ>(τ) . 
var (φ(τ)) = J- . Γ ( 1 + P2 ) • ( 1 - P;J_) _ 2τ ρ 2 τ for l ^  2 ( з Л 5 а ) 
<2(τ) L ( ι - Ρ2 ) 
with (2 (τ) denoting the number of pairs of observations actually involved when 
computing φ(τ) for τ = 0,1 ..., M according to Eqn. 3.10 following Eqn. 3.14. 
For autocorrelation estimates φ(τ) at time lags τ > 2, the variances were 
calculated by replacing N - τ in Eqn. 3.13 by /Ι/(τ) : 
1 
var (ί>(τ)) = 
/m) 
X A + Ρ 2 ) · ( ι - ρ 2 τ ) _
 2 τ р 2 т for τ > 2 (3.15b) 
( ι - Ρ' ) 
with Ν(τ) denoting the number of observations actually involved when 
computing φ(τ). 
The validity of Eqn. 3.15a and Eqn. 3.15b is demonstrated in section 3.2.1. 
Simulations were performed to test the validity of the procedure. 
First order stationary stochastic processes were simulated with a discrete 
'white noise' generator from the IBM-library. 
2 
With г representing a discrete white-noise process with zero mean, variance σ 
equal to 1, and C( ζ · ζ ) = 0 for m / η, a Markov process is generated 
η m 
according to 
x , = a · χ + b · ζ ,, (3.16) 
n+1 η n+1 
2 -h 
where a = exp ( -1/2 ) and σ = b · ( 1 - a ) following Naylor et al. (10) 
x x 
and Gelb and Palosky. (11) 
The series χ,, x„, ..., χ of N successive terms according to Eqn. 3.16 were 
1 2 N 
then compared with gaps containing sequences of the same realization length 
( N.àt , ) V. » '-/„/ · • · , У ι submitted by the participants taking part in 
sampling ' »i' ¿г' ÖN * e 
the investigation mentioned. A term of the ¿c-series was thus omitted and 
replaced by an arbitrary recognizable value when the observation at the same 
place in the ¡/-series was not present. If not, the x-value remained unchanged. 
Thus a series x, , . . ., χ was formed containing I! values and /« - ¡i missing 
1 N 
values. 
According to the procedure described, autocorrelation estimates and the variance 
in these estimates were calculated for τ = 1, ..., 20, for both original 'gap-
free' series χ as well as 'gap-containing' series x. A weighted least-squares 
fitting procedure, based on an iteration method developed by Meiron (12) was 
-т/Т 
used to estimate the fitting function ρ = e χ, τ = 0, ..., 20, for both 
66 
performances. The curve-fitting program itself was based on the iteration 
formula Τ = I - ( Б + pC ) . G , where Τ , is the value of parameter 
m + l m m m m m+1 
Τ of the model, calculated in the ( m+1 )th iteration; В is the matrix of the 
m 
partial derivatives of the fitting function using the parameter value from 
the mth iteration, С as matrix В , but with the off-diaqonal elements zero: 
m m 
ρ is the damping constant and G the matrix of the residual differences between 
m 
observed and calculated data points from the mth iteration. 
The reduced chi-square statistic X*, defined as the ratio of the estimated 
variance of the fit s to the parent variance σ (times the number of degrees 
of freedom) and described by Bevington (13), was used as the goodness of fit 
criterion. The standard deviation ay of the fit parameter Τ was calculated 
by the error propagation expression described in many textbooks. (13) 
Table 3.1 shows the effect of missing values in time series analysis on ί?(τ) 
and №(τ) when φ (τ) and var (φ (τ)), τ = 0,1, ..., 20 are calculated for the 
performed simulations. There are 2 extreme situations. With the sequence 
¡J = 250 and ' = 99, a series arose in which many observations at the beginning 
were followed by a gap followed by very few missing values towards the end 
of the series. 
Table 3.1 
Effect of missing values on Q[j) and IV(T) in simulated time series with " 
observations and / - // missing values. 
N 130 250 424 587 1992 
/V1 87 99 338 400 218 
τ 
0 
1 
2 
3 
4 
5 
10 
15 
20 
0(τ) 
87 
66 
48 
47 
47 
48 
45 
59 
57 
Λ (τ) 
87 
86 
82 
64 
65 
81 
63 
81 
80 
С (τ) 
99 
18 
51 
36 
35 
48 
35 
14 
13 
Ν (τ) 
99 
26 
81 
62 
60 
77 
63 
26 
21 
ο(τ) 
338 
269 
257 
261 
263 
257 
256 
257 
253 
Ν (τ) 
338 
334 
324 
321 
325 
328 
322 
332 
326 
Q(T) 
400 
303 
230 
235 
232 
231 
231 
295 
292 
Λ/ (τ) 
400 
390 
381 
318 
315 
382 
315 
388 
386 
<2(τ) 
218 
77 
10 
_ 
Ν (τ) 
218 
148 
20 
_ 
The sequence with il = 1992 and Ν =218 was the result of the following practical 
situation. A process was sampled during a maximal 3 h per day at a sampling 
rate of 1 h during 83 consecutive days. Calculating autocorrelation estimates 
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calls for equispaced observations. The procedure now described warrants this. 
Suppose the process had been sampled during 24 h, resulting in 24 observations. 
With only 3 observations on one day, and, say, also 3 for the next, proceed as 
follows. Insert 24 - 3 = 21 arbitrary recognizable values not already present 
in the series, leading to the sequence xx.x. (ΛΙΟ χ χ χ (AV) . . . 
I ¿ i ¿IZO ¿Ь / I 2 1 
Autocorrelation estimates w i t h 2 < T < 2 1 cannot be calculated from Eqn. 3.10 
following Eqn. 3.14. The autocorrelation function is thus to be calculated from 
only 3 data points, τ < 2. Λ(τ) and (2(τ) in this situation are therefore only 
given for τ < 2 (Table 3.1) . With the time constant used for generating the 
process in Eqn. 3.16 denoted as W , Table 3.2 shows the estimated time constants 
ƒ and Άψ , according to the fit procedure described, for both series with (£>) 
χ -"x 
and without (a) missing values. The reduced chi-square statistic, X2, indicated 
a reasonable fit unless stated otherwise. From Table 3.2, the following 
observations were made. 
1. The time constants calculated from time series with and without missing 
values are in close agreement, as summarized in Table 3.3. Here the 
discrepancy Δ between the average time constant from the series with and 
without missing values, i.e. ΐ (¿>) and Ί (a), is calculated from 
X X 
Δ = 100-¡г (b) - 7 (a) | /7 (a) (3.17) 
X X X 
2. At c o n s t a n t r e a l i z a t i o n length, j r increases in both s i t u a t i o n s with i n -
J
x 
creasing Ί ,
 l·у being larger when missing values are present, according to 
expectation. 
Table 3.3 
Discrepancy, Δ, between the average time constant from the series with and 
without missing values i.e. Τ (£>) and Τ (α), calculated from Eqn. 3.17. 
N 
130 
250 
424 
/V1 
87 
99 
337 
Τ
χ
 (a) 
0.99 
1.75 
5.45 
1.00 
1.89 
6 .41 
0 .96 
1.86 
6 . 1 6 
2
x
 Φ) 
1 .03 
1.81 
5 .53 
0 .96 
1.83 
5.26 
0 . 9 3 
1.85 
6 .09 
Δ(%) 
4 . 0 4 
3.43 
1.47 
4 . 0 0 
3.18 
17.94 
3.13 
0 .54 
1.14 
N 
588 
1992 
/V1 
398 
218 
Γ
χ
 ( a ) 
0 . 9 7 
1.83 
5.28 
1.04 
2 .00 
2
x
 № ) 
1.00 
1.86 
5.36 
1.02 
2 .18 
Δ(%) 
3.09 
1.64 
1.52 
1.92 
9 . 0 0 
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e 3.2 
Estimated time constants for series with (¿>) and without (a) missing values 
N = 1 30 Λ' 
TW = 
a 
1
 x 
1 22 
1 51 
0 91 
0 90 
0 61 
0 89 
0 87 
0 96 
0 90 
1 12 
1 
ST, 
0 17 
0 18 
0 14 
0 12 
0 11 
0 17 
0 14 
0 20 
0 17 
0 26 
1
 x
 0 99 
S,
x
 024 
V - 424 iV ' 
1 08 
0 98 
1 03 
0 95 
0 71 
0 90 
0 92 
0 08 
0 08 
0 08 
0 09 
0 07 
0 09 
0 10 
1
 = 87 
Ь 
'τ 
1 34 
0 98 
0 79 
1 06 
081 
0 77 
1 11 
0 93 
1 31 
1 17 
ST, 
0 24 
0 24 
0 26 
0 24 
0 17 
0 20 
0 22 
0 24 
0 22 
0 23 
1 03 
0 21 
1
 - 337 
1 18 
0 99 
1 04 
0 80 
0 70 
1 00 
0 86 
0 13 
0 10 
0 13 
0 12 
0 10 
0 12 
0 10 
TW = 
α 
Τχ 
1 76 
1 60 
1 51 
1 57 
1 93 
1 66 
2 21 
1 97 
1 66 
1 59 
1 
2 
s
', 
0 20 
0 23 
0 25 
0 21 
0 34 
0 36 
0 50 
0 11 
0 26 
0 25 
75 
0 22 
1 72 
I 77 
1 75 
2 06 
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0 34 
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0 38 
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4 65 
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3. With increasing number of observations m the series, with and without 
missing values, Sj decreases, as expected. Furthermore, the results of the 
2 extreme situations considered ( N = 130, У 1 = 8 7 and N = 1992, N1 = 218; 
Table 3.2 ) indicate possible restrictions to the procedure. In both 
situations the reduced chi-square test criterion indicated a poorly fitting 
function with X values with a probability of less than 0.01. 
The strong decline in Q(T) and '(τ) at τ = 1, compared with τ = 0 (Table 3.1) 
as a result of which φ(τ) and var (φ(τ)) are less reliable, is considered to 
be the main cause, valid for both situations. 
The results of Table 3.2 for N = 1992, І 1 = 218, show the effect of insufficient 
autocorrelation estimates when calculating the autocorrelation function. In 
this particular situation only estimates for Ί •( 2 were available. This results 
very quickly in significant JC^-values. (13) 
Based on the theory of first order autoregressive stochastic stationary 
processes, a procedure is described which enables a direct autocorrelation 
analysis of discrete time series with missing values. The average time con­
stants calculated for both series with and without missing values are in close 
agreement, and differ by less than 4%. In extreme situations, the procedure 
sometimes yields less reliable results. 
3.2.1 Effect on standard errors of autocorrelation estimates 
In the previous section, the influence of missing values m time series on the 
estimated time constant, Τ , of first order stationary stochastic process was 
derived. 
In the following the effect of missing values on the standard errors of auto­
correlation estimates, φ(τ) , is of concern. This m order to verify 1) if found 
autocorrelation estimates differ significantly from zero at the various lags τ 
or not i.e. does the process quantity studied exhibit a time variant behaviour, 
yes or no 2) does the autocorreiogram conform the zero limiting assumption 
for τ -»• <*> i.e. is there a significant deviation from the exponential auto­
correlation function (Eqn. 3.12). To that purpose Monte Carlo simulations were 
performed. 
Two modifications of Bartlett's original formula (Eqn. 3.13) were investigated: 
σ
2 ( φ ( τ ) > 
Ν(τ) 
( l+e 2 Λ χ ) · ( 1-е 2 τ / 7 χ ) . - 2 τ / 2 
' Í , -2/Τ ι 
( 1 - е χ ) 
( З . і б а ) 
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with Ν(x) equal to the number of observations actually involved when computing 
φ (τ) , and 
1 
σ£(φ(τ)] 
ο(τ) 
( 1+e 2/Τχ )·( l-e"2T/îx ) . -2τ/Γ 
-2те χ 
( 1-е-2/Т
Х
 ) 
(3.18b) 
With β(τ) denoting the number of pairs of observations actually correlated 
when computing φ (τ) . 
Example. 
Suppose we have the sequence: XXXMMXMXMX, with M representing a missing 
value and X a real observation. This would lead to the following values of Q(T) 
and Ν(τ) , when computing φ (τ) : 
τ <2(τ) ff(T) 
1 2 3 
2 3 5 
3 1 2 
Bartlett (5) and Fuller (3) indicated the possibility of both modifications 
to be appropriate. Both state that for time series where the correlations 
rapidly approach zero, the standard errors of φ(τ), for larger τ, can best be 
approximated by Eqn. 3.13, when in the denominator the number of multiplications 
N - τ, is replaced by N, when computing σ(φ(τ)) . 
In order to verify which formula was appropriate to estimate the standard 
errors of autocorrelation estimates, derived from time series with missing 
values, the following procedure was applied. 
For fixed time constant Τ and variance σ , a first order stationary stochastic 
X X 
process, henceforth called process, was generated according to Eqn. 3.16. This 
was repeated 100 times with different starting values of the Monte Carlo 
simulation. 
The result was, that a sample realization of 100 discrete time series was 
obtained, each consisting of Η observations, representative of a process with 
properties Τ and σ2. In each of these series, missing values were thereafter 
created according to the procedure mentioned in section 3.2, and also by 
omitting randomly observations in the series. Thus time series consisting of N1 
observations and N - N gaps were obtained. Within one simulation session, 
consisting of 100 series, these 'gaps' were located at the same places in each 
of these series. For various Τ and Ο , N and N - Ν , 30 of such simulation 
X X 
sessions were performed and their characteristics are summarized in Table 3.4. 
The procedure thereafter proceeded as follows. 
71 
Table 3.4 
Characteristics of simulation sessions 
simulation 
session 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
Τ 
X 
1 
2 
1 
2 
1 
2 
1 
1 
2 
1 
1 
1 
2 
3 
2 
1 
2 
1 
1 
6 
1 
2 
1 
2 
1 
1 
2 
1 
1 
2 
series 
gap free 
number of 
observations 
130 
130 
150 
150 
176 
176 
186 
220 
220 
250 
270 
359 
359 
359 
360 
424 
424 
473 
510 
510 
587 
587 
630 
720 
720 
720 
720 
790 
790 
790 
with gaps 
number of 
observations 
O1) 
94 
94 
108 
108 
88 
113 
103 
143 
105 
162 
166 
119 
148 
257 
174 
304 
304 
194 
133 
365 
420 
420 
300 
364 
204 
178 
342 
565 
199 
490 
% 
missing 
28 
28 
28 
28 
50 
36 
45 
35 
52 
35 
39 
68 
59 
28 
52 
28 
28 
59 
74 
28 
28 
28 
52 
49 
72 
75 
53 
28 
75 
38 
Each simulation session consisted of 100 mutually independent generated discrete 
time series (Eqn. 3.16) 
Ί' : time constant used in Eqn. 3.16 to generate the time series. 
Autocorrelation estimates φ (τ) , 7 = 1, ...10 were computed. (Sec. 3.2) 
For each of the 100 series in a simulation session, leading to 100 auto­
correlation estimates φ(τ) at lags τ = 1, ...10. From these, the mean auto­
correlation estimate value and variance at each lag τ were computed: 
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100 φ (τ) 
φ(τ) = Σ - i — 
1=1 100 
100 ( φ (τ) - φΤτ) )2 
β
2(φ(τ)) = Σ (3.19) 
ι=1 99 
At the same time the standard error of φ(τ) was derived according to both 
Eqn. 3.18a and 3.18b i.e. σ2(φ(τ)) and σ2(φ(τ)), upon substitution of the time 
constant Τ , used to generate the series in that simulation session. (Table 3.4) 
χ 
Thereafter the validity of Eqn. 3.18a and 3.18b was verified with a χ 
statistic (7). 
2 2 
X_ 
df 
with 
,2 
df 
S 2 
„2 
number of degrees of freedom i.e. N - 1 
variance estimate of the sample 
population variance 
The estimation of σ by confidence limits is based on the sampling distribution 
of s 2. From the appropriate tables (7), percentiles Ρ of the s /σ -distribution 
can be obtained. 
For a two-sided significance level of 5% pertaining to 95 per cent confidence 
limits for σ these percentiles are Ρ = 0.742 and Ρ = 1.30, when s 
is derived from a sample of size 100 i.e. df = 99, leading to 
/ s/1.30'< σ< / s/0.742' (3.20) 
Consequently the validity of Eqn. 3.18a and Eqn. 3.18b was verified, according 
to this x2-statistic i.e. Eqn. 3.20, as follows. 
37(φ(τ)) was computed from Eqn. 3.19. The 95 per cent confidence interval for 
σ(φ(τ)) was derived according to Eqn. 3.20 and it was verified if σ (φ(τ)), 
Eqn. 3.18a, was situated within this interval. When this was the case, σ (φ(τ)) 
was considered to be appropriate and if not, it was rejected as an acceptable 
estimator of the standard error of the autocorrelation estimate at the specific 
time interval. 
This procedure was repeated for σ (φ(τ)), Eqn. 3.18b, as estimator of the 
standard error of autocorrelation estimates. 
The validity of the total testing procedure was checked by simultaneous testing 
of Bartlett's original formula (Eqn. 3.13) for the 'gap' free series, next to 
the 'gap' containing series in the same simulation session. Tables 3.5 - 3.7 
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show the results of simulation sessions 3,18 and 23. The information in 
columns 1 - 9 of these tables concern results obtained for one simulation 
session. Columns 2 - 4 pertain to the 'gap' free series and 5 - 9 to the same 
series with 'gaps'. 
column 
1 
2 
3 
4 
5 
δ 
7 
8 
9 
information 
time lag τ 
з(ф(т)) 
σ(φ(τ)) 
appropriate ? 
а(ф(т)) 
σ (φ(0) 
а 
appropriate ^ 
σ (φ(τ)) b 
appropriate ? 
according to 
Eqn. 
Eqn. 
Eqn. 
Eqn. 
Eqn. 
Eqn. 
Eqn. 
Eqn. 
-
3.19 
3.13 
3.20 : 
3.19 
3.18a 
3.20 : 
3.18b 
3.20 : 
yes 
no 
yes 
no 
yes 
no 
= 0 
= * 
= 0 
= 0 
= * 
The results for the 'gap' free series, indicate the validity of Bartiett's 
formula (Eqn. 3.13) for estimating the standard errors of the autocorrelation 
estimates. Similar results were obtained for all simulation sessions. 
From these findings, it was concluded that the suggested testing procedure 
was appropriate. Hence it was applied for testing the validity of Eqn. 3.18a 
and Eqn. 3.18b. 
The results pertaining to the 'gap' containing series of all simulation sessions 
(Table 3.4) are summarized in Table 3.8. The results shown are restricted to 
those obtained at time interval τ = 1, 2, 3, 4, and 10 to facilitate visual 
inspection. Under the heading a it is shown whether Eqn. 3.18a is appropriate 
at that lag τ (column 7, Tables 3.5 - 3.7) , and under b_, if Eqn. 3.18b is 
appropriate (column 9, Tables 3.5 - 3.7). If appropriate this is indicated 
with a '0' and if not with a '•*' . 
The results of the 'gap' containing series shown in Table 3.5 - 3.7 are also 
listed. 
The results indicate that for 1 i 2, Eqn. 3.18b, and for τ > 2, Eqn. 3.18a 
leads to best estimates. In view of the magnitude of the time constants both 
equations were tested for (Table 3.4) i.e. autocorrelation functions which 
rapidly approach zero, this is according to expectation. 
74 
Tables 3.5, 3.6 and 3.7 
Results pertaining to simulation sessions 3,18 and 23, which characteristics 
are listed in Table 3.4, to test the validity of Eqn. 3.18a and/or Eqn. 3.18b 
in estimating the standard error of autocorrelation estimates φ(χ) when 
confronted with time series with missing values. 
Eqn 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Table 3 .5 Simulationsession 3 
time series without 
missing observations 
standard error 
of (f(T) 
accord 
3.19 
0.0831 
0.0957 
0.0932 
0.0878 
0.0900 
0.0933 
0.0972 
0.0922 
0.0953 
0.0950 
Table 3 
0.0419 
0.0495 
0.0539 
0.0508 
0.0490 
0.0471 
0.0455 
0.0536 
0.0610 
0.0534 
Table 3 
0.0377 
0.0441 
0.0453 
0.0524 
0.0535 
0.0469 
0.0456 
0.0462 
0.0483 
0.0486 
m g to 
3.13 
0.0759 
0.0900 
0.0929 
0.0934 
0.0935 
0.0936 
0.0936 
0.0936 
0.0936 
0.0936 
Eqn.3.13 
valid 
9 
3.20 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
t ime series with missing observations 
standard error 
of φ(τ) 
according to 
3.19 
0.1043 
0.1345 
0.1298 
0.1244 
0.1496 
0.1111 
0.1009 
0.1305 
0.1561 
0.1470 
.6 Simulationsession 18 
0.0428 
0.0507 
0.0523 
0.0526 
0.0527 
0.0527 
0.0527 
0.0527 
0.0527 
0.0527 
0 
0 
0 
0 
0 
0 
0 
0 
-* 
0 
0.0968 
0.1427 
0.1172 
0.1274 
0.1243 
0.1028 
0.0909 
0.1138 
0.1360 
0.1161 
.7 Simulationsession 23 
0.0370 
0.0439 
0.0453 
0.0456 
0.0456 
0.0457 
0.0457 
0.0457 
0.0457 
0.0457 
0 
0 
0 
-к 
*-
0 
0 
0 
0 
0 
0.0788 
0.0879 
0.1057 
0.1020 
0.1088 
0.C785 
0.0777 
0.0767 
0.0993 
0.0923 
3.18a 
0.0895 
0.1066 
0.1234 
0.1241 
0.1113 
0.1113 
0.1103 
0.1113 
0.1129 
0.1258 
0.0770 
0.1024 
0.1070 
0.1122 
0.1046 
0.0948 
0.0932 
0.1001 
0.1033 
0.1124 
0.0603 
0.0761 
0.0826 
0.0844 
0.0796 
0.0747 
0.0713 
0.0757 
0.0796 
0.0849 
Eqn.3.18a 
valid 
7 
3.20 
# 
* 
0 
0 
-X-
0 
0 
-* 
* 
* 
-X 
-* 
0 
0 
* 
0 
0 
0 
*-
0 
* 
x-
* • 
X 
it 
0 
0 
0 
0 
0 
standard error 
of φ (τ) 
according to 
3.18b 
0.1003 
0.1378 
0.1434 
0.1442 
0.1443 
0.1258 
0.1129 
0.1265 
0.1467 
0.1479 
0.0980 
0.1378 
0.1370 
0.1442 
0.1400 
0.1208 
0.1135 
0.1258 
0.1410 
0.1421 
0.0747 
0.1015 
0.1034 
0.1067 
0.1055 
0.0909 
0.0833 
0.0926 
0.1069 
0 1050 
Eqn.3.18b 
valid 
^ 
3.20 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
-* 
0 
0 
-* 
-X-
0 
0 
• * 
0 
0 
0 
0 
0 
0 
0 
-X-
0 
0 
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Table 3.8 
Results of Monte Carlo simulations to test the validity of Eqn. 3.18a (a) and 
Eqn. 3.18b (b) as estimators of the standard error of autocorrelation estimates 
computed from discrete time series with missing values, at time lags τ = 1,2,3, 
4, and 10. 
simulation τ = 1 τ = 2 τ = 3 τ = 4 τ = 10 
session a b a b a b a b a h 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
0 
•X 
-X 
0 
-X 
-X 
0 
* 
* 
0 
* 
•X 
-X 
* 
•X 
0 
-X 
* 
-X 
•X 
0 
0 
•X 
•X 
-X 
-X 
-X 
-X 
•X 
•X 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
-X 
0 
0 
0 
0 
-X 
X 
•X 
•X 
-X 
•X 
•X 
0 
0 
0 
-X 
* 
0 
0 
-X 
X 
-X 
-X 
-X 
0 
•X 
•X 
-X 
-X 
•X 
-X 
•X 
•X 
-X 
•X 
0 
0 
0 
0 
0 
0 
0 
0 
-X 
-X 
0 
0 
-X 
0 
0 
0 
0 
0 
0 
•X 
0 
0 
0 
0 
•X 
0 
0 
0 
0 
0 
0 
0 
0 
0 
-X 
0 
0 
0 
0 
0 
0 
•X 
0 
-X 
0 
0 
0 
0 
•X 
0 
0 
0 
* 
0 
X· 
-X 
0 
0 
X-
0 
0 
-X 
0 
•X 
0 
-X 
0 
0 
-X 
0 
-X 
0 
•X 
-X 
* 
0 
0 
•X 
0 
•X 
0 
X 
0 
* 
0 
0 
-X 
0 
0 
-X 
0 
0 
0 
•X 
•X 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
X 
0 
0 
•X 
-X 
-X 
0 
0 
0 
0 
X-
0 
•X 
-X 
0 
X-
0 
X 
0 
0 
X-
0 
0 
0 
-X 
-X 
X· 
0 
•X 
0 
0 
-X 
•X 
•X 
0 
X-
* 
•X 
X 
0 
•X 
•X 
0 
0 
X-
*-
0 
0 
0 
0 
0 
0 
0 
-X 
-X 
X 
0 
0 
0 
0 
0 
0 
0 
•X 
0 
0 
0 
-X 
0 
0 
0 
X-
0 
• * 
0 
-X 
-X 
-X 
0 
X 
•X 
0 
0 
0 
X-
•X 
-X 
0 
X 
* 
* 
-X 
0 
-K 
0 
X 
X 
0 
-X 
0 
•X 
X 
Each simulation session consisted of 100 mutually independent discrete time 
series, generated according to Eqn. 3.16. 
0 : the equation considered is appropriate following Eqn. 3.20. 
•X : the equation considered is not appropriate. 
The time constants were taken of this order since similar time constants were 
found for the analytical processes which are to be discussed in paragraph 4. 
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3.2.2 Reliability of the procedure for stationary stochastic processes with 
superimposed error 
Up till now, first order stationary stochastic processes were considered. In 
the following autocorrelation analysis of first order stationary stochastic 
processes with superimposed error is discussed. 
The time series available from such a process i.e. y , ...y , are considered 
to be the result of the superposition of two mutually independent stochastic 
variables i.e. ν = χ + У . For the autocovariance function of у this implies a t t t "'t 
ψ (τ) = ψ (t) + ψ (τ) τ = 0, 1, к 
уу XX νν 
and for the autocorrelation function: 
ψ (τ) + ψ (τ) 
φ
 (τ, =-«5 TL τ = 0, 1 к 
УУ s
2
 + s
2 
χ ν 
The origin of such an autocorrelation function lies in the fact that the 
observations of a discrete time series themselves are error prone due to 
measuring errors V . Consequently the observations of the time series do not 
reflect the exact value of the process variable studied, χ , at time of the 
sampling action, but χ + 0 . 
Hence indeed y can be considered as the sum of two mutually independent time 
series, whereby y is representative of the measurement error ν and of χ , 
the process value at the time of the sampling action. The time constant of the 
former will generally be small and when it is approximately zero, or at least 
smaller than the sampling frequency, the theoretical autocorrelation function 
of y , ρ (τ) , Henceforth denoted ρ (τ) , equals (4) : 
Ρ(0) = 1 τ = 0 
-Ι τ Ι/Τ 
ρ(τ) = a-e ' ' χ for τ ^  0 (3.21) 
with α 
<* 
ο
2
 + σ
2 
χ ν 
Comparing Eqn. 3.21 with Eqn. 3.12, shows that the latter is a special case 
of Eqn. 3.21, namely when σ = 0 i.e. α = 1. α is derived through extrapolation 
of the autocorrelation function to r = 0. (4) 
From a limi bed discrete series of observations however only estimates of ρ(τ) , 
φ(τ), can be obtained. The standard errors for autocorrelation estimates φ(τ), 
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obtained from such a series of tJ successive observations, being a sample 
realization of a first order stationary stochastic process with superimposed 
error is given by (4): 
аЧФСП) 
Ν-τ 
(l +e-
2 / r
x) . { l + n - ^ a V - ^ x }
 + 2 τ ( 1 . 2 α ) θ - 2 τ / Τ χ 
( l-e-2/2,x ) 
(3.22) 
For α = 1, i.e. σ = 0, Eqn. 3.22 leads to Bartlett's formula for deriving the 
standard errors of autocorrelation estimates when dealing with a first order 
stationary stochastic process, Eqn. J. 13. Hence Eqn. 3.13 is a special case of 
Eqn. 3.22. 
In the following, the estimation of a) Τ and a, and b) the standard errors 
of autocorrelation estimates φ(τ), from discrete time series with missing 
values, being representative of a first order stationary stochastic process 
with superimposed error, is discussed. 
A) Estimation of Τ and a. 
χ 
The procedure followed was apart from some modifications, similar to the one 
discussed in section 3.2. The modifications concerned: 
1. missing values were also created by omitting randomly observations 
2. the variance of the autocorrelation estimates were calculated according to 
following modified equations, of Eqn. 3.22. 
For τ > 2 : 
σ
ζ(φ(τ)) 
(/(τ) 
(1
+
е-
2 / У
х) . { ΐ
+
( 1 - 4 α
+
2 α 2 ) 6 -
2 τ / Γ
χ }
 + 2 τ {1.2α)Β^/Τχ 
( 1-е- 2/ Гх ) 
(3.23а) 
with Ж т ) equal to the number of observations actually involved when computing 
φ(τ). For r < 2: 
σ/(φ(τ)) 
Q[T) 
(l
+
e-
2 / T
x) Л і
+
( 1 - 4 а
+
2 а 2 ) е - 2 Т / У х }
 + 2 τ ( 1 . 2 α ) β - 2 τ / Γ χ ^ ^ 
( 1-e-2^ ) J 
with Ç(r) denoting the number of pairs of observations actually correlated 
when computing φ(τ). 
The validity of Eqn. 3.23a and 3.23b is demonstrated later in this section. 
First order stationary stochastic processes with superimposed error were 
generated according to Eqn. 3.16. This was achieved by generating a first 
order stationary stochastic process with properties Τ and a2, leading to the 
series X 
Γ 
.χ , and addition of V,, ...v generated accordingly but with ΐ 
η 1 η χ 
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Table 3.9 
Effect of missing values in time series on the estimated time constant and a, 
of first order stationary stochastic processes with superimposed error. 
simulation 
session 
1 
2 
3 
4 
5 
6 
7 
0 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
number of 
observations 
354 
354 
354 
354 
354 
354 
424 
424 
424 
424 
424 
424 
424 
424 
611 
611 
611 
611 
611 
611 
611 
611 
724 
724 
724 
% 
missing 
31 
31 
31 
31 
31 
31 
30 
30 
30 
30 
30 
30 
30 
30 
55 
55 
55 
55 
80 
80 
80 
80 
31 
31 
31 
gap free 
series 
Τ 
X 
9.8 
10.1 
11.3 
11.7 
15.4 
15.5 
8.4 
9.0 
9.3 
10.8 
12.7 
12.8 
13.4 
15.0 
16.5 
17.9 
19.3 
20.0 
15.4 
16.4 
16.9 
17.2 
14.9 
16.2 
18.7 
α 
0.56 
0.45 
0.98 
0.56 
0.76 
0.63 
0.51 
0.49 
0.81 
0.71 
0.86 
0.67 
0.69 
0.86 
0.82 
0.69 
0.83 
0.68 
0.82 
0.68 
0.68 
0.90 
0.71 
0.85 
0.68 
X 
(%) 
4.9 
0.7 
0.8 
5.6 
0.6 
0.7 
2.7 
1.6 
1.1 
0.2 
0.4 
1.3 
0.4 
1.6 
3.4 
7.7 
5.0 
1.9 
1.9 
30.8 
32.0 
1.9 
1.4 
0.3 
0.8 
Δα 
(%) 
0.5 
2.8 
1.2 
0.3 
2.9 
1.4 
3.7 
2.2 
1.1 
1.3 
1.2 
1.6 
0.8 
1.5 
8.3 
9.4 
3.6 
0.9 
2.9 
4.6 
4.3 
6 7 
0.4 
0.1 
0.3 
Δϊ* and Δα denote the absolute relative error between the average Τ and u 
x
 y
 χ 
of the discrete time series with and without gaps. 
Each simulation session consists of 10 independent simulations. 
approximately zero and variance α . 
Table 3.9 summarizes the results of the performed Monte Carlo simulations. 
Each of those sessions concerned 10 independent simulations generated with 
different starting values of the Monte Carlo simulation. Within each simulation 
session, the original 'gap-free' series consisted of N observations before 
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and Л/1 observations after creating missing values, leading to 100· (Λ/-Λ/1) /N -per 
cent missing values or gaps. Τ and α are the mean result of the Τ 's and 
a's computed for each of the gap-free series of the simulation session. 
Accordingly 1 and α of the 'gap-containing' series were calculated. The 
relative errors ΔΪ and Δα, were computed similar to the procedure followed 
in section 3.2. 
From Table 3.9 follows that: 
1. The time constants derived from the series with and without missing values 
are in close agreement and differ by less than 6°. 
In extreme situations the procedure sometimes yields less reliable results 
(Simulation sessions 20 - 21, where 1ST > 30%) 
χ 
2. Similar holds for a, with Δα's mostly less than 5%. 
Only simulation sessions 1 5 - 1 6 - 2 2 show larger discrepancies of 
aporoximately 8,9 and 7"„. 
3. With increasing t-missing values, larger Δ' and Δα are observed i.e. 
simulation sessions 15, 16, 20, 21. 
This could be expected in view of the magnitude of the time constants and 
the number of observations actually left in the series after creation of 
the gaps. 
The effect of missing values in time series was further investigated according 
to the following. 
In view of the Δα's shown in Table 3 9, simulation sessions were performed with 
constant a, in particular α = 0.7 (Table 3.10) . Here again each session is the 
result of 10 performed Monte Carlo simulations. With constant number of 
observations //, various processes with properties / and α = 0.7 were simulated, 
according to the procedure mentioned before. The mean time constants, Τ , for 
the 'gap-free' series, are listed in Table 3.10. Thereafter missing values 
were created randomly in the series, whereby within one simulation session the 
gaps were created at the same places in each of the 10 generated series. Δ2 
was computed as dealt with. After that, with the same starting value of the 
Monte Carlo simulation, the same series were again generated, leading to the 
same Γ for the gap-free series, within that simulation session, but now the 
% missing values was increased. This was again repeated for still higher % 
missing values. 
Thus each simulation session shows the effect of increasing number of missing 
values in time series when dealing with the same process on the magnitude of 
the estimated time constant of that process. In Table 3.10 this is denoted 
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Table 3.10 
Effect of missing values in time series on the estimation of the time constant 
of a first order stationary stochastic process with superimposed error. 
(All simulation sessions performed with α = 0.7) 
simulation number of gap free 
session observations series 
la 
b 
a 
2a 
b 
с 
За 
b 
a 
4a 
b 
a 
ba 
b 
с 
6α 
Ъ 
a 
la 
Ъ 
а 
8α 
Ъ 
а 
9а 
b 
а 
10а 
b 
а 
На 
Ъ 
а 
12а 
b 
а 
270 
270 
270 
540 
540 
540 
724 
724 
724 
810 
810 
810 
3.6 
7.0 
8.0 
4.4 
12.2 
16.0 
6.9 
10.5 
18.5 
5.0 
9.4 
12.9 
missing 
28 
45 
66 
28 
45 
66 
28 
45 
66 
28 
45 
66 
28 
45 
66 
28 
45 
66 
28 
46 
68 
28 
46 
68 
28 
46 
68 
28 
46 
68 
28 
46 
68 
28 
46 
68 
Δϊ
χ 
(î.) 
3.5 
7.9 
8.5 
3.3 
7.8 
10.1 
10.3 
13.0 
30.0 
0.3 
4.0 
1.9 
1.2 
3.6 
20.4 
2.7 
1.4 
8.2 
1.0 
4.7 
7.8 
0.5 
5.0 
1.4 
7.1 
2.9 
14.0 
1.1 
1.1 
3.3 
0.5 
1.0 
2.6 
0.5 
0.8 
4.4 
The notation is the same as used in Table 3.9. 
as for example simulation session 1, а, Ъ, с indicating % missing values of 
28, 45 and 66. 
At higher time constants this procedure was repeated with the same number of 
observations actually in the 'gap-free' series. 
The Δα for all sessions shown in Table 3.10 was less than 5% and is therefore 
not contained. 
From Table 3.10 following observations were made: 
1. With increasing % missing values at constant N and Τ , there is a trend for 
increasing à? . 
χ 
2. With increasing Τ at constant /V and constant % missing values of 28 and 
46%, ΔΓ stabilizes within the uncertainty of the derived results. 
With 66 - 68% missing values there is a slight trend towards higher ΔΪ" . 
3. The overall result indicates that up to approximately 46% missing values 
may be contained in discrete time series to obtain a time constant 
estimate with an absolute relative error less than = 10%. 
The reliability of the procedure increases a) with decreasing number of 
missing values and b) with increasing total number of observations in the 
series, which is according to expectation. 
B) Effect of missing values in time series on the standard errors of auto­
correlation estimates. 
The procedure followed was similar to the one described in section 3.2.1. The 
equations tested concerned Eqn. 3.23a and 3.23b. 
Table 3.11 summarizes the properties of the performed Monte Carlo simulations 
and the results obtained at time lags τ = 1 - 4. In Table 3.11 the same 
notation is used as dealt with m section 3.2.1. 
From Table 3.11 follows. 
1. τ = 1: Eqn. 3.2 3b is valid at all levels of Τ and α except for simulation 
session 20. 
For 'f > 7 Eqn. 3.23a yields practically identical results 
2. τ = 2: For Τ > 10 preference for Eqn. 3.23a 
For 1 < 10 both equations yield practically similar results 
3. τ > 2: Distinct preference for Eqn. 3.23a 
From these findings it was concluded that, for the range of time constants 
and a's considered, the standard error of the autocorrelation estimate at time 
lag τ = 1, is best approximated by Eqn. 3.?3b, and that at time lags τ > 1 
these are best approximated by Eqn. 3.23a, when the series is considered 
to stem from a first order stationary stochastic process with superimposed 
error. 
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Table 3.11 
Results of Monte Carlo simulations to test the validity of Eqn.3.2 3a (a) and 
Eqn. 3.2 3b (b) as estimators of the standard error of autocorrelation estimates 
at time lags τ = 1 - 4. 
The results concern the situation where these estimates are derived from 
discrete time series with missing values which are considered to be representa­
tive of a first order stationary stochastic process with superimposed error. 
simulation 
session 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
gap 
Τ 
X 
7 
7 
7 
7 
7 
10 
10 
10 
10 
10 
16 
16 
16 
16 
16 
20 
20 
20 
20 
20 
free series 
α 
0.94 
0.90 
0.85 
0.80 
0.40 
0.90 
0.85 
0.80 
0.75 
0.55 
0.91 
0.85 
0.80 
0.75 
0.65 
0.98 
0.93 
0.80 
0.80 
0.65 
m 
750 
200 
450 
350 
750 
450 
300 
750 
600 
700 
750 
250 
750 
450 
650 
200 
360 
450 
750 
750 
% 
missing 
28 
45 
38 
37 
46 
28 
28 
53 
52 
46 
29 
44 
38 
46 
38 
28 
28 
38 
38 
28 
1 = 
a 
0 
• * 
* 
-K 
·* 
0 
0 
-* 
0 
0 
0 
-* 
0 
0 
0 
-X 
0 
0 
0 
0 
1 
b 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
* 
τ= 
a 
0 
0 
0 
* 
* 
0 
X-
•X 
0 
0 
0 
0 
0 
0 
0 
* 
0 
0 
0 
0 
=2 
b 
* 
•X 
0 
0 
0 
0 
0 
0 
0 
•X 
0 
•X 
•X 
•X 
X· 
0 
* 
* 
*· 
•X 
τ= 
a 
0 
0 
0 
0 
•X 
0 
0 
0 
0 
0 
0 
0 
0 
•X 
0 
0 
0 
-X 
0 
0 
=3 
b 
•X 
-X 
-X 
•X 
•X 
-X 
0 
•X 
-X 
•X 
•X 
•X 
-X 
•X 
* 
0 
•X 
•X 
•X 
-X 
τ= 
a 
* 
0 
0 
0 
* 
0 
0 
0 
0 
0 
0 
0 
* 
•X 
0 
0 
0 
•X 
•X 
0 
=4 
b 
X-
•X 
•X 
•X 
0 
•X 
•X 
•X 
•X 
•X 
-X 
•X 
•X 
•X 
-X 
0 
•X 
-X 
•X 
•X 
Each simulation session consisted of 100 mutually independent generated discrete 
time series. 
0 : the equation considered is appropriate following Eqn. 3.20. 
•X : the equation considered is not appropriate. 
Pertaining to the gap free series: 
N: number of observations 
'J' : time constant 
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3.3 Influence of rounding-off errors on the magnitude of the time constant 
The quality control data submitted by some of the participants were in several 
instances adversely influenced by rounding-off errors. (Sec. 2.6.1) 
The effect of rounding-off errors on the magnitude of the estimated time 
constants from autocorrelation analysis of discrete time series, with and 
without missing values, being representative of a first order stationary 
stochastic process, is now of concern. 
To that purpose 13 simulation sessions, each conbisting of 10 mutually 
independent discrete time series were performed. These time series were 
generated according to Eqn. 3.16, and missing values were created according to 
the procedure described (Sec. 3.2). The effect of roundmg-off data in time 
series and the implication this has on the estimated time constant from 
autocorrelation analysis was investigated per simulation session as follows. 
From the 10 gap free series, the average standard deviation and average time 
constant Τ were calculated. Thereafter the data in each of these series were 
χ 
rounded-off at 1 decimal place and the average time constant Τ (0.1) was 
calculated. For the same series after creating missing values, similarly the 
average time constant before and after rounding-off was calculated. 
Table 3.12 summarizes the results of the performed simulation sessions and 
contains following information: 
column information contained 
1 simulation session number 
2 number of observations in each of the gap free series the simulations 
session is composed of 
3 roundmg-off criterion 0.6 xs (14), with s being the average standard 
deviation of the 10 mutually independent generated gap free time 
series, whereby the observations were not rounded-off. 
4 average time constant of the gap free series 2 
5 discrepancy ¡\T (0.1) between the average time constant of the gap 
free series with and without rounding-off errors of the observations 
in the series: 
Δ?' (0.1) 
χ 
Τ (0.1) - f 
χ з 
г" 
χ 
100% 
6 %-missing values created in the series of that simulation session. 
7 discrepancy ΛΓ between the average time constant of the series with 
and without missing values, whereby the observations in both series 
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were not rounded-off. This discrepancy was computed according to 
Eqn. 3.17 only here not the absolute relative error is given but 
strictly the relative error 
8 discrepancy ΔΪ (0.1) between the average time constant of the gap 
containing series whereby the observations were rounded-off at 1 
decimal place and Τ (column 4). 
Table 3.12 
The effect of rounding-off data in discrete time series and its influence on 
the magnitude of estimated time constants from autocorrelation analysis. 
gap free series gap containing series 
simulation % 
:ssion 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
N 
726 
726 
726 
359 
319 
319 
319 
319 
196 
196 
196 
162 
162 
0.6 χ s 
0.102 
0.104 
0.103 
0.047 
0.270 
0.272 
0.030 
0.270 
0.063 
0.063 
0.059 
0.029 
0.042 
Τ 
χ 
1 
3 
6 
1 
1 
2 
2 
3 
1 
2 
3 
2 
3 
ΔΤ (0.1) 
χ 
-2.4 
-4.7 
-5.2 
-9.7 
-0.5 
-0.1 
-28.3 
-0.9 
-4.9 
-9.1 
-7.6 
-26.0 
-26.7 
missing 
31 
31 
31 
31 
31 
31 
32 
31 
39 
39 
39 
33 
33 
LT 
χ 
1.0 
-3.6 
0.4 
5.8 
3.7 
-1.3 
0.7 
-0.4 
-3.4 
5.2 
0.7 
-8.4 
2.4 
ΔΓ (0.1) 
χ 
-1.4 
-7.9 
-4.8 
-7.2 
2.7 
-1.4 
-24.7 
-1.4 
-9.2 
-5.7 
-6.9 
-26.8 
-24.4 
From Table 3.12 follows: 
1. The time constants derived from the gap free and the gap containing series 
(column 7) are in close agreement according to expectation. (Sec. 3.2) 
2. Rounding-off the observations introduced for both gap free and gap containing 
series a negative systematic error in the estimated time constants (column 
5 respectively 8), according to expectation. 
3. The magnitude of this systematic error is comparable for both gap free as 
well as gap containing series. 
4. For practical use, this bias is negligible. Only when the observations in the 
series are rounded-off to an extent that is in severe conflict with the 
roundmg-off rule (column 3) , the estimated time constants may be sub­
stantially affected, (simulation sessions 7,12 and 13) 
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3.4 Relationship between the autocorrelation technique and an analysis of 
variance scheme in time series analysis of first order autoregressive 
stochastic stationary processes * 
Summary 
Autocorrelation analysis of time series yields information on the transient 
behaviour of such series. An appropriately designed scheme for the analysis of 
variance can, in principle, give the same information. A relationship between 
the two techniques, with regard to their ability to verify and quantify a 
time constant of first order autoregressive stochastic stationary process, 
is described. Monte Carlo simulations were performed to test the validity and 
applicability of the theory. A practical example of the procedure is included. 
Introduction 
Quality control procedures are indispensable for maintaining working standards 
in clinical chemistry laboratories. The goal is to assess the accuracy and 
precision of analytical procedures and to detect deviations from a target value. 
Any deviations can then be suppressed so that their accumulation does not cause 
the analytical procedure to run out of control. In clinical chemistry, quality 
control standard sera containing analytes such as calcium, urea, cholesterol, 
etc. are used. Samples of these standards are included in series of unknown 
samples which are analyzed for the particular analyte so that the performance 
of the analytical procedure during the working time can be assessed. Statistical 
analysis of the quality control data then indicates the accuracy and precision 
of the analytical procedure. 
Dynamic aspects of these analytical procedures are under current investi­
gation. (1) The underlying hypothesis is that an analytical procedure can be 
represented as a first order autoregressive stochastic stationary process. 
Figure 1 shows the analytical procedure as the process, with underlying 
disturbances χ it), that converts a physical or chemical quantity of samples, 
* Limonard, C.B.G., and Pijpers, F.W., Anal. Chim. Acta, Computer Techniques 
and Optimization, 103, 253, 1978. 
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into a quantity representative of these samples i.e. data. The quality control 
data, measured at equally spaced time intervals Τ , contain the information on 
A 
the behaviour of the process. These data are assembled by the measuring unit M, 
which in turn is subject to measuring errors, V{t). Interventions initiated by 
control unit C, based on the quality control data, are intended to neutralize 
the effects causing the discrepancies from the target value. For appropriate 
interventions to be made, the measurements must conform to the actual process 
value as closely as possible. The efficiency of the control unit (Fig. 1) 
can be derived from the measurability and controllability rules of Van der 
Grinten (2). 
m r i E N T AND QUALITY 
CONTROL SAMPLES ANALYTICAL 
PROCEDURE 
tWIENT AND QUALITY 
CONTROL DATA 
/J' 
Fig. 1 Schematic diagram of an analytical procedure as a process to be 
controlled. M, measuring unit; C, control unit; 1/T' , sampling frequency of 
quality control data; ν(t), measuring errors; x{t), disturbances causing the 
process to run out of control. 
The practical application of these rules is that the efficiency of various 
control systems can be quantified and compared. The important characteristics 
are the analysis time, the sampling frequency, the standard deviation and time 
constant of the process, and the measuring errors V(t). The time constant of 
the process, Τ , is inversely proportional to the rate of the process 
fluctuations. 
Autocorrelation analysis makes it possible to identify processes from discrete 
time series, m this case quality control data over a prolonged period of time. 
The technique allows quantification of Τ . A necessity for application of the 
technique is that data over a large time span are available or can be collected. 
During the project mentioned (1), situations arose where these data were not 
available from files documenting the recent history of a laboratory. However, 
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some laboratories could retrieve the results of analysis of variance schemes, 
because such schemes formed part of their laboratory control systems. The basic 
idea behind the present investigation is that both autocorrelation and analysis 
of variance give information on the transient behaviour of a process. It is 
demonstrated that the time constant Τ of a first order autoregressive 
χ 
stochastic stationary process can be estimated from the results of an appro­
priate analysis of variance scheme. A functional relationship between auto­
correlation and analysis of variance for such processes is derived. Monte 
Carlo simulations were done to test the validity and applicability of the 
theory, й practical example is given. 
AutocorreZation 
The processes investigated are considered to be first order autoregressive 
stochastic and stationary. This means that the process value x at time t 
is not fixed by a mathematical model, but is defined only as probability 
distributions p{x ) . For Gaussian processes this distribution is determined 
by the mean value £(x ) and the standard deviation σ
χ
 (3): 
E(x ) = ƒ av · ρ ( · 0 Ac,. a n d σ2 = / {χ- E(xJ}2 p(xj dx t t t t χ „ t t t t 
If E(x ) and σ are constant in time, the process is called stationary. In t x t 
this case E(x) and σ
χ
 can be estimated from a limited time series, consisting 
of N values observed at constant time intervals. Thus 
_ ι N I N _ 
χ = — · Τ χ and s 2 = Σ ( χ - χ )2 
Ν ι=1 1 Χ Ν - 1 ι=1 1 
The correlations between successive observations are calculated by computing 
the autovanance estimates, ψ (τ), from 
XX 
Λ-τ _ 
ψ ( τ ) = Σ ( a: - χ )·{ χ - χ ) / ( Ν - τ. ) (τ = 0, 1, ...m) (1) 
χχ , ι ι+τ 
1 = 1 
where τ is the time lag expressed in units of sampling interval and N is the 
length of the series in the same units. Autocorrelation estimates, φ (τ), are 
then obtained from φ (τ) = ψ (τ)/ψ (0) where τ = 0, 1, ... m. For first 
XX XX XX 
order stochastic stationary processes, the autocorrelation function φ (τ), is 
a contmuonsly decreasing function described by φ ( Τ) = exp ( -τ /2' ) , in which 
Τ , the time constant of the process, is a measure of the frequency of the 
process flustuations. For Τ = 0 all frequencies occur and such a process is 
called 'white noise'. 
Analysis of variance 
The analysis of variance (anova) technique permits estimation of one or more 
factors suspected of contributing significantly to the total uncertainty of a 
measured quantity. Generally, a scheme is designed which allows the mean square 
between groups, s¿, to be estimated in relation to s , the mean square within 
В w 
groups of time series. 
Here the variance of the measured quantity with respect to its average value 
over a considerable period of time, is compared with the variance of the same 
quantity over a relative short period. For a first order autoregressive 
stochastic stationary process (henceforth called process), with Τ ~ 0, this 
would result in equal expected values for both variance estimates, whereas a 
process with Τ φ 0 (provided that the sampling frequency is greater than Τ ), 
should show a smaller variance for the short period than for the total period, 
because of the correlation between successive measurements. 
Theoretical model 
According to this anova scheme, the ratio s /s, is given by 
-, w b 
κ η _ 
Σ Σ ( χ - χ f 
i-I ^ ^ 3 1 -( к ν _ 
2 пк( η 
1 ) 
1 ) 
'к 
Σ ( χ - χ ) 2 
ι=1 1 
(2) 
Whereby ί; is the number of groups; η is the number of measurements a; per 
1.3 _ 
group,- χ is the mean value of the η measured quantities of group i; and χ is 
the mean value of all n.k (=tl) measurements. After the process has been sampled 
at a constant sampling rate, the time series consists of ¡ι! observations. Groups 
are formed from equal sets of consecutive measurements and the ratio shown in 
Eqn. 2 is calculated. The autocorrelation estimate, φ(1), which is the maximum 
likelihood estimate of Τ , is also computed. 
In order to relate the 1/T value of this calculated estimate to the results 
χ 
of the anova scheme, the summations in Eqn. 2 are rearranged to give 
к η к η 2 
( fe-1 ) 
к ( n-1 ) 
η Σ Σ χ 
1 . 3 
Σ {Σ χ } 
ι 3 ^ 3 (3) 
г к η к η 2 
Σ { Σ χ } -Ι/ΗΣ Σ χ } 
1.3 ι <3 
1 3 1 3 . 
w i t h к } = 
1 
к 
Τ and 
ι = 1 
η 
τ = 
3 
η 
ί 
3 = 1 
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г
и 
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ι - D 
-
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In Eqn. 4, all χ values have been diminished by X, in accordance with the auto­
correlation technique. The summation of the denominator can be expended: 
( X , - X f + ( X „ - X ) 2 + + ( χ - X ) 2 
1,1 1,2 ι ,n 
+2 Σ ( a; . - x ) (a; . - χ ) + 1,1 1,2 + Σ ( χ . - a; ) ( a; - x ) 
i,n-l i,n 
+2 Γ ( χ - χ ) (χ 
ι,1 ι,3 
) + 
к 
+ Σ ( χ ., - Χ ) ( ~ - Χ 
ι,η-2 ι,η 
+2 Σ ( χ , - χ ) ( χ - χ ) 
ι,Ι ι,η 
ι 
The expression in the first set of curly brackets is an estimate of η. ψ(0) 
(Eqn. 1 for 1 = 0 ) ; in the second set, ψ(0)·( n-1 ) exp ( -1/7 ), ( Eqn. 1 for 
τ = 1); in the third set ψ(0)·( η-2 ) exp ( -2/T ) ; and in the last 
ψ(0) · {η- (r-1)} exp ( - ( n-1 )/T ) . 
Substitution in Eqn. 4 and some rearrangement yields 
( 7ч-1 ) 
' ( '--I ) 
1 - 2 Σ ( η - j )/n exp ( -j/T 
(5) 
1 + 2 Σ ( η - 3 )/n exp ( -j/T ) 
3 x 
In Eqn. 5, s /s is used instead of s /s , the more commonly used expression 
w b b w 
in the anova scheme, because of the limiting values of the former expression, 
which are 0 and ( k-\ )/k for Τ •* °° and Τ -+ 0, respectively. 
In the derivation of Eqn. 5 it was assumed that the time series are a sample 
from an infinite population of such series, representative of a first order 
autoregressive stochastic stationary process. 
bimulation model 
First order autoregressive stochastic stationary processes were simulated with 
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a discrete 'white-noise' generator from the IBM library. With и representing 
a discrete white-noise process with zero mean, variance σ equal to one, and 
Π ( и ' и ) = 0 for m ¿ η, a. Markov process can be generated (4) : 
η m 
x . = ax + bu (6) 
where a = exp ( -1/T ) and σ = b · (1-a2) . Time series of 1024 observations 
X X 
with various Ι/Γ values were generated and s /s, values were calculated. The 
χ w b 
ratio of the number of measurements within groups (и) to the number of groups 
(k) was varied from 2:512 to 512:2 in multiples of four for each simulation. 
Results and discussion 
Highly correlated x values were obtained upon substitution of \/'l -values of 
approximately zero in Eqn. 6. In such time series, a was small, approaching 
w 
zero as ¿' •* <». As s, had higher values than s2, the ratio с /s, approached 
χ b w w b 
zero for all ratios of n/k. 
Generating a process with high Ι/Γ values gave time series with practically 
uncorrelated χ values. Here the ratio s /s, depended on the number of groups 
t w b 
к only and approached the asymptotic value ( к - 1 )/к. 
These observations are in close agreement with the graphical representation 
of Eqn. 5 shown in Fig. 2, where s /s, is plotted as a function of 1/T for 
w b χ 
likelihood estimate of this parameter, from the equation φ(τ) = exp ( - τ/Τ ), 
various values of k. Here Τ was computed from φ(1), which is the maximum 
f 
and the value was substituted m Eqn. 5. 
Table 1 gives a comparison between the experimental s 2/s 2 ratios calculated 
w b 
from Eqn. 5, and those predicted by calculation by anova from the generated 
time series. An increase in n, which directly implies a decrease in k, results 
in larger deviations between predicted and simulated values. To test the 
dependence of the predicted ratios on k, at constant total time, eight mutually 
independent simulations were performed, all with Τ = 1.0, a =1.0 and χ = 1.0 
_
 x x 
(Table 2). The last columns show that both χ and S values agree well with the 
χ _ 
input values. The bottom two lines demonstrate that y , the average over eight 
measurements of 8 /s, , and s,, increase with increasing n. This is accordance 
w b Уп * 
with the results obtained for other values of 1/T . The increase in s,, as a 
χ »n 
function of к is due to a reduction in the number of groups k; its influence 
on the variance of У is illustrated in Fig. 3. With increasing s,, , the 
n
 un 
predictability of s2/s^ decreases; this is illustrated in the same figure by 
w b , 
plotting | y - y I/y . a s a function of 1/k ; 
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Fig. 2. S /s, ( = и ) ratio as a function of l/T according to Eqn. 5 for 
w b ^ χ 
various numbers of groups h. 
Fig. 3. Standard deviation of eight s /s, ratios from independently simulated 
w b 
time series with χ = 1.0, s = 1.0, and Τ = 1.0 as a function of \/k , 
X X 
where к is the number of groups, compared with relative differences 
between calculated and simulated s /s, ratios (о) s,, 
w b an 
C0>b -2/ th /У th 
Table 1 
Comparison between experimental and predicted s2/s/~ values calculated from 
w b 
Eqn. 5 for various l/T values and к = 1024/n 
1/T 
X 
η 
2 
4 
8 
16 
32 
64 
128 
256 
512 
Exp. 
0.18 
0.16 
0.15 
0.17 
0.26 
0.30 
0.17 
0.19 
0.09 
0 
s
2 
w 
36 
/ sb 
Cale. 
0.18 
0.16 
0.16 
0.16 
0.16 
0.16 
0.16 
0.16 
0.12 
Exp. 
1.04 
0.99 
0.98 
0.99 
1.10 
1.16 
1.43 
0.99 
0.36 
4 
? 
w 
.84 
Cale. 
0.98 
0.98 
0.98 
0.97 
0.95 
0.92 
0.86 
0.74 
0.49 
Exp. 
1.05 
1.00 
0.99 
0.99 
1.10 
1.17 
1.44 
0.99 
0.36 
5 
s
2 
w 
10 
Cale. 
0.99 
0.98 
0.98 
0.97 
0.96 
0.93 
0.86 
0.74 
0.49 
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Table 2 
Eight independent simulations with 1/5" = 1.0, s 1.0 and 1.0 
η
 ; 
a 
b 
с 
d 
e 
f 
В 
h 
« Ж • 
= 2 
0 493 
0 "ils 
0 436 
0 396 
0 517 
0 443 
0 446 
0 432 
Уп 
4 
0 480 
0 449 
0 422 
0 364 
0 514 
0 472 
0 468 
0 444 
8 
0 489 
0 504 
0 384 
0 387 
0 495 
0 530 
0 457 
0 372 
16 
0 556 
0 499 
0 358 
0 378 
0 498 
0 588 
0 529 
0 369 
32 
0 799 
0 536 
0 311 
0 295 
0 546 
0 460 
0 498 
0617 
64 
1 000 
0 495 
0 258 
0 290 
0 508 
0 596 
0 455 
0 695 
128 
0 678 
0 742 
0 197 
0 354 
0 535 
0 570 
0 413 
1 013 
256 
0712 
0 463 
0 099 
0 216 
0 311 
0 550 
0 366 
1 919 
512 
0 316 
1 960 
0 034 
0 254 
0 184 
0 528 
0 250 
1 483 
je 
1 062 
1 018 
1 037 
0 977 
0 925 
0 936 
0 956 
1 015 
«χ 
0 983 
1 010 
1 040 
1 018 
0 966 
0 994 
1 008 
1 018 
у
п
 0 460 0 451 0 452 0 472 0 508 0 537 
s
v
 0 043 0 045 0 062 0 091 0 163 0 236 
0 562 О 580 0 626 
О 253 0 574 0 702 
Гог the above example, it is clear that prediction of a ¿/-value with an accuracy 
>85% from a time series with s =1.0, the value of l/fe"5 should be less than 
0.2, i.e. more than 25 groups are required. (See numerical example in Table 3.) 
Table 3 
Comparison between calculated and predicted S /s, values as a function of the 
w b 
number of groups 
к 
512 
256 
128 
64 
32 
16 
8 
4 
2 
a 
0.461 
0.444 
0.445 
0.447 
0.443 
0.431 
0.403 
0.346 
0.231 
\ l 
0.460 
0.451 
0.452 
0.472 
0.508 
0.537 
0.562 
0.580 
0.626 
о 
8
Уп 
0.043 
0.045 
0.062 
0.091 
0.162 
0.236 
0.253 
0.574 
0.702 
0.044 
0.063 
0.088 
0.125 
0.177 
0.250 
0.353 
0.500 
0.707 
^-»tJ^th 
0.002 
0.016 
0.016 
0.056 
0.147 
0.246 
0.395 
0.676 
1.710 
''calculated 82/ч,2 from Eqn. 5 with / = 1.00. 
, w b χ 
Mean s /s, from eight independent simulations with j 
w b χ 
Standard deviations of eight с /ь values (Table 2). 
w b 
1.00 (Table 2) 
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Table 4 
Comparison between Τ values calculated from Eqn. 7, with substitution of s2/s,2 
χ w b 
directly, computed from the anova scheme, and those derived from the auto­
correlation estimate φ(1) of the time series. 
run 
a 
b 
a 
d 
total time 
к 
(days) 
268 
146 
228 
283 
S
2/S¿ 
w b 
iy) 
0.284 
0.246 
0.312 
0.353 
Τ 
X 
from eqn. 7 
1.7 
2.0 
1.5 
1.4 
Τ 
X 
from φ ( 1) 
2.0 
1.9 
-
-
l/fe'ï 
(%) 
6 
8 
7 
6 
Example of applzcation to cLinical data 
Table 4 gives an example of the application of Eqn. 5 to clinical chemical 
data. During the period 1974/1975, four control sera were used to surveil a 
urea determination. The total time during which each of these sera was used 
is listed in column 2. For the more recently employed control sera (groups 
a. and Ъ) actual analytical results as well as results from a one-way analysis 
of variance (5) were available. The anova scheme permitted the calculation of 
between-day and withm-day variance contributions and thus s 2/s 2 (Eqn. 7, 
w b 
next page). Laboratory organization was such that every analysis series 
included one control serum sample to check the performance of the procedure; 
the quality control samples, within a working day, were used at equally spaced 
intervals. Various analysis series were run per day. For the control sera 
(groups a and b) , the autocorrelation estimate ф(1) was calculated from 
ф(1) = ψ;ΐ)/ψ(0) and τ was estimated. Τ was also computed from the anova 
results obtained from the measurements of these sera by Eqn. 7 on substitution 
of the s2/s. ratio from the laboratory files. It can be seen that the results 
w b 
of the two methods agree well. For the older groups (c and d) only anova 
results were available. The Τ estimates listed in column 4 of Table 4 stem 
χ 
from these data and were obtained by application of Eqn. 7 after substitution 
of the s 2/s 2 ratio from the anova results. 
w b 
The values of £ are expressed in units of 'time required to process one 
complete analysis series of patient and quality control samples'. This time 
unit depends on the number of analysis performed per series and may vary between 
40 and 50 min. Up to twelve analysis series per day were available. 
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However, because extra series did not change the numerical value of the s /s, 
vi b 
ratio (Eqn. 5) significantly, the ratio was computed from two equally spaced 
quality control results, which were obtained m two successive analysis series. 
In such a situation, when η = 2, Eqn. 5 reduces to 
< 
^ = l n 
T
x 
-Í/T • 
1
 + e-
1/2x 
1 - к ( у + 1 ) 
1 + fe ( у - 1 ) 
(7) 
where fe is the total time expressed in days. The results listed in column 4 of 
Table 4 were calculated using this equation. 
Conalusbons 
Based on the theory of first-order autoregressive stochastic stationary pro­
cesses, the relationship derived between a one-way analysis of variance scheme 
and the autocorrelation technique is shown to be valid and applicable for esti­
mation of the time constant of first order autoregressive stochastic stationary 
processes from discrete time series. 
In situations where original data are not available but analysis of variance 
results are, the time constant can be estimated after it has been verified that 
the processes under investigation are indeed first order autoregressive sto­
chastic and stationary. Verification of such a model from the analysis of 
variance results alone is impossible. Consequently, it is necessary to 
ascertain if the process investigated is of this kind. 
The project investigating the dynamic behaviour of analytical processes in 
clinical chemistry laboratories was based on the hypothesis that analytical 
procedures can be represented as first order autoregressive stochastic 
stationary processes. The results of autocorrelation analysis applied to the 
data of one of the participating laboratories confirmed this assumption (1). 
Consequently the relationship derived between the output of a one-way analysis 
of variance scheme and the results of autocorrelation analysis was investigated 
for this practical example. 
The results indicate the validity of the procedure with discrepancies of + 15% 
and - 5%, respectively, when both techniques were applied to the same discrete 
time series. These discrepancies do not hamper practical application of the 
95 
time constant in measurability and controllability rules for quantifying the 
efficiency of the quality control systems of a laboratory. 
The estimated time constants (1.5 and 1.4) of the series where only analysis 
of variance results were available, confirmed the behaviour of the process, 
i.e. a time constant between 1 and 2 analysis series. The merit of the derived 
relationship between analysis of variance and autocorrelation is that although 
original data were not available, time constants could still be estimated. 
The autocorrelation technique is preferable for verifying the time constant 
of a process, because it also indicates the correctness of an applied model. 
However, where this is impossible and where it can be presumed that the data 
under consideration stem from a first order autoregressive stochastic stationary 
process, the derived relationship gives insight into the transient behaviour 
of the process. 
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3.5 Processes with a deterministic trend component 
To this point, the theory presented assumed that the time series were stationary. 
The time series actually worked with during the present investigation, however 
sometimes exhibited a non stationary behaviour. Such a behaviour was caused by 
the fact that the mean value of the time series was a function of time other 
than a constant function, as dealt with previously. In the former situation, 
the process quantity studied y , can be represented as 
yt = ^ t + / t (3.24) 
with χ representing the stationary stochastic component with properties Τ 
and σ , and with ƒ denoting the deterministic or trend component. 
When the course of the trend, with slope S and constant shift D is given by 
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ƒ = S · t + D. (3 .25) 
J
 t t t 
The t h e o r e t i c a l a u t o c o r r e l a t i o n function of y , ρ ( τ ) , i s approximately 
given by (4) 
φ ν
2 / 1 2
 + σ
2
 e - | T l / T
x 
ρ ( τ ) = (3 .26) 
5 2 - / 2 / 1 2 + σ 2 t χ 
with S ·. slope of the trend component (Eqn. 3.25) 
N : number of observations in the time series = observation time 
expressed in units of sampling interval 
σ
2
 : variance of the stationary stochastic component 
Τ : time constant of this component 
From Eqn. 3.26 it is seen that ρ(τ) is dependent on the observationlength from 
which the autocorrelations are calculated and also that when σ2 is much smaller 
χ 
than S 2 · /V2/12, ρ(τ), equals 1 for all lags τ. In particular Eqn. 3.26 offers 
the possibility to estimate the slope S^of the trend component of a process 
directly from the autocorrelation functnon. 
In the following the effect of missing values in time series on the estimation 
of the slope 5 of the trend component, from autocorrelation analysis of 
processes exhibiting such a behaviour, is of concern. 
3.5.1. Effect of missing values in time series on the estimation of the slope 
of a process with a trend component 
The procedure followed to investigate the effect of missing values in time 
series on the estimation of the slope of the trend component of a process 
exhibiting such a behaviour, was the following. 
First order stationary stochastic processes with properties I and σ2 were 
generated according to Eqn. 3.16 leading to the time series x,, x„, , χ . 
1 2 η 
After that a deterministic component ƒ (Eqn. 3.25) was simulated with 
properties S and D , leading to the series ƒ ƒ , , f . Addition of 
both a; and /-series at time t = 1, , PI, subsequently led to the senes y , 
y , , y (Eqn. 3.24). Missing values, located at the same places in each 
of the series of that simulation session, were created by randomly omitting 
observations in the series. After that the autocorrelation function of each 
of the series was calculated and a non weighted least squares fitting procedure 
was used to estimate ¿ and ± from this function. The average 3 and Τ per 
t χ t χ 
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Table 3.13 
Effect of missing values in time series on the estimation of the time constant 
and slope from autocorrelation analysis, when the process contains a stationary 
stochastic component and a trend component with slope 5.· 
simulation 
session 
la 
b 
a 
2a 
Ъ 
a 
3a 
Ъ 
о 
4a 
b 
c 
5a 
b 
с 
6a 
b 
с 
la 
b 
a 
8a 
b 
с 
gap free series 
number of 
observations 
<;/) 
270 
720 
270 
720 
270 
720 
270 
720 
slope 
<£t) 
0.0005 
0.0005 
0.0010 
0.0010 
0.0015 
0.0015 
0.0020 
0.0020 
gap containing 
% 
missing 
20 
37 
45 
28 
37 
45 
28 
37 
45 
28 
37 
45 
28 
37 
45 
28 
37 
45 
28 
37 
45 
28 
37 
45 
Δϊ'χ 
(1) 
-13.5 
-7.0 
13.5 
2.5 
-3.7 
9.1 
19.0 
32.1 
20.9 
-5.8 
11.9 
-1.5 
-17.5 
6.5 
1.2 
-5.5 
-18.0 
-30.0 
18.5 
19.9 
-20.0 
-17.7 
-26.3 
-33.2 
series 
AS 
Г-.) 
5.В 
-5.8 
2.9 
0.0 
-2.1 
-3.1 
1.8 
2.9 
-4.1 
-0.5 
3.4 
2.0 
0.0 
4.5 
7.1 
-0.3 
1.3 
2.0 
0.0 
-6.5 
6.5 
0.0 
2.0 
0.5 
Each simulation session consisted of 10 mutually independent generated discrete 
time series. 
During all simulation sessions the time constant of the stationary stochastic 
component Τ was 1. 
simulation session subsequently were calculated and these are listed in Table 
3.13. After that, with the same starting value of the Monte Carlo simulation 
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the same series were again generated, leading to the same Τ and S for the gap 
free series, within that simulation session, but now the % - missing values 
was increased. This was again repeated for still higher % - missing values. 
Thus each simulation session shows the effect of increasing number of missing 
values in time series when dealing with the same process on the estimation 
of S and Τ of that process from autocorrelation analysis. In Table 3.13 this 
is denoted as for example simulation session 1, a, b, a indicating %-missing 
values of 28, 37 and 45. 
In Table 3.13 the results of the performed Monte Carlo simulations are shown. 
/V denotes the number of observations in the gap free series. 
bS indicates the discrepancy between the average slope determined from auto­
correlation analysis of the 10 gap containing series and the input value for 
the slope used to simulate the trend component (Eqn. 3.25): 
AS 
S - 5 input 
S input 
100% 
Similarly the discrepancy between the average time constant derived from the 
gap containing series and the input value Ί = 1, for the stationary stochastic 
component of the process was derived: 
ΔΤ = 
χ 
Τ - Τ 
x x 
input 
Τ 
xinput 
100% 
From Table 3.13 follows: 
1. ΔΪ1 is generally quite large ranging from 1 - 33%. 
In view of the fact that use was made of a non weighted fitting procedure 
whereby the uncertainty in each of the data points of the fit (autocorrela­
tion estimates from τ = 1 - 20) was taken as being the same, undoubtably 
contributed to this observation. 
Another cause is the fact that the time constant of the stationary stochastic 
component of the process was small (= 1), as a result of which the exponen­
tial function of this process component was only determined by the auto­
correlation estimate at τ = 1, since this was the only estimate exceeding 
the trend component of the autocorrelation function. 
2. The discrepancy Δ5 is statisfactory with deviations from 0 - 7 % . Here it is 
seen that although the fitting procedure was non weighted the results are 
in close agreement. This according to expectation in view of the fact that 
the trend component is well described from the 20 datapoints used in 
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the fitting procedure. 
3. The results also show that àS decreases with increasing realisation length 
Λ', according to expectation. 
The % missing values created m the series, has in the range 28 - 45 %, 
little effect on the magnitude of AS. 
3.6 Conclusions 
The effect of missing values in discrete time series on the results of auto­
correlation analysis was investigated for various time series models. 
For first order stationary stochastic processes, the time constant estimates 
obtained from gap containing and gap free series are in close agreement and 
differ by less than 4%. In extreme situations, the procedure sometimes yields 
less reliable results. (Sec. 3.2) 
The standard errors of autocorrelation estimates computed from gap containing 
series are best approximated by Bartlett's formula when m the denominator of 
this formula for φ(τ) at lags τ < 3, the number of pairs of observations 
actually involved when computing φ(τ) is taken into account. For φ(τ) at lags 
τ ^ 3, it is best to consider the number of observations actually involved when 
computing the standard errors of these autocorrelation estimates. (Sec. 3.2.1) 
For first order stationary stochastic processes with superimposed error, the 
estimated α and Τ from autocorrelation analysis of discrete time series with 
χ 
and without missing values, are in close agreement and differ by less than =6%. 
Here also in extreme situations the procedure sometimes yields less reliable 
results. (Sec. 3.2.2) 
The standard errors of autocorrelation estimates computed from gap containing 
discrete series are best approximated by the formula derived by Muskens (4) 
when in the denominator of this formula for φ(τ) at lags τ < 2, the number 
of pairs of observations actually involved when calculating φ(τ) is taken into 
account. For φ(T) at lags τ i 2, it is best to consider the number of obser­
vations actually involved when computing the standard errors of these auto­
correlation estimates. (Sec. 3.2.2) 
Rounding-off the numerical values of observations in discrete time series, 
representative of a first order stationary stochastic process, introduces a 
negative systematic error in the time constants estimated from autocorrelation 
analysis. For practical use this bias is negligible. However, in situations 
where the numerical values of the observations are rounded-off to an extent 
that is in severe conflict with the rounding-off criterion, the estimated time 
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Constant may be substantially adversely influenced. (Sec. 3.3) 
In section 3.4 a relationship between the autocorrelation technique and an 
analysis of variance scheme in time series analysis of first order stochastic 
stationary autoregressive processes is derived. The validity and applicability 
are shown. 
With the aid of this relationship it is possible, under the restriction that 
in advance it has been verified that the process considered is a first order 
stationary stochastic process, to use analysis of variance results, to get 
insight m the time variant behaviour of analytical processes. 
For laboratories already employing the analysis of variance technique as part 
of their intralaboratory quality control program, this relationship offers 
the possibility to verify the time variant behaviour of analytical processes 
from files documenting the recent history of the laboratory. Also no extra 
workload is introduced in the laboratory and no additional expenses are 
involved when considering this relationship as part of the presently used 
intralaboratory quality control program. 
In section 3.5 the estimation of the slope S of a process with a trend com­
ponent from autocorrelation analysis of discrete time series with missing 
values, is dealt with. The results indicate discrepancies Δ5 not larger than 
7%. The time constant of the stationary stochastic component of such a process, 
is not very well estimated from autocorrelation analysis of discrete gap 
containing time series with discrepancies Δ2 up to 33%. The reason for this 
probably is A) the fact that use was made of a non weighted least squares 
fitting procedure and B) the fact that the magnitude of the time constant 
(equal to 1 during all simulations) is small in comparison with the magnitude 
of the trend component. 
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Chapter 4 
DYNAMICS OF ANALYTICAL PROCESSES 
4.1 Introduction 
In the following it is investigated whether analytical processes are time 
invariant or timevariant. 
For that purpose discrete time series composed of intralaboratory quality 
control data, being representative of the events occurring in the analytical 
process, were subjected to autocorrelation analysis. 
The results of this analysis pertain to the analytical processes used in a 
group of Dutch clinical chemistry laboratories for the serum calcium and urea 
determination m the period 1974-1975. 
The implications of a dynamic process behaviour are discussed and suggestions 
are given to prevent some of the problems encountered during this investigation. 
4.2 Definition of the analytical process 
The analytical procedure is defined as the process underlying disturbances w(.t) , 
which converts a physical or chemical quantity of samples, into a quantity 
representative of these samples i.e. data. 
In the schematic diagram shown in Figure 4.1 this is illustrated. 
w(t) 
patient and quality 
—* 
control samples 
Fig. 4.1 Schematic diagram illustrating the analytical procedure as a process 
underlying disturbances w(t) . 
ANALY 
PROC 
TICAL 
EDURE 
patient and quality 
control data 
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4.3 Time series of quality control data 
The information obtained from quality control measurements in clinical chemistry 
laboratories, is often derived from a sequence of such measurements. When these 
observations are generated sequentially in time, and pertain to the same 
variable quantity, such a sequence of observations is called a time series as 
was dealt with in section 3.1. 
Consequently every quality control serum used in a laboratory to surveil an 
analytical process during a certain time period, leads to a discrete time 
series of quality control observations. Each of these series is thereby regarded 
to be a sample realization from an infinite population of such series, that 
could have been generated by that particular analytical process. 
In the situation where only one quality control result is available per day, 
time series were compiled of equispaced observations with a time interval of 
1 day between the successive observations. 
When several quality control data, pertaining to the same control serum, are 
available per day, time series are compiled with a time interval between 
successive observations which is dependent on the frequency of implementation 
of the control specimens in the analytical run. From Table 2.7.a (Section 2.5) 
it is seen that this implies for most laboratories a time interval between 
sequentially generated data pertaining to the same control serum that generally 
equals the time required to analyze one analysis series. 
The time series thus compiled were subjected to autocorrelation analysis, to 
quantify the dynamic behaviour of analytical processes. 
4.4 Observed autocorrelation functions 
The working hypothesis is that analytical processes can be described as first 
order stationary stochastic processes with a time constant unequal to zero. 
For such processes, the autocorrelation function, henceforth denoted 'auto-
correlogram', is a continuously decreasing exponential function described by: 
Φ (τ) = e~'T' w (Eqn. 3.12, section 3.1.2) 
WW 
Here Τ is the time constant i.e. the parameter which is inversly proportional 
to the velocity of the processfluctuations U(t).(Fig. 4.1) 
The autocorrelograms and estimates of Τ were calculated according to the 
procedure described in section 3.2. 
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Both Τ and τ are expressed in units of sampling interval i.e. time interval 
w 
between successive observations in the time series. During this investigation, 
these time intervals were either 'days' or 'analysis series'.(Section 4.3) 
Consequently the magnitude of Τ is expressed in 'days' or 'analysis series', 
w 
henceforth referred to as 'series'. 
Whenever time constants are expressed in the general unit 'series', the 
following considerations should be kept in mind. 
The composition of the analysis series within an analytical run (Table 2.7.a, 
section 2.5), and the time required to analyze such a series, together with 
possible time delays between successive series, may vary considerably from 
laboratory to laboratory and from determination to determination. 
Consequently, obvious similarities between computed time constants, pertaining 
to different analytical processes, when these are expressed m 'series', can 
be misleading, when not taking the above mentioned considerations into account. 
The correct frame of reference is obtained when time constants are expressed 
in the time domain. Thus possible differences in the time variant behaviour of 
analytical processes may be verified. 
Whether the assumption that the particular time series stems from a first order 
stationary stochastic process is to be accepted or rejected, was verified 
according to the procedure dealt with in section 3.1.3, whereby the standard 
errors of the autocorrelation estimates were calculated according to equations 
3.18.a and 3.18.b , section 3.2.1. With the aid of these equations, also the 
upper and lower limit of the time constant estimate, related to a certain 
probability P(%), can be derived (l).This is important to realize. The computed 
time constant from an autocorrelogram is the most probable value of this process 
parameter. However, since Τ is estimated from a limited number of observations 
w 
during a certain time period, the real time constant may still deviate from the 
estimated Τ . 
w 
Considering that during this investigation, in general, several time constant 
estimates were available, the average time constant Τ and its coefficient of 
w 
variation CVy (%) were computed to obtain a more reliable estimate of the real 
w 
time constant of the process i.e. one that is valid beyond the considered 
observation periods. 
4.4.1 Calcium 
The autocorrelation analysis results of the laboratories where daily only one 
observation of a particular quality control serum preparation was available 
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are first dealt with. Table 4.1 summarizes the results of the analytical proces­
ses where the working hypothesis was accepted i.e. the considered analytical 
processes is a first order stationary stochastic process with Τ φ О 
Table 4.1 
Results of curve fitting procedure with time series model eqn. 3.12 applied 
to autocorrelograras of daily sampled analytical processes. 
laboratory 
analytical 
method 
(calcium) 
realization 
w w 
(days) (days) 
cv
m
 CO 
204 
205 
206 
207 
209 
2 
209 
213 
214 
218 
222 
022 
024 
023 
023 
023 
023 
022 
026 
023 
023 
1.34 
0.92 
1.11 
0.68 
0.85 
0.50 
0.82 
1.33 
1.17 
1.39 
2.29 
1.26 
1.65 
1.74 
2.38 
1.61 
1.62 
1.75 
0.68 
0.85 
0.90 
1.30 
0.95 
1.1 
0.7 
1.3 
1.7 
1.9 
1.7 
1.0 
26 
22 
30 
22 
20 
V : see Table 2.1.a, section 2.1.3 for details 
1 : apparatus 'Manus Calcium Titrator' 
2 : apparatus 'Corning Calcium Analyzer' 
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From Table 4.1 the following observations can be made: 
- a weak time variant behaviour is seen in laboratories 206 and 218 with Τ 
less than the sampling interval of one day. 
Figure 4.2 shows the autocorrelogram of realization 1 of laboratory 206. 
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Fig. 4.2 Autocorrelogram of realization 1. 
(here, and m the subsequent figures, | 1 indicates the 95% con­
fidence region of the autocoirelation estimates at time lags ι ) 
- a slightly stronger time constant is noticed in laboratories 204, 205, 207 
and 209 (apparatus Marius Calcium Titrator). 
Figure 4.3 shows the autocorrelogram of realization 1 of laboratory 209. 
Figure 4.4 shows the autocorrelogram of realization 1 of laboratory 205. 
- a more distinct time constant is found in laboratories 213, 214 and 209 
(apparatus Corning Calcium Analyzer). 
Figure 4.5 shows the autocorrelogram of realization 2 of laboratory 213 
Due to the limited number of realizations from which Τ generally is derived 
w 
and the uncertainty m this estimate i.e. large ol'y (I), differences in the 
w 
dynamic behaviour of the listed analytical processes as far as the magnitude 
of the time constant concerns cannot be verified here. The results however do 
indicate that the analytical processes used in laboratories 209 ('Corning Cal­
cium Analyzer'-period), 213 and 214, exhibited a first order stationary 
stochastic process behaviour with a more distinct magnitude of Τ as compared 
w 
to the analytical processes that were used in the other laboratories. 
The autocorrtlograras of daily sampled analytical processes used in laboratories 
208, 211, 212 and 219 for the serum calcium determination revealed a time 107 
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Fig . 4.3 Autocorrelogram of r e a l i z a t i o n 1, Manus Calcium T i t r a t o r per iod. 
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Fig. 4.5 Autocorrelogram of realization 2. 
invariant process behaviour with no autocorrelation estimates eli tiering 
significantly from zero with 2a = 0.05. 
In laboratories 207 (realizations 3 and 4) and 217, il.e workimj hvpothosis had 
to be rejected. Here, other time series models were appropriate. 
In laboratory 207, two realizations (3 and 4) during the same observation period 
could be described as being representative of a first order stationary stochastic 
process with superimposed error, (section 3.2.2) 
In Table 4.2 these results are shown. 
Table 4.2 
Results of curve fitting procedure with time series model eqn. 3.21 applied to 
autocorrelograras of a daily sampled analytical process. 
laboratory 
analytical 
method 
(calcium) 
realization 
w 
(days) 
207 023 16.89 0.62 0.0506 0.040 0.031 
12.93 0.56 0.0560 0.042 0.037 
V 
τ 
α --
s7 -
У 
= s¿ 
w 
= s2 
w 
' · ; 
t s ' 
ν 
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In Figure 4.6 the autocorrelogram of realization 3 of Table 4.2 is contained 
to illustrate this particular process behaviour. 
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Fig. 4.6 Autocorrelogram of realization 3 of which the numerical results are 
shown in Table 4.2. 
In this laboratory a different time variant behaviour in subsequent time periods 
can be observed for the particular analytical process on comparing the results 
of Table 4.1 for this laboratory (number 207) with those of Table 4.2. 
In howfar the large time constant is representative of the analytical process 
or of the control sera themselves, is of concern now. 
Both preparations were purchased from different manufacturers. Since the batch 
and serial number of both sera were known, it was possible to verify whether 
the results of other laboratories, which had used the same preparations 
indicated a similar behaviour. This was not the case. 
The results pertaining to the urea determination of laboratory 207, for both 
control sera, also did not reveal this behaviour. 
The storage of the control sera prior to use was not altered during the 
observation period. Taking into account that both control sera were purchased 
from different firms, manufacturing errors affecting both preparations similarly 
are impossible. From these considerations it is concluded that the large time 
constant is a process characteristic. The fast fluctuating pattern is considered 
to be representative of the measuring errors, which are to be placed in the 
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following context. 
Quality control samples are used to measure the performance of the analytical 
process during the analysis of patient specimens. In fact they reflect the 
events occurring in that process. However, the quality control samples them­
selves are subject to certain errors as will be dealt with in chapter 5. 
The quality control data in that case do not only reflect the disturbances 
«(t) acting upon the analytical process (Fig. 4.1), but also these measuring 
errors Vit), by which the control samples are affected ι.e. c 2 = s^ + s 2 . 
y w ν 
In the situation where the process fluctuations exhibit a time variant 
behaviour with a small time constant, both parts cannot be distinguished unless 
the sampling frequency is increased. 
Why in laboratory 207 the analytical process exhibits a different dynamic 
behaviour in subsequent observation periods remains unexplained. Following 
this process during a longer time, can possibly give a decisive answer. 
In laboratory 217, two realizations during the same observation period could 
be described as being representative of a process with a first order stationary 
stochastic component with variance s and time constant Τ , and a trend 
W W 
component with slope S . (section 3.5) 
Table 4.3 shows the estimated values of s , Τ and S from the autocorrelograms 
w w t 
according to the curve fitting procedure with time series model eqn. 3.26. 
Table 4.3 
Results of curve fitting procedure with time series model eqn. 3.26 applied to 
autocorrelograms of a daily sampled analytical process, during an observation 
period of length N. 
analytical 
]aboratory method realization Π s Τ S 
w w t 
(calcium) (days) (days) (mmol/l.day) 
217 024 1 486 0.0955 0.6 -0.0003 
2 486 0.1037 0.5 -0.0003 
The two control sera used in laboratory 217 were purchased from the same firm. 
Other laboratories did not employ either of these preparations. The results 
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pertaining to the urea determination of this laboratory, for which surveillance 
both control sera also were used, did not show this instationary character. 
If the observed process behaviour is valid beyond the observation period or is 
to be attributed to deterioration of the control sera, as far as the calcium 
constituent is concerned, can only be verified when more realizations are 
available. Considering that the results of Table 4.3 were obtained from time 
series with a percentage of missing values of =35 , for both rcali/ations, and 
that the observations m the time series were scverly affected by a rounding 
off error i.e. they were roundca-off at 1 accimal olace with α standard 
deviation of - 0.10 for both realisations (Table 4.3), the time constant 
estimates are very unreliable, (section 3.5.1 and 3.3) 
The estimates of the slope of the trend component i.e. S are more reliable 
as was dealt with m section 3.5.1. 
Both estimates show a remarkable mutual agreement. Due to the retrospective 
character of the investigation, it was not роьыЬ]ι to trace the origin of 
this particular behaviour in the considered observation period. 
To this point, the analytical processes which were sampled per day were dealt 
with. In the following, the autocorrelation analysis results of the laboratories 
where the analytical processes were sampled per series (section 4.4) are of 
concern. Table 4.4 summarizes the results. Here the working hypothesis i.e. 
the analytical process can be described as being a first order stationary 
stochastic process with Τ ^ 0, is accepted. 
w 
Autocorrelation estimates computed for time lags exceeding a day, did not differ 
significantly (2a = 0.05) from zero. 
From Table 4.4 it is seen that when the time constant estimates are expressed 
in the general unit 'series', the various analytical processes seem to behave 
quite similar. When expressed in 'minutes', which is the correct frame of 
reference (section 4.4), the difference in magnitude of the estimated time 
constants is more clearly indicated. 
In view of the limited number of participants that were able to supply the 
data on this time basis i.e. per series, the results do not allow the general 
conclusion that a difference in dynamic behaviour of analytical processes 
exists as far as the magnitude of i' is concerned. The only exception forms 
the result of laboratory 216 in comparison with the others. Figure 4.7 shows 
the autocorrelogram of realization 4 of this laboratory. 
In the same laboratory when the SMA 12/60 was installed, the results indicated 
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that on sampling this process per series, it was time invariant. Of the 
participants that supplied data 'per series', it was the only one where an 
analytical process was seen to be time invariant. 
In general however the results shown in Table 4.4 allow to conclude that the 
working hypothesis is correct, and that analytical processes can be described 
as first order stationary stochastic processes with Τ φ 0. 
Table 4.4 
Results of curve fitting procedure with time series model eqn. 3.12 applied to 
autocorrelograms of analytical processes that are sampled per series. 
laboratory 
201 
202 1 
2022 
215 
2163 
220 
analytical 
method 
(calcium) 
024 
023 
023 
023 
022 
022 
realization 
1 
2 
3 
4 
1 
1 
1 
1 
2 
3 
4 
5 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
Τ 
w 
(series) 
1.74 
1.78 
2.86 
2.60 
2.02 
2.70 
1.32 
1.78 
1.59 
1.27 
1.11 
1.19 
0.92 
0.88 
1.50 
2.02 
1.51 
1.75 
1.23 
0.88 
0.76 
0.70 
1.50 
1.68 
0.89 
1.57 
1.01 
0.72 
Τ 
w 
(series) 
2.2 
1.4 
1.2 
CV
r
 (%) 
w 
25 
20 
35 
X 
W 
(minutes) 
37 
32 
32 
26 
6 
31 
ι apparatus: Manus Calcium Titra tor 
2 apparatus: Corning Calcium Analyzer 
3 apparatus : SMAC 
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Fig . 4.7 Autocorrelogram of r e a l i z a t i o n 4, when in t h i s laboratory the SMAC 
was i n s t a l l e d . The numerical r e s u l t s are contained in Table 4 .4 . 
4.4.2 Urea 
Similar to the previous section, the autocorrelation analysis results pertaining 
to the analytical processes used for the serum urea determination are now dealt 
with. 
Table 4.5 shows the results of the analytical processes that were sampled once 
a day, and where the working hypothesis was accepted. 
From Table 4.5, following observations can be made: 
- a weak time variant behaviour is seen in laboratory 214. 
- a slightly stronger dynamic behaviour is noticed in laboratories 202, 207, 
212, 213, 217, 218 and 221. 
- a more distinct time constant is observed in laboratory 222, whereas in 
laboratory 211 with Τ - 13 (days), a large time constant characterizes the 
dynamic behaviour of the particular analytical process. 
The three listed realizations of laboratory 211 all covered the same obser­
vation period. Figure 4.8 shows the autocorrelogram of realization 1. 
The three quality control serum preparations used in this laboratory were 
purchased from different manufacturers and supplied as lyophilized sera. 
The autocorrelograms of daily sampled analytical processes used in laboratories 
203,204 and 215 for the urea determination revealed a time invariant behaviour. 
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Table 4.5 
Results of curve fitting procedure with time series model eqn. 3.12 applied to 
autocorrelograms of daily sampled analytical processes. 
v 
analytical 
laboratory method realization Τ Τ CVr (%) 
w w •'w 
(urea) (days) (days) 
202 051 1 1.97 1.5 34 
2 0.95 
3 1.57 
207 051 1 1.01 1.1 15 
2 1.03 
3 1.21 
4 1.24 
5 1.41 
6 0.99 
7 0.99 
211 053 1 12.47 12.7 9 
2 13.88 
3 11.65 
212 052 1 1.86 1.3 38 
2 0.98 
3 0.90 
4 0.81 
5 2.01 
6 1.52 
7 0.95 
8 1.00 
213 052 1 0.61 1.0 49 
2 0.77 
3 1.49 
214 052 1 0.81 0.8 3 
2 0.85 
217 053 1 0.81 1.3 26 
2 1.40 
3 1.68 
4 1.12 
5 1.24 
218 053 1 1.20 1.1 11 
2 1.02 
221 053 1 1.42 1.4 2 
2 1.47 
222 052 1 2.19 
see Table 2.1.b, section 2.1.3 for details 
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Fig. 4.8 Autocorrelogram of realization 1. 
Tables 4.6 and 4.7 summarize the autocorrelation analysis results of the 
laboratories where the working hypothesis had to be rejected, and other 
time series models were appropriate. 
Table 4.6 
Results of curve fitting procedure with time series model eqn. 3.21 applied 
to autocorrelograms of a daily sampled analytical process. 
analytical 
laboratory method realization Τ 
(urea) (days) 
208 053 26.10 0.75 
25.30 0.77 
0.1720 0.149 0.086 
0.1718 0.151 0.082 
„2 / „2 S /S W y 
Τ S' π2 + S 
W V 
In the laboratory shown in Table 4.6, two realizations, in subsequent periods 
could be described as being representative of a first order stationary stochastic 
process with superimposed error (section 3.2.2). The preparations were obtained 
from different manufacturers. Similar to the considerations given in section 
4.4.1 for the observed autocorrelograms in laboratory 207 (Table 4.2), s and 
w 
2 are parameters descriptive of the process fluctuations, s is considered 
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to indicate the magnitude of the measuring error i.e. the errors by which the 
control serum samples themselves are affected. 
Figures 4.9.a and 4.9.b show the autocorrelograms of the realizations listed 
in Table 4.6. 
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Fig. 4.9.a Autocorrelogram of r e a l i z a t i o n 1 of which the numerical r e s u l t s 
are l i s t e d in Table 4 .6 . 
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Fig .4 .9 .b Autocorrelogram of r e a l i z a t i o n 2 l i s t e d in Table 4 .6 . 
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The autocorrelograms pertaining to the various realizations in the laboratories 
shown in Table 4.7 were best approximated with time series model eqn. 3.26. 
Table 4.7 
Results of curve fitting procedure with time series model eqn.3.26 applied to 
autocorrelograms of daily sampled analytical processes, during an observation 
period of length //. 
analytical 
laboratory method realization N 
(urea) (days) (days) (mmol/l.day) 
201 
206 
209 
222 
052 
051 
053 
052 
1 
1 
1 
2 
3 
345 
146 
298 
226 
226 
0.3111 
0.1817 
0.1581 
0.2761 
0.1525 
1.4 
0.5 
0.7 
0.4 
0.5 
-0.0033 
-0.0032 
-0.0021 
-0.0098 
-0.0022 
Figure 4.10 shows the autocorrelogram of realization 1 of laboratory 201. 
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Fig. 4.10 Autocorrelogram of realization 1 listed in Table 4.7. 
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The autocorrelogram of a second control serum used in laboratory 201, during 
the same observation period, did not reveal this behaviour. Consequently this 
instationary behaviour was not a general characteristic of the process. 
The trend component obviously is caused by some control serum characteristic. 
On confronting the supplier of this control serum preparation with the results 
of Table 4.6, it turned out that a preservative had been added to this control 
serum of which they had found that it had an inhibitory effect on the urease 
activity. In other laboratories this particular control serum batch had not 
been used or at least data pertaining to this batch were not submitted. 
Consequently this observation could not be verified. 
In laboratories 206 and 209, only during 1 realization a trend component 
occurred. Other realizations during other observation periods, did not reveal 
this feature in either laboratory. On the contrary. The autocorrelograms of 
these realizations indicated that both the analytical processes were time 
invariant, when sampled on a day to day time basis. 
Since in both laboratories the analytical run only contained one control serum 
specimen (section 2.5,Table 2.7.a), the cause for this trend could not be found. 
In laboratory 222, the autocorrelograms of two realizations, during the same 
observation period, revealed a trend. The control sera were from a different 
source. One had been prepared in the laboratory and the other had been purchased. 
In comparison to the foregoing and subsequent periods, the way in which these 
sera were stored prior to use was not altered. Since it would be quite a 
coincidence if both preparations would have a factor in common apart from some 
characteristic of the analytical process which caused the trend component, it 
is concluded that in this period, this feature is due to the performance of the 
analytical process. The degree in which the control sera react on, and the data 
reflect this behaviour, differs, as is seen from Table 4.7. A possible expla­
nation is that errors in the calibrating procedure occurred. With a non linear 
calibration curve, the different slope estimates of the trend could very well 
be explained in view of the average values for the urea component in both 
control sera. These were respectively 13.31 mmol/l for realization 2 and 
6.97 mmol/l for realization 3. In howfar this explanation is valid , however 
cannot be verified due to the retrospective character of this investigation. 
What can be concluded is that this behaviour is not a general process feature 
valid beyond the particular observation period. For, the autocorrelogram 
pertaining to the realization of the subsequent time period indicated that the 
working hypothesis had to be accepted with a Τ of - 2 days. (Table 4.5) 
w 
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The autocorrelation analysis results of the laboratories where the analytical 
processes were sampled per series are summarized in Table 4.8. 
Table 4.θ 
Results of curve fitting procedure with time series model eqn. 3.12 applied to 
autocorrelograms of analytical processes which were sampled per series. 
analytical 
laboratory method realization Τ 
(urea) (series) (series) 
CV- (%) Τ 1 w 
(minutes) 
201 
205 
216' 
216^ 
219 
052 
051 
053 
053 
053 
2 
3 
4 
1 
2 
1 
2 
3 
4 
5 
1 
2 
3 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
1.62 
1.36 
1.46 
2.55 
1.71 
1.30 
1.61 
2.17 
1.06 
1.06 
1.64 
0.98 
1.52 
1.34 
2.63 
2.13 
2.21 
2.12 
1.59 
3.15 
2.80 
1.94 
1.71 
3.67 
2.39 
3.07 
3.38 
3.19 
1.39 
1.28 
1.82 
1.5 
2.1 28 
1.4 32 
1.4 25 
2.3 32 
47 
20 
24 
39 
1 apparatus: ΞΜΑ 12/60 
2 apparatus: SMAC 
V Table 4.0 is continued on the next page. 
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Table 4.θ (continued) 
analytical 
laboratory method realization Τ Τ 
W W 
(urea) (series) (series) 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
1.76 
0 . 8 7 
2 . 0 8 
2 .50 
2 .39 
1.95 
1.55 
0 . 9 8 
1.29 
1.23 
1.38 
2 .22 
1.51 
1.67 
1.31 
1.12 
In all instances the working hypothesis was accepted. 
No autocorrelation estimates, computed for time lags τ exceeding a day, were 
observed that differed significantly from zero with 2a = 0.05. 
From Table 4.8 follows that the magnitude of the time constant for the various 
analytical processes ranges from 6 - 4 7 minutes. 
Figure 4.11 contains the autocorrelograms of realizations 1, 5, 8, 9, 10 and 
12 of laboratory 219. 
In the various autocorrelograms shown in Figure 4.11 only those autocorrelation 
estimates which differed significantly from zero, with 2a = 0.05, are shown. 
As in the previous autocorrelograms, the dotted vertical bars indicate the 
95% confidence region of the various autocorrelation estimates. 
Furthermore the autocorrelograms are shown till τ = 5 to prevent the various 
graphical representations from becoming too large. 
The time constants however were calculated from at least 10 data points in the 
various autocorrelograms, according to the procedure dealt with in section 3.2. 
ον
ψ
 (%) Τ 
I vi 
(minutes) 
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Fig. 4.11 Autocorrelograms of realizations 1 (a) , 5 (£>) , 8 (e) , 9 (d) , 10 (e) 
and 12 (ƒ), of which the numerical results are shown in Table 4.11. 
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4.5 Discussion and conclusions 
The autocorrelation analysis results indicate that in general, the analytical 
processes used for the serum calcium and urea determination are time variant 
and can be described as being first order stationary stochastic processes 
with Τ φ 0. 
w 
During some of the observation periods, other time series models were ЗРРП 
to be appropriate. 
For the realizations listed in Tables 4.2 and 4.6 this is time series model 
eqn. 3.21. The error superimposed on the actual process fluctuations here, 
is considered to be inherent to the control serum specimens that were used to 
surveil the analytical processes. The magnitude of these 'measuring errors', 
expressed as coefficients of variation is: 
- for the control serum used in laboratory 207 to surveil the serum calcium 
determination, =1.2% (realization 3) and =1.5% (realization 4). (Table 4.2) 
- for the control serum used in laboratory 208 to surveil the serum urea 
determination, =1.0% (realization 1) and =0.9% (realization 2). (Table 4.6) 
The magnitude of these 'measuring errors', derived for the urea component, 
confirms more or less the 'measuring errors' that were estimated by another 
supplier of control sera, namely 0.7% (chapter 5). Although it concerned quite 
a different control serum, this resemblance gives reason to believe that our 
interpretation of this additional error term could be correct. 
That these 'measuring errors' could not be verified in other situations is 
accounted for by . 
- the large time interval at which the analytical processes are sampled i.e. 
often only once a day. 
- the magnitude of the time constants on this time basis, which generally 
indicates the strongly fluctuating pattern of the process fluctuations 
(Tables 4.1 and 4.5), in which case these 'measuring errors' cannot be 
quantified from autocorrelation analysis unless the sampling frequency 
is increased. 
- the circumstance that this error may vary from control serum to control 
serum and may be of such a magnitude that it is negligible in comparison 
with the magnitude of the process fluctuations, as can be seen from the 
results of laboratory 211, shown in Table 4.5. 
Autocorrelograms that indicated the presence of a deterministic component 
(here a trend), next to a stochastic part, are listed in Tables 4.3 and 4.7. 
The trend component is considered to be accounted for by the following: 
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- laboratory 201 (Table 4.7): a preservative in the control serum. 
- laboratory 222 (Table 4.7): a characteristic of the analytical process 
during a certain observation period and not a general feature of the process 
in view of the autocorrelogram calculated in the subsequent period. (Table 4.5) 
In the other situations it was not possible to trace the origin of this trend. 
This is due to a) the retrospective character of this investigation b) the 
limited number of realizations as a result of which certain observations 
could not be verified and c) the circumstance that when a trend occurred in 
a particular period, not always control sera from different sources were used, 
hampering the possibility to verify whether an observed behaviour was inherent 
to a particular control preparation. (Laboratory 217, Table 4.3) 
To this point the autocorrelation analysis results of time series compiled 
of quality control observations with a time interval of one day between 
successive observations were of concern. 
In evaluating the results of Tables 4.1 and 4.5, this large sampling interval 
should be kept in mind, since it implies that no fluctuations can be observed 
that occur at higher frequencies than this sampling frequency. On this time 
basis, the results of Tables 4.1 and 4.5 indicate that most of the considered 
analytical processes are characterized by a pattern of strongly fluctuating 
process variations. For quality control this inplies that in order to actually 
measure these variations really, with the aim to control these, the sampling 
frequency needs to be increased. (Chapter 5) 
In howfar it is realistic to base a dynamic system of process deviation control 
on time constants of this magnitude can be doubted in view of the time constants 
that were estimated for the processes that were sampled per series (Tables 4.4 
and 4.8). The autocorrelograms of the latter show that the autocorrelation 
estimates that were computed for time lags exceeding one day, did not differ 
significantly from zero (2a = 0.05), when the standard error of these estimates 
was computed with the time constant estimate expressed in 'series'. 
However, the results of Tables 4.1 and 4.5 do indicate that the listed analytical 
processes are time variant. In view of the magnitude of most of these time 
constants we however recommend that before adopting these for a dynamic system 
of process deviation control, dealt with m chapter 5, it would be better to 
compute firstly autocorrelograms of time series with a smaller time interval 
between successive quality control observations. In that way more insight is 
obtained about the processfluctuations occurring at higher frequencies. 
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For the analytical processes that were sampled per series. Tables 4.4 and 4.8, 
this was possible. 
The results show that the listed analytical processes are time variant and 
give reason to believe that differences between the dynamic properties of 
these processes exist. As it was not an objective of this investigation, no 
further studies have been done on this issue. Taking into account that in most 
instances, only a limited number of realizations were available, this would 
also not be very relevant at this stage. 
Overall conclusion is that the assumption underlying the presently used 
statistical controlling methods for quality control purpose in clinical 
chemistry laboratories i.e. analytical processes are time invariant, cannot 
be generally accepted. In the present investigation these processes were seen 
to be time variant and could in general be described as being first order 
stationary stochastic processes with Τ Φ 0. 
Based on the dynamics of analytical processes new possibilities for quality 
control in clinical chemistry could be in prospect. 
In the following, the implication of a time variant process behaviour is dis­
cussed and suggestions are given to prevent in future some of the problems 
encountered in this investigation when performing autocorrelation analysis 
of time series of quality control observations. Thereafter in chapter 5, first 
incentives towards the introduction of a dynamic system of process deviation 
control in clinical chemistry laboratories, are dealt with. 
4.6 Implication of a dynamic process behaviour 
Whenever the correlation time or time constant of a process is very small, 
the application of the statistical controlling methods, in use for quality 
control purpose in clinical chemistry, is not impeded. The influence of an 
enhanced value of this parameter, however cannot normally be neglected. (2) 
However, since most statistical controlling methods are especially focussed 
on the detection of any instationary process behaviour, they also keep their 
significance in the case of a correlated series of observations. 
Due to their unpredictable character, these instationanties can however never 
be statistically controlled. 
The most widely adopted statistical controlling method used in clinical 
chemistry today, is the Levey-Jennings (3) control chart concept. The informa­
tion from these charts however mainly concerns history and lacks a vital 
characteristic i.e. the power of prediction. 
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The control theory dealt with in chapter 5, operates wthm the stationary 
fluctuating pattern of the process variations and aims to control deviations 
from a target value or setpomt by means of controlling actions. 
Based on the time variant behaviour of analytical processes, the autocorre-
lation function thereby is used to make a statistical prediction of what the 
process value is likely to be a timelag t ahead. Due to the predictability 
of the process fluctuations m time, the ability of a controlling system to 
measure actually the events occurring in the analytical process and the effect 
of performed controlling actions can then be quantified. Valuable tools thereby 
are the measurability and controllability rules of Van der Grinten. (4) 
In the situation where processes are time invariant, control in this context 
is not possible and the performance of the analytical process can only be 
verified afterwards. Based on the time variant behaviour of analytical process 
fluctuations, information in this regard could be obtained in advance. 
4.7 Suggestions 
The intralaboratory quality control data which were received from the partici-
pants were not always suited for autocorrelation analysis. 
The causes hampering this analysis were the following: 
- the short time span a quality control serum preparation was used for the 
surveillance of an analytical process, leading to too few data to permit 
autocorrelation analysis. 
This was appropriate for all data received from laboratory 203 and 221 
for calcium, and 210, 224 and 225 for both calcium and urea. 
- the irregular way the control specimens were used during an observation 
period. For example in laboratory 210 (calcium and urea). 
- the roundmg-off error by which the data were severly affected, which error 
hampers a correct estimation of a time constant. This for example was the 
case in laboratory 217 for the serum calcium determination. 
These matters should be prevented. Furthermore, the following is recommended: 
- whenever possible it should be pursued to insert several control specimens 
at regular time intervals between the patient specimens within the daily 
workload. 
- to gain insight in the process fluctuations, occurring at higher frequencies, 
the time interval should, in first instance, be chosen as small as possible 
i.e. preferably the analytical run should contain only control specimens. 
Thereafter the optimal interval can be chosen. 
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- the control specimens should be placed at regular time intervals between 
the patient specimens and not be placed directly after the calibrating 
standards. 
- during an observation period , at least, two different control sera, 
preferably from different sources should be used. In that way the quality 
of these sera can be checked and any irregular behaviour noticed in the 
autocorrelograms can more easily be attributed to either the analytical 
process or to one of the control preparations. 
Assumptions inherent to the idea of using quality control specimens are the 
following: 
- the pattern of variability of the analyzed control specimens is similar to 
that of the whole production output. 
- the testing methods used, have a quality equal to the required degree of 
perfection. 
- the control data are relevant to the final purpose of the patient data. 
Recognizing these assumptions and their consequences for quality control in 
clinical chemistry, the autocorrelation technique is a valuable tool to study 
the dynamic properties of analytical processes. 
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Chapter 5 
DYNAMIC DEVIATION CONTROL IN CLINICAL CHEMISTRY LABORATORIES 
BASED ON THE TIME VARIANT BEHAVIOUR OF ANALYTICAL PROCESSES* 
C.B.G. Limonard 
Summary 
Based on the time variant behaviour of analytical processes, a dynamic system 
of deviation control is discussed. 
Originating from industrial process control, measurability and controllability 
rules as measures of the optimum reconstructing and controlling efficiency of 
quality control systems are introduced. It is seen that when trying to recon-
struct and control an analytical process, properties of the process and charac-
teristics of the control system need to be taken into consideration. 
Application of these rules offers the possibility of jnvestigation the effect 
of actions aimed at improving the performance of a controlling system, but also 
indicates if a certain precision requirement can be achieved with less effort 
and expense. 
An example illustrates the time variant behaviour of an analytical process 
used for the urea determination in a clinical chemistry laboratory. It shows the 
applicability of measurability and controllability rules, with the emphasis on 
the measuring or reconstructing efficiency of the controlling system used in 
that laboratory for the surveillance of the urea determination. 
Introduction 
Quality control systems are used in clinical chemistry laboratories to detect 
and control deviations from a target value, so as to prevent these deviations 
accumulating as a result of which the analytical process víould tend to go out 
of control. 
Thereafter, the stabilization procedure aims to keep the process on a set-
point (= threshold control) and to minimize the deviations from this setpoint 
(= deviation control). 
Consequently, all these features can be optimized, and questions then arise 
as to what extent these actions achieve their purpose. At present, the analytical 
* Clin. Chim. Acta 94, 137, 1979. 
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processes in clinical chemistry laboratories are considered to be time invariant, 
suggesting total unpredictability of the fluctuation pattern of the disturbances 
acting upon these processes. The objective of this investigation is to show 
that an analytical procedure can be defined as a time variant process to which 
a dynamic system of deviation control can be applied. 
Merits of such an approach are that measuring and controlling efficiency of 
quality control systems can be quantified and optimized. The information con­
tent of quality control data and the effect, which intervening or controlling 
actions upon the analytical process, have, can be quantified and optimized 
using these data. 
Dynamic aspects of analytical processes and the theory of measurability and 
controllability are dealt with. The merits and potential of such an approach 
are discussed. An example illustrates the applicability of the theory, with 
the emphasis on the measurability or reconstructability of quality control 
systems, to actually measure/reconstruct the events occurring in the analytical 
process. 
Theory 
Analytical laboratories are very often part of a control loop and produce 
analytical data from regularly sampled time variant or time invariant processes 
(Fig. 1). To describe the quality of the control loop shown in Fig. 1, Van der 
Grinten (1) derived the so called measurability and controllability rules. 
These indicate, respectively, the optimum measuring/reconstructing and 
controlling efficiency of a control system. 
* INPUT 
LABORATORY l rtiCL_rR 
;: 
RLSLLTS 
Fig. 1 The a n a l y t i c a l laboratory as p a r t of a c o n t r o l loop. 
Λ 
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Examples of the applicability of measurability and controllability rules in 
the field of industrial process control were described by Van der Grinten (1) 
and Leemans (2). 
During the present investigation, the analytical procedure itself is the time 
variant process controlled by a feed back control system as illustrated in 
Fig. 2. 
The analytical procedure is defined as the process (underlying disturbances 
w(t)) which converts a physical or chemical quantity of samples into a quan­
tity representative of these samples, i.e. data. 
WO) 
ENT AND QUALITY CONTROL SAMPLES 
" 
ANALYTICAL 
PROCEDURE 
1 I 
PATIENT AND QUALITY CONTROL DATA 
У' 
' ' 
Fig. 2 Schematic diagram illustrating the analytical procedure as a process 
to be controlled, where: M; measuring unit; C: controller; Τ · sampling 
interval; V(,t). measuring errors; W(t). disturbances causing the process to 
run out of control. 
To get insight into the disturbances ω(ί) acting upon the analytical process 
during the analysis of a series of patient samples, quality control samples 
are included and the information content of these samples is supplied in the 
form of quality control data. These data show m which direction the events 
occurring in the process proceed and govern possible controlling actions 
performed in the process. Thus, quality control data, sampled at a rate 1/T 
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contain information about the disturbances w i t ) acting upon the process, and 
this information is assembled in the measuring unit M, which in its turn is 
also error-prone due to measuring errors ν(t) . The information assembled in M 
is forwarded to controller C, which performs a controlling action on the 
process to neutralize the effect of measured discrepancies from a target value 
or set point due to W(t). In order for these interventions to be appropriate, 
the measurements must conform to the actual value as closely as possible. 
Fig. 3 illustrates both features. 
W 
W 
S A M P L I N G 
W 
A N A L Y S I S 
R E C O N S T B U C T I O N 
w 
Fig. 3 Reconstructing and controlling a process (a) on the basis of regularly 
sampled data (b) which are error-prone (c), leading to a reconstruction of the 
process (d) which is controlled (e). 
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Assume that the analytical process behaves as shown in Fig. 3a. This behaviour 
however, we never get to know. In order to get insight into the fluctuation 
pattern, the process is sampled at time intervals Τ (Fig. 3b), leading to a 
series of measurements which are error-prone due to measuring errors v(t) and 
which may be affected by certain time lags Τ. From these measurements (Fig. 3c), 
the process is reconstructed (Fig. 3d). The resemblance between the reconstructed 
(Fig. 3d) and actual process (Fig. 3a), is quantified according to the measur-
ability m 2. 
The intervening or controlling actions consequently are performed on the basis 
of the reconstructed process (Fig. 3d) and aim to minimize the deviations of 
the process quantity around its average value (Fig. 3e). The efficiency of these 
actions is quantified by the controllability p 2. The theory of measurability 
and controllability and the interpretation of these rules when used to quantify 
measuring and controlling efficiency of quality control systems m clinical 
chemistry laboratories will now be discussed. 
The parameters characteristic of the controlling system or control loop shown 
in Fig. 2 are similar to those valid for the situation shown in Fig. 1. 
a : standard deviation of the 'uncontrolled' analytical process. 
w 
Ί 
w 
time constant or correlation time of the analytical process. 
standard deviation of the measuring error y(t) imposed on the measuring 
unit M (dealt with later in the paper) . 
Τ . dead time of the control loop, which is the sum of several time delays 
such as: 
T,{T ) : dead time of sampling. The time interval between consecutive quality d a 
control samples in a run of patient specimens. 
Τ^('1 ) : analysis time of 1 quality control or patient specimen. 
α s 
Τ AT ) • time delay introduced by taking an accumulated sample or duration of 
the sampling action. 
Τ(Ϊ ) dead time of the process. The time between the moment the quality 
control data (Fig. 2) or data (Fig. 1) become available and the moment 
the intervening action m the process is performed. 
The time constant or correlation time of the process Τ is the parameter which 
is inversely proportional to the velocity of the process fluctuations W(t). 
The standard deviation of the process σ , together with Τ , characterize the 
w w 
amplitude and velocity of the fluctuation pattern of the analytical process. 
The correlation time or time constant of the process is obtained from the auto­
correlation function of time series of equispaced quality control data over a 
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prolonged period of time. 
The concept of autocorrelation analysis is dealt with in most advanced 
textbooks on statistics, e.g. Ref. 3, therefore only a brief outline of the 
autocorrelation technique is given. 
The autocorrelation function is calculated as follows: 
Compute autocovanance estimates ψ^^τ) according to 
Ψ™ (τ) = Γ <W{t) - »> · iu(t + T) - " > (1) 
t=l η - τ - 1 
where η = number of quality control data (Fig. 2) or data (Fig. 1) in the time 
series. 
Wit) = fluctuating process signal as function of time. 
U = average value of the process signal, 
τ = time interval between the data expressed in units of sampling interval. 
For τ = 0, φ (0) is seen to be a2, the process variance. Autocovanance 
ww w 
estimates ψ (τ) normalised to tk„,(0), i.e. a2, are called autocorrelation 
ww
 T
ww
 w 
estimates Φ (τ), because they correlate the value of a signal at a certain 
ww
 J 
time t, with the value of the same signal at time τ later. 
Consequently : 
Φ,.„.,(Ό = = WW 
ψ (0) σ' T
ww w 
when Τ = 0, each process value is correlated with itself and Ф,„,(0) has the 
•^  ww 
ideal correlation value 1. 
For small timelags or time intervals τ, there may still be some resemblance 
or correlation between process values. With increasing τ, this resemblance 
generally decreases and the corresponding autocorrelation estimates Φ (ι) 
ww 
rapidly diminish to zero. 
For a stationary time series with one dominating time constant Τ ψ 0, the 
autocorrelation function Φ (τ) is adequately described by (1): 
$
ww<
T
> = exp(-T/T
w
) 
and the corresponding autocovanance function by: 
Ψνη.
( τ )
 =
 σ 2 -
 exp(-r/ ï" ) (2) 
WW W W 
The correlation time or time constant '1 can be found at the point of the 
w 
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Fig. 4 (a) Autocorrelogram of an uncorrelated series of measurements. (Ь) Un-
correlated series of measurements with M denoting the mean value of process 
quantity W studied and N the number of observations. 
curve where τ = ?,, i.e. ψ (У ) = 0.37 · σ2 or Φ (Τ ) = 0.37 (= e - 1 ) , and is 
W rww V) W WW w 
expressed in units of sampling interval. 
Fig. 4a illustrates an autocorrelogram of the uncorrelated series of measure­
ments presented in Tig. 4b. It is already clear that for small τ, Φ ^ ί Ό is 
practically zero. Such a pattern is characteristic for so-called white noise. 
Fig. 5a shows the autocorrelogram of the correlated series of measurements of 
Fig. 5b. The correlogram gradually diminishes to zero. Successive measurements 
show some resemblance to one another, this resemblance decreasing with 
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Fig. 5 (a) Autocorrelogram of a correlated series of measurements, (b) Corre­
lated series of measurements with M denoting the mean value of process quantity 
W studied and Λ' the number of observations. 
increasing τ (the memory fades out). Here we observe that, despite the complete 
randomness of the disturbances w(t) acting upon a process, the final 
fluctuation pattern has a distinct correlation function with respect to time. 
Upon substitution of Eqn. 1 in Eqn. 2, which implies that if looking at the 
process deviation at time t= 0, w(0), the most probable value of the deviation 
at time t, will give 
WÍL) = ω(0) . exp(- t/T
v
) (3) 
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We can make a statistical prediction of what the process value is likely to be 
at time L after the actual analysis. Therefore we can describe the effect of 
time delays in a control loop. 
Fig. 6 illustrate the predictability of a disturbance at time t , wit), when 
the change in the initial disturbance w(0), conforms to the prediction function 
(Eqn. 3) . 
w(t) 
w(o) 
Fig. 6 Predictability of a disturbance in time, when the change in the initial 
disturbance U(0) conforms to the prediction function ω(ί) = u(0) · expi-t/T ) . 
From Fig. 6, it follows that when a process is controlled at a time T^ after 
the sampling action, only those disturbances occurring after Τ , can m the 
case of optimum control be controlled and completely reduced to zero. The con­
trolling action is such that it compensates exactly for the process deviation 
at the moment of the intervention i.e. « ( T J . 
α 
The disturbances or deviations occurring before T, cannot be controlled at time 
Τ and remain in the process after the controlling action (= action which 
compensates exactly for the process deviation at the moment of this control­
ling action i.e. w ( T J . 
d 
Now the aim of a controlling system is to make the fluctuations of a process 
quantity around its average value as small as possible or desirable. 
Consequently the process fluctuations are measured and the information content 
of these measurements is translated into a controlling action upon the process 
m order to minimize the measured discrepancies from the average process vaJue 
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or setpoint. 
In evaluating the efficiency of a control loop as shown m Fig. 1, both process 
and control system properties will determine the ability to measure/reconstruct 
the events taking place in the process and our sucess in controlling these. 
Van der Grinten (1) defines for optimum measuring or reconstructing efficiency 
the measurability m : 
2 öw - σε /~2 Τ m  = -*•
 σ
 = / α,2, · (1 - m 2) σ г α
Γ
 (4) 
_2 t W W t 
U
w 
Here сг denotes the variance of E(t), the difference between the measurement 
and the actual process value at time t and a2 is the variance of the uncontrolled r
 w 
process, 
m is referred to as the measurability factor. 
The definition of the measurability according to Eqn. 4 quantifies which part 
of the signal actually is measured under optimum conditions. Therefore we only 
consider the variation in u(i) and Z(t), as their averages are supposed to be 
zero. Systematic errors are not taken into consideration because they cannot 
be influenced statistically. Returning to Eqn. 4, we see that in the ideal 
situation m equals 1, i.e. σ = 0, which means no reconstruction error at all, 
and the process value is known exactly. 
When σ2 = σ2, m2 = 0, viz. the reconstruction error equals the process error. 
In such a situation we have a defective measuring system. 
Table 1 
Magnitude of the reconstitution error 0 depending on the measurability 
factor m, according to equation 4. 
m 
1.00 
0 .99 
0.97 
0.87 
0 .75 
0 .50 
0 .30 
0 .00 
σ
ε ( % o f V 
0 
14 
24 
49 
66 
87 
95 
100 
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Consequently 0 Í m < 1 . 
Table 1 gives some idea of the magnitude of the reconstruction error depend-
ing on the measurability factor "1 (Eqn. 4) . 
Analogous to the measurability m , Van der Grinten (1) defines as a measure 
of the optimum controlling efficiency, the controllability 
2 2 
a - ai w e 
σ
=
 = /al · (1 - r2) σ, > σ„ (5) 
2 
where 3" indicates the extent to which disturbances can be suppressed by op­
timum control; where 0 .< r £ 1, r is called the controllability factor and σ 
is the variance of the process fluctuations after optimum control. 
When Og = σ^, r = 0 , the controlling actions have no effect at all, the distur­
bance suppression being 0%, whereas when f = 1 , this is 100%, the ideal control, 
a = 0 . Since a process can never be controlled to a greater extent than the 
ability of the control system to actually measure or reconstruct the underlying 
process, ai >. a2 i.e. r2 ζ m2. 
when a2 = a2, r2 = m2. 
From Fig. 6 it is seen that the magnitude of a disturbance at time i, wit) , can 
be predicted when the change in the initial disturbance ω(0) conforms to Eqn. 3. 
Squaring W(i) and subsequent integration between the limits 0 -*- <>> and 0 •+ Τ , 
yields the variance of the uncontrolled process σ , and the process variance 
left after the controlling action is performed at time T, i.e. σ2. 
OD 
al = f w2 (t) dt (6) 
w
 о 
î 'd 
a
2
 = f w2(t) dt (7) 
e
 0 
Subs t i tu t ion of Eqns. 6 and 7 i n t o Eqn. 5, bearing in mmd Eqn. 3 leads t o : 
3" = exp(- г у У
и
) (8) 
Van der Grinten (1) determined for the situation shown in Fig. 1, that the 
period of enforced action or dead time of the control loop Τ equals the sum 
of the separate time delays according to: 
Td = ^  + Τ + ^ + Τ (9) 
α
 2 s 3 Ρ 
where T
a
 = sampling interval, Τ = analysis time of the sample, Ί = duration 
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of the sampling action, Γ = dead time of the process. 
Substitution of Eqn. 9 into Eqn. 8 leads to: 
I- = exp(- "J2^) . exp(- IJT^ . exp(- Г
т і
/ЗГ
и
) . exp(- Tp/Tw) (10) 
in which 
the measurability factor due to sampling, m = exp(- J. /21! ), 
a a w 
the measurability factor due to duration of the sampling action, m
m i = 
exp(- r
m l/3'/ w), 
the measurability factor due to analysis, m
s
 = exp(- ^
s
/?
w
) · 
the controllability factor due to I , ν = exp(- У/™ ). 
Van der Grinten also determined the measurability factor due to the repro­
ducibility of the analytical method m . Since this is a rather complicated 
equation (1), use is made mostly of the graphical representation of this 
equation, shown in Fig. 7. From Fig. 7 one can derive m
n
, when the ratios 
σ /cîw and T^/^y, are known for a given situation. Thereby σ is the precision 
of the measuring system, σ is the standard deviation of the process to be 
controlled, 'ΐ the sampling interval and Τ the time constant of the process. 
*
 TA/TW 
Fig 7 Graph from which the numerical value of m
n
 can be obtained when the ratios a
v
/ a
w
 and T^fT^ 
are known σ
ν
 = standard deviation of the measurmß unit a w = standard deviation of the process, I a = 
sampling mterval T w = time constant of the process m n = measureabihty factor due to the precision of 
the measuring unit M (Ь ig 2) or analytical laboratory (Fig 1 ) 
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For example, when σ
ν
/σ
Μ
 = 1 and T
a
/T
v
 = 1, m equals - 0.7 (Fig. 7). 
Consequently Eqn. 10 is extended by this factor m giving: 
a
 s
 mi η ρ 
That part of the controllability factor (r1) determined by the applied 
analytical technique is referred to as the total measurability factor m t where 
mt = ma • ms • %,ι • mn t 1 1 ' 
so that 
r = m . r (12) 
Since OTt is the product of a number of measurability factors and r is the prod­
uct of OTt and V (Eqn. 12), Equations 4 and 11 and 5 and 12 respectively will 
enable us to quantify the measuring and controlling efficiency of the control­
ling system or control loop. 
It will be evident that when trying to optimize a control system the smallest 
contributing measurability and/or controllability factor will have marked 
influence on the overall performance of the control system, despite the fact 
that other factors might be quite satisfactory. Therefore, if the performance 
of a control system is considered to be insufficient, efforts should concentrate 
on improvement of the smallest contributing factor(s). 
Variation of the parameters which cause a poor performance of the control system 
as for example T
a
, Т
т 1, Τ , Tp or σ ν then offer, by means of Equations 11 and 
12 in combination with Equations 4 and 5, the possibility of investigating which 
alterations would most benefit measurability and controllability. However, one 
should keep in mind that every increase in precision usually involves a quadratic 
rise in expense (1). 
A decision to adjust the control system to increase its measuring and control­
ling efficiency therefore should be balanced against the additional expense 
and/or workload. If this increase in efficiency is considered to be worth the 
effort, application of measurability and controllability rules indicate what 
is to be expected from the modified control system. 
For the situation shown in Fig. 2, where the analytical process is controlled 
by a feed back control loop. Van der Grinten's theories are interpreted as fol­
lows . 
The total measurability factor (mt) for this situation is given by 
^t = ma · "¡mi · "h (13) 
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Comparing Eqn. 13 with Eqn. 11 shows that in the former, the measurability 
factor due to the dead time of analysis m
s
 is put equal to 1. 
The reason for this is as follows. 
In Fig. 1, we have the situation where at the moment of the sampling action 
the only samples available, have first to be analyzed in the laboratory before 
data are available from which conclusions can be drawn about the events taking 
place in the process and which govern the controlling actions. 
Consequently an extra time delay i is introduced in the control loop. For the 
situation shown in Fig. 2, however, the data are already available at the 
moment of the sampling action, and the corresponding dead time of analysis Τ 
is 0, in which case m
s
 equals 1. There is no extra time delay introduced m 
the control loop and no information lost. 
The measurability factors in Eqn. 13 have following interpretation 
m
a
 = exp(- Γ /2T ) the measurability factor due to dead time of sampling 21, 
which is determined by the intervals at which quality control samples are 
implemented among a run of patient specimens. 
"L. = exp(- Τ /зТ ) : measurability factor due to ÎL, , the duration of the mi ^ mi w mi' 
sampling action i.e. the time needed to accumulate several quality control 
data of which the average value is used to measure/reconstruct the events 
taking place in the analytical process. 
"i · measurability factor due to the reproducibility of the measuring unit M 
(Fig. 2) which is error-prone due to V(t), characterized by the standard devia-
tion σ„. The value of m
n
 is obtained from Fig. 7 when σ /σ,, and T./T,, have 
V ii э V W a' w 
been computed for a given situation. 
The precision of the measuring unit, characterized by σ is considered in the 
following context. 
Quality control samples are used to measure the performance of the analytical 
process during the analysis of a run of patient samples. They reflect the events 
taking place in that process and govern the controlling actions. When, however, 
these quality control samples themselves are subject to certain causes of 
variation, the quality control data do not only reflect the disturbances W(t) 
acting upon the process (Fig. 2), but also the measuring errors v(i) charac­
terized by their standard deviation σ
ν
. 
This is demonstrated in Fig. 2 by imposing the measuring errors V(t-) on the 
measuring unit M. This is done because in fact each quality control sample can 
be considered as a measuring unit in its self. The smaller these measuring 
errors are i.e. the smaller σ
ν
, the better m and m. (Eqn. 13) will be. 
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Possible sources of error which affect the measuring unit(s) when use is made 
of lyophilized quality control material are for example: (1) inter-vial 
variation during the filling process, (2) differences in final humidity due to 
the fact that each lot of control serum will consist of several freeze-dned 
batches as a result of which different degrees of dryness may arise between 
different batches and between the individual vials in each batch (3) difference 
in the content of dry material in the vials of each batch may occur due to the 
reason stated under (1) and due loss of material during the freeze-drying 
process, (4) pipetting errors when the freeze-dned material is reconstituted. 
Bacterial contamination of the control serum and non-homogeneity also cause 
gross errors which will decrease m since σ
ν
 increases. Similar to the situation 
in Fig. 1, the controllability of the controlling system shown m Fig. 2 is 
given by Eqn. 12 and m by Eqn. 13 so that 
r m m
a · " W · "»η · rp ( 1 4 ) 
Here r = exp(- Τ /T ) i.e. the controllability factor due to the dead time of 
Ρ Ρ w 
the process Τ . 
Ρ 
Τ is the time lag between the moment the result of the quality control sample 
becomes available and the moment the controlling action is performed in the 
analytical process. 
If for example a quality control result is available at ten o'clock in the 
morning but action is taken say at three o'clock in the afternoon, Τ is 5 h. 
Whether the controlling action will produce any effect after this time is to a 
large degree dependent on the velocity of the process fluctuations i.e. 1/T , 
the inverse of the time constant of the analytical process. 
The time constant Τ in general will determine to what extent parameters, 
characteristic of a controlling system, influence measurability and control­
lability of that system. Not taking into account the magnitude of Ϊ may have 
a great impact on the effect of the controlling actions performed. Trying to 
compensate for example at time T^ (Fig. 6), a measured deviation from a target 
value at time t ' , W{t') entirely by a controlling action with an opposite sign 
equal to wit'), when t'«T¿, leads to the often observed situation of "under-
shoot" of the process. The result of the intervention is that the measured 
deviation in the ultimate case is of the same magnitude as before but with 
opposite sign. 
It is also possible that the measured deviation at time t' , b)(t') , is amplified 
by a controlling action made at T,. This may happen if the process value at 
time Τ is actually as large as wit'), but with opposite sign, m which case a d 
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controlling action, also with an opposite sign, amplifies the process signal 
in an adverse way. 
When confronted with a time constant approximately zero i.e. white noise 
(Fig. 4a), a dynamic system of process deviation control is impossible. The 
process is time invariant and the process fluctuations are unpredictable in 
time and considered to be inevitable to the process quantity measured. 
We would like to emphasize that of course every quality control sample 
supplies information about the analytical process. To reconstruct accurately 
and control the events taking place in the process requires a dynamic system 
of process deviation control. 
Valuable tools, therefore, are measurability and controllability rules as mea-
sures indicating the optimum measuring and controlling efficiency of control-
ling systems. 
The word "control" in clinical chemistry usually referred to the quality con-
trol techniques in which the observations are assumed to vary independently. 
Placed in the context of feed-back control, as discussed in this paper, it 
assumes that observations are inter-dependent and that this dependence is 
related to the place of the observation in time. 
"Control" then refers to adaptation of control schemes which are appropriate 
for the periodic, optimal adjustment of a manipulated variable so as to 
minimize the variation of that quality characteristic about some target or 
mean value. 
Results 
In 1974, a project investigating the dynamic aspects of analytical processes 
in clinical chemistry laboratories started in The Netherlands (4). The 
objectives were twofold. 
(1) Are analytical processes time variant or time invariant i.e. are they 
characterized by time constants unequal or approximately equal to zero. 
(2) What is the measuring efficiency of the quality control systems used in 
the participating laboratories to control these processes. 
25 laboratories participate in the project and have submitted their intra-
laboratory serum calcium and urea quality control data over the period 1974/ 
1975. 
The results pertaining to the urea determination in blood serum of one of 
the participants are discussed. 
The analytical process to be controlled was the urea determination performed 
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on a Techmcon Auto-Analyzer model AA2 (Ol 1-A952-01) according to a procedure 
described by Skeggs (5) and Marsh et al. (6) . 
The organization within the laboratory was that all patient and quality con­
trol samples were analyzed in one run. Here the term "run" is consistent with 
the IFCC definition which refers to "run" as "a set of consecutive assays per­
formed without interruption" and for which "the results are usually calculated 
from the same set of calibration standard readings" (7). 
Within each run, groups of patient and control sera samples could be distin­
guished which will be referred to as analysis series from now on. Conse­
quently a run consists of several analysis series and in this particular 
laboratory the sequence was : 
6 different calibration standards, (water sample, с , с , 17 patient samples)
n 
c, and c, were in most instances 2 different control sera samples which were 
placed at the beginning of each analysis series. 
The time needed to analyze one sample was approximately 12 min. The time lag 
between successive samples was 50 seconds. Therefore one complete analysis 
series was analyzed in approximately 28 m m . 
The process is sampled at a rate of 1 control serum sample of level 1 and level 
2 every 17 m m (= T
a
) . 
All analyses were performed once. 
сj and c 2 were commercial lyophilized human control sera. 
According to the manufacturer the inter-vial coefficient of variation was 0.7%. 
During the period 1974/1975, 4 lyophilized control sera from the same firm 
were used for the mtralaboratory quality control program and no modifications 
or alterations were made in the analytical process. The results of the auto­
correlation analysis are summarized in Table 2. The time series, coded 1-4, 
consist of equispaced quality control data over a prolonged period of time and 
are considered to be sample realizations of an infinite series, representative 
of the analytical process. 
A practical problem we encountered during the investigation was that of missing 
values in the series, which hamper the application of the formula to calculate 
autocovanance and autocorrelation estimates directly. A minor adjustment of 
these formula overcomes this problem (8). The results in Table 2 were computed 
accordingly. 
They show that the analytical process is time variant with an average time 
constant J of 2.32 analysis series with a standard deviation of 0.19 analysis 
series (= 8%). Since the time constant is expressed in units of sampling 
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Table 2 
Autocorrelation analysis results 
Control 
serum 
1 
2 
3 
4 
code 
Number of 
observations 
(и) 
1334 
1040 
829 
1490 
Mean value 
(mmol/l) 
7.56 
18.47 
7.43 
18.54 
s
w / standard 
deviation of the 
uncontrolled 
process 
0.2708 
0.6445 
0.3137 
0.6546 
cv
w
(%) 
3.58 
3.49 
4.22 
3.53 
Τ 
w 
(analysis 
series)* 
2.08 
2.29 
2.53 
2.36 
* 1 analysis series is analyzed approximately in 17 minutes. The average time 
constant of the process 1 - 2.32 + 0.19 analysis series. The average 
w 
coefficient of variation of the uncontrolled process CV (%) = 3.67 
w 
interval, here 17 minutes, Τ , equals 39.36 minutes. 
These results indicate that despite the complete randomness of the disturbances 
ω(ί) working upon the process (Fig. 1 ) , the final fluctuation pattern has a 
distinct correlation function in time i.e. the disturbances are predictable in 
time. The time constant Τ together with the coefficient of variation of the 
w 
"uncontrolled" process (CV (%)), the inter-vial coefficient of variation (CV (%)) 
and the sampling interval (T ) , consequently enable us to compute the efficiency 
of this quality control system to actually measure or reconstruct the events 
taking place in the analytical process. 
Table 3 shows the results of each realization separately and the average time 
constant ΐ calculated from these realizations. 
w 
The measurability due to the duration of the sampling action m ^ is 1, since 
Τ = 0 i.e. each quality control result is considered seperately and not first 
accumulated with other results before action is undertaken. 
From Table 3 the following observations can be made: 
(a) The average coefficient of variation of the "uncontrolled" process of 
3.67% (=CV (%)), can in the case op optimum control be reduced to 2.24% 
w 
(assuming that the dead time of the process Γ is zero, Eqn. 14). 
Ρ 
(b) The reconstruction error is 61%. 
(c) The limiting factor is m , the measurability factor due to dead time of 
sampling (T ) . 
These observations for example could have following impact: 
(a) The performance is satisfactory, in wich case the controlling system remains 
unchanged and the coefficient of variation of the "controlled" process 
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Control 
serum 
code 
1 
2 
3 
4 
CV
,r 
(%) 
3.58 
3.49 
4.22 
3.53 
"w 
(min) 
35.36 
38.93 
43.01 
40.12 
Cvm 
(%) 
0.7 
0.7 
0.7 
0.7 
T
a 
(mir 
17 
17 
17 
17 
Table 3 
Reconstruction or measuring efficiency of the controlling system during the 
period 1974/1975 for the urea determination 
m r¡ m CV,- Reconstruc-
a η t ,„;-(%) tion error 
(%) 
0.786 0.98 0.770 2.28 63.68 
0.004 0.98 0.788 2.15 61.60 
0.821 0.99 0.813 2.46 58.29 
0.809 0.98 0.793 2.15 60.90 
Based on the average time constant 
of the process i.e. Ϊ = 39.36 and 
w 
the average coefficient of variation 
of the uncontrolled process CV (%) = 
w 
3.67 0.806 0.982 0 .790 2.24 61 .12 
Note. More decimal places are given than strictly are required to illustrate 
the exact computations to facilitate understanding the various steps when 
verifying the results given. 
never becomes better than 2.24%. 
(b) A CVç- of 2.24% is not considered necessary. One would be satisfied if this 
were approximately say 31. 
(c) An increase of the measuring efficiency is thought desirable. 
For situation b, one could calculate the effect of decreasing the sampling 
rate on the performance of the system i.e. CV (%). 
Table 4 shows the results when the control samples are implemented every 2, 3, 
..., 10 and 17 analysis series i.e. 34, 51, ..., 170 and 289 min. The require-
ment was in the example for a coefficient of variation of the controlled process 
of 3%. This can be achieved at lower cost by decreasing the number of control 
samples in the "run" from 1 every analysis series (=17 min) to approximately 
1 every 2 analysis series (= 34 min). We again would like to stress that of 
course every quality control sample supplies information about the disturbances 
acting upon the analytical process. To measure and reconstruct these however 
with the aim to control the disturbances within a certain precision requirement 
as for example here of 3%, one quality control sample every 2 analysis series 
is enough in the case of an optimal controlling action. The effect of alterations 
of Τ and Τ on CV (%), m , m and m as compared with the present situation, 
a mi m a η mi 
which could lead to an improvement of the measuring efficiency of the system, 
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Table 4 
The effect of increasing the sampling interval on the reconstructability 
of the quality control system, with Τ 
0.982 (Table 3) 
39.36 minutes, CV = 3.67% and m 
w η 
τ 
J
a 
(min) 
34 
51 
68 
85 
102 
119 
136 
153 
170 
289 
• Equation 4 
V Reconstruc 
m 
a 
0.649 
0.523 
0.422 
0.340 
0.274 
0.220 
0.178 
0.143 
0.115 
0.025 
upon subs 
tion error 
m 
t 
0.638 
0.514 
0.414 
0.334 
0.269 
0.217 
0.174 
0.141 
0.113 
0.025 
titution of m and 
=
 C V L (%)/CV (ΐ) . 
w 
cv
r
 Τ 
( ° ) 
2.83 
3.15 
3.34 
3.46 
3.53 
3.58 
3.61 
3.63 
3.65 
3.67 
CV = 3.67% 
w 
Reconstruction 
error V 
(%) 
77.1 
85.8 
91.0 
94.3 
96.2 
97.6 
98.5 
99.0 
99.4 
100.0 
as given in situation с of the example, are shown in Table 5. Whether or not the 
measuring efficiency is increased by such modifications follows from Equation 13. 
An increase in m can then be balanced against the possible costs and additional 
workload and determines if the effort is worth-while. 
Table 5 
The effect of possible modifications of the control system, on various measur-
ability factors. 
The notation c, > and < indicate respectively a constant, increasing and 
decreasing value of the specific parameter in comparison with their present 
values (see Table 3) . 
Action Effect 
Τ 7 
Analysis , a . , m l. (min) (min) 
c v
m 
(%) 
0.70 
с 
< 
< 
m
a 
0.806 
> 
с 
> 
" η 
0.982 
> 
> 
> 
m 
mi 
1.00 
с 
< 
< 
Single 
Single 
Duplicate 
Duplicate 
17 
< 
с 
< 
0 
с 
> 
> 
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As Kurtz et al. (9) stated. 
'It is important to identify what medically useful precision limits are 
neeaed m order to avoid useless or net" needed precision'. 
We have shown that measurability and controllability rules work both ways. 
They indicate in which direction a measuring/controlling system needs to be 
modified to reach a certain precision requirement of the analytical process. 
Suppose that the precision requirements need to be increased. It would then 
of course be possible to install highly sophisticated analytical procedures in 
clinical chemistry laboratories to achieve this goal. However, apart from the 
fact that such procedures have not as yet been developed for all clinical 
chemistry determinations, such procedures are often not suited for daily 
routine work, require highly qualified personel and are uneconomic, 
especially in small laboratories. An effective controlling system in which 
the characteristics of the analytical process and controlling system properties 
are well balanced, may also lead to a higher standard of precision in clinical 
chemistry laboratories, if such an increased precision requirement is thought 
medically useful for that specific determination. 
Discussion and conclusions 
The statistical controlling methods used in clinical chemistry laboratories 
today are based on the presumption of the independency of measurements, 
representative of a sampled analytical process. In the case of a small correla-
tion time or time constant of the process, the applicability of these methods 
is not impeded. The influence of an enhanced value of the correlation time, 
however, cannot normally be neglected. 
In view of the fact that most statistical controlling methods are specially 
focussed on the detection of mstationarities they also keep their significance 
in the case of a correlated series of measurements. Instationanties can 
however never be statistically controlled, because of their unpredictable 
character. 
The control theory discussed in this paper consequently operates within the 
stationary fluctuating pattern of a process. The autocorrelation technique 
which in fact is a filtering method, can verify such behaviour and apart from 
that, though not further discussed here, is superior to the normal statistical 
controlling methods in detecting variables such as trends and periodic compo-
nents of a fluctuating process signal. 
The objective of a deviation control system is to control deviations from a 
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target value or setpoint by means of intervening/controlling actions. Measur-
ability and controllability quantify the efficiency of these actions. 
An example to illustrate the applicability of these rules in clinical chemistry 
laboratories is given. 
The results of the autocorrelation analysis indicate that the process under 
investigation was time variant with a time constant of approximately 39 min. 
The reconstructability of the quality control system installed was 39% implying 
a reconstruction error between the reconstructed and actual process of 61%. 
The implication of this result is discussed. 
The ultimate goal is of course to control accurately the analytical processes 
and so called "controllers" are capable of doing so. These controllers are 
devices which compensate exactly for a measured deviation from a setpoint 
with an action with an opposite sign. Controllers operate according to certain 
control characteristics which also determine the efficiency of the controlling 
actions. 
In this paper we restricted the discussion to the time aspects affecting these 
actions. 
The objective of the project was to verify if analytical processes were time 
variant or time invariant and to quantify the measuring efficiency of 
installed quality control systems in clinical chemistry laboratories. 
With present knowledge the measuring efficiency of quality control systems 
m terms of their capability actually to reconstruct the events occurring in 
the analytical process can be quantified. 
We see at present the major field of operation of the theory discussed to be 
automated continuous flow systems, although the theory also lends itself for 
non-automated systems. 
We realize that a lot of study still is to be done before these control 
theories become operational in clinical laboratories. The main objective of 
the present paper was to show and introduce another approach to quality control 
thinking. The fundamental difference, in comparison with the statistical 
controlling methods, is the philosophy that analytical processes are time 
variant, with a predictable fluctuation pattern in time which is not just 
watched but really controlled. 
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Chapter б 
A QUALITY CONTROL PROGRAM TO EVALUATE ACCURACY AND 
PRECISION OF CLINICAL CHEMISTRY DETERMINATIONS* 
C.B.G. Limonard 
Summary 
An external quality control program is described which, apart from documenting 
the routine performance of clinical chemistry laboratories with respect to 
accuracy and precision, also indicates the control efficiency of intra-labora-
tory quality control procedures. 
Participants are supplied with a large lot of stable control serum to be used 
in their intra-laboratory quality control program during a prolonged period of 
time. 
The statistical analysis of the submitted data consists of an analysis of vari­
ance scheme in order to separate systematic from random errors. The systematic 
laboratory errors are thereafter graded according to a scoring system indepen­
dent of the standard deviation. 
The control efficiency of intra-laboratory quality control procedures is 
derived from a modified version of the measurabrlity and controllability rules 
of Van der Grinten (1968) Stat. Neerl. 22, 43-63. Application of these rules 
in clinical chemistry laboratories is a first s~гр towards a dynamic system of 
process deviation control. Merits of such an approach are discussed. 
Principles of the analysis of variance technique are dealt with. A graphical 
procedure to display its results is shown. Testing procedures to justify appli­
cation of the analysis of variance technique are discussed and several features 
are illustrated. 
Introduction 
The objective of internal and external quality control programs in clinical 
chemistry laboratories is to establish working standards of quality in terms 
of precision and accuracy. 
Two fundamentally distinct but equally important types of quality assurance 
procedure are used. 
* Clin. Chim. Acta 95, 353, 1979. 
Within each laboratory, intra-laboratory procedures make use of experimental 
and statistical protocols to achieve this. The consequence of not sufficiently 
and continuously monitoring measuring processes is that these tend to get out 
of control, i.e. they lose their predictability. With respect to long-term 
quality assurance, external mechanisms are designed which not only document the 
performance of a laboratory with respect to accuracy and precision but also 
serve m establishing and maintaining initial requirements. 
The objective of the present investigation is to present an external quality 
control program in which both systems function not apart but cooperate with 
each other. 
The fundamental idea of the program is the distribution of a sample of stable 
control serum, sufficient for each participant to use in his internal quality 
control system, during a prolonged period of time. After this period the routine 
quality control data of each participant are collected and statistically 
analyzed. All collected results are thereafter reported to each participant ard 
give an indication of his particular internal performance during the trial 
period and the behaviour of his laboratory in comparison to all others. 
The statistical analysis consists of an analysis of variance scheme to separate 
systematic from random errors. After this step the laboratory bias disposed of 
possible time and/or interaction components, is quantified according to a score 
system, which operates independently of the standard deviation. This scoring 
system was introduced in the Dutch proficiency testing survey by Jansen (1). 
The random errors are graded according to a modified version of the measur-
ability and controllability rules of Van der Grinten (2). Application of these 
rules in clinical chemistry laboratories is a means of striving for a dynamic 
system of process deviation control. Measuring and controlling efficiency of 
intra-laboratory quality control procedures could then be quantified. 
In order to optimize this efficiency, if at all possible, measurability and 
controllability rules are valuable tools. Process and control system properties 
will be seen to be important parameters, both of which have to be taken into 
consideration. At the same time, when attempting to increase this efficiency, 
one can verify if the actions undertaken produce the expected effect. It may 
turn out that the benefit is quite small in comparison with the possible in-
crease in workload and expense. 
The reporting system of the external program is governed by a rule not to 
overwhelm participants with results, but to reduce these to a manageable size 
without appreciable loss of information. 
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The scoring system to grade the systematic laboratory errors, together with the 
application of measurability and controllability rules to quantify the random 
errors, are a means of achieving this. 
In the following, the analysis of variance technique, together with a graphical 
procedure to display its results is dealt with in greater detail. 
Various features are illustrated, applying the routine quality control data of 
several laboratories. The theory of measurability and controllability rules 
applied in the field of quality control in clinical chemistry is dealt with in 
a separate paper (3). Here, the possibilities of such an approach to strive for 
a dynamic system of deviation control are discussed. 
Analysis of variance 
During the present investigation, analysis of variance schemes with and without 
replicated were considered. The linear models used to partition the total 
variance (s£ ) were the following: 
without replicates: St0tal=síaboratones + stime + sresidual 
with replicates: sL·^^, =s? , ^ + sf + s2 ^ ^ + s2 . , total laboratories time interaction residual 
Partitioning of an interaction term thus has the advantage that the assumption 
of additivity of the linear model can be verified. 
A significant interaction component may be due to some outlying observations in 
the raw data. Removing these and repeating the analysis may result m a non-
significant Fisher ratio. If, however, no outliers are found, a more complex 
situation exists. 
When the experiment is designed as above, we assume that the various effects 
are additive. This implies that the laboratory and time component do not have 
an effect in combination, different from the sum of their separate effects. Not 
taking interaction effects into account may lead to useful results, but caution 
is required, since little is known about the effect of interactions on the 
results of the analysis of variance technique. 
Considering the analysis of variance as a tool to analyze data statistically, 
means that the validity of the applied mathematical model has to be verified. 
The assumptions and limitations underlying the analysis of variance technique 
consequently must be taken into consideration in order to prevent misinterpre-
tation of the results. 
The two basic assumptions on which we would like to concentrate are the gaussian 
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distribution of tha data and the homogeneity of the sample variances. 
Various tests to verify whether a distribution is gaussian have been suggested. 
More interesting however, when using the analysis of variance technique, is the 
question of which departures from this distribution are acceptable without 
leading to misinterpretation of the analysis of variance results. 
The effect of a non-gaussian distribution on the power of the Fisher test used 
in the analysis of variance technique was studied by Snvastava (4) , who using 
the degree of skewness (/£> ) and kurtosis (fc ) (dealt with in many textbooks (5)) 
made the following observations: (1) The effect of skewness (equal to zero m 
the case of a gaussian distribution) on the power of the Fisher test is 
negligible. (2) The presence of a fair degree of kurtosis, not uncommon in 
practice, lead to a noticable deviation, particularly with small sample sizes. 
Small departures from a gaussian distribution with respect to kurtosis, of the 
order 2.5 < b 4 3.5, again do not cause any significant change in the power 
of the Fisher test. Its effect also diminishes with increasing sample size. 
The second assumption concerns the homogeneity of the sample variances. In a 
one-way analysis of variance scheme, the variance within any group г, s2., is 
an estimate of the residual or method error σ2. All estimates of the group are 
pooled to obtain the mean square within-groups as the best estimate of o2. If, 
however, not all s2. are estimates of σ7, the summation procedure is invalid. 
ъ о 
The change is significance of a Fisher test can consequently be substantial as 
reported for example by Brown and Forsythe (6). 
Various tests on the homogeneity of the sample variances have been suggested. 
For example Barlett's test (7), applicable even when the number of obser­
vations (n.) within a group г, varies from group to group, with the limiting 
factor n- ^3. When nt is constant for all groups and £3, Hartley's test is 
recommended (8). If η. < 3, neither test is applicable. 
Performing an analysis of variance scheme with replicates, then offers the 
possibility of detecting outlying observations which may interfere with the 
assumption of homogeneity of the sample variances. 
Data 
Tha data base underlying the present investigation originates from a project 
which started in the Netherlands in 1975 to investigate dynamic aspects of 
analytical processes in clinical laboratories (9). 
For this project 25 laboratories participating in the Dutch Foundation on 
Quality Control in Clinical Chemistry Hospital Laboratories, submitted their 
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routine intra-laboratory serum calcium and urea quality control data for the 
period 1974-1975. 
In this period, several laboratories used the same control serum during a rela-
tively short (3 months) or longer time span (12 months). In the present inves-
tigation, laboratories which had employed the same control serum during a 
common period were considered to be participants in an inter-laboratory trial. 
Because the common period length is determined by that laboratory which had 
used the serum during the shortest time span, not all data of a participant 
who had employed it longer, were used. 
Therefore we proceeded as follows. Having determined the common period, we 
selected out of this period 1 or 2 observations per week, per participant, 
from the data base of each laboratory with a random noise generator from the 
IBM-library, to guarantee randomization of the data. Thus we were able to 
undertake analysis of variance schemes with and without replicates. 
Results and discussion 
Tables 1 and 2 summarize the statistical characteristics of the 3 control sera 
which had been used by several laboratories during a common period. Although 
some participants employed two or all three sera, this is not shown in the 
tables, since it is not essential in the context of this paper. Consequently 
the statistical properties of 27 populations, indexed 1 -27, are summarized, 
and under the heading "control serum" one can find to which of the control sera 
the listed characteristics belong. 
From Tables 1 and 2, it is seen that populations 5, 7, 11, 19, 22 and 27 arc 
not m agreement with the ¿2-rule i.e. 2.5 4 b 4 3.5. Therefore, these should 
not be used when applying the analysis of variance technique. However, kurtosis 
is dependent on the number of observations considered. In order to verify the 
direct applicability and validity of the b2-rule, we include the probability 
of finding a b2-value as large or small as indicated, i.e. Prob(b2) , which is 
calculated according to a procedure described by d'Agostino and Pearson (10). 
It is seen that according to this criterion, only population 27 is not suitable 
for the analysis of variance scheme, because of a Prob(b?) below our 5% rejec-
tion criterion. 
Fig. 1 shows the frequency distribution of population 27. A salient feature is 
that both class 10.7 and 11.7 are empty, indicating a rounding-off error. On 
closer study, it even seems as if we have to deal with a mixture of 2 different 
control sera. The results of all other populations show the validity and direct 
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Table 1 
Statistical characteristics of intra-laboratory serum calcium quality control 
data 
Population 
1 
2 
3 
4 
5 
6 
7 
Я 
9 
1 0 
1 1 
1 2 
1 3 
Control 
serum 
1 
1 
1 
2 
2 
2 
2 
2 
3 
3 
3 
3 
3 
Number of 
observations 
(") 
5 5 0 
2 1 0 
7 7 
4 1 0 
6 2 
4 1 2 
1 4 3 
58 
2 7 4 
9 0 
2 9 
3 2 4 
7 7 
Mean value 
( X ) · 
2.67 
2.65 
2.64 
2.66 
2.62 
2.65 
2.63 
2.68 
2.63 
2.64 
2.70 
2.60 
2.63 
Variance 
(s 2 ) 
0.0015 
0.0032 
0.0031 
0.0015 
0.0033 
0.0023 
0.0022 
0.0042 
0.0036 
0.0057 
0.0027 
0.0020 
0.0062 
Kurtosis 
( b : ) 
2.61 
3.36 
3.14 
3.17 
3.78 
3.04 
2.45 
2.72 
2.84 
2.96 
2.07 
2.78 
2.82 
Probability 
Prob(b2> 
0.12 
0.27 
-
0.07 
— 
0.05 
0.46 
— 
0.40 
0.09 
— 
0.46 
* χ in mmol/1. 
applicability of the b2-rule, when not dealing with too small sample sizes n. 
With small n, caution is needed when confronted with b2-values outside these 
limits i.e. populations 7, 11 and 19. 
Table 2 
Statistical characteristics of intra-laboratory serum urea quality control data 
Population 
1 4 
1 5 
1 6 
17 
18 
19 
2 0 
21 
2 2 
2 3 
2 4 
2 5 
2 6 
27 
Control 
serum 
1 
1 
1 
1 
2 
2 
2 
2 
2 
3 
3 
3 
3 
3 
Number of 
observations 
(n) 
4 5 5 
7 8 
2 1 1 
2 0 5 
2 6 2 
6 6 
1 1 5 
1 7 7 
3 8 
2 0 1 
9 4 
2 7 
3 1 8 
9 6 
Mean value 
(* )* 
10.88 
10.69 
11.20 
11.39 
9.23 
9.75 
9.89 
9.71 
10.14 
8.68 
9.75 
10.00 
9.99 
10.65 
Variance 
(s 2 ) 
0.20 
0.19 
0.09 
0.29 
0.21 
0.08 
0.19 
0.22 
0.03 
0.25 
0.12 
0.02 
0.12 
0.21 
Kurtosis 
(Ьз) 
2.84 
3.09 
3.11 
3.37 
2.86 
4.08 
2.66 
3.39 
2.32 
2.76 
3.35 
2.90 
2.88 
2.21 
Probability 
Prob(b2) 
_ 
0.35 
0.27 
0.10 
— 
0.0 5 
0.25 
0.12 
0.20 
0.25 
0.17 
0.34 
— 
0.02 
* χ in mmol/1. 
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Fig. 1. Frequency distribution of population 27, pertaining to the urea 
determination, whose statistical characteristics are summarized in Table 2. 
From populations 1 - 26, data were selected for various inter-laboratory trials 
according to the described procedure. 
Tables 3 and 4 summarize the results of the analysis of variance calculations 
for calcium and urea respectively. Here ¿ denotes the number of participating 
laboratories,- j represents the length of the common period expressed in weeks; 
к indicates the number of observations selected per week per laboratory. 
Trials 2a/2b, 4a/4b, 5a/5b, 7a/7b and 9a/9b illustrate results of the same 
Table 3 
Analysis of variance results obtained for various inter-laboratory serum 
calcium surveys 
Control 
serum 
1 
2 
2 
2 
2 
2 
3 
3 
Trial 
1 
2a 
2b 
3 
4a 
4b 
5a 
5b 
I 
3 
3 
3 
3 
4 
4 
3 
3 
; 
4 8 
2 0 
2 0 
16 
12 
12 
8 
8 
fe 
1 
1 
2 
1 
1 
2 
1 
2 
F 
(laboratory) 
3.63 * 
8.56 ** 
5.64** 
5.04 ** 
7.01 ** 
7.02 ** 
0.70 
2.33 
F 
(week) 
1.08 
1.75 
1.44 
3.31 ** 
1.14 
1.57 
0 80 
1.62 
í 
(interaction) 
— 
— 
1.66 * 
— 
— 
1.43 
— 
2.29 
* Significant at ρ = 0.95. 
** Significant at ρ = 0.99. 
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group of laboratories during the same period but with к = 1 respectively к = 2. 
The results of Tables 3 and 4 illustrate the predominance of laboratory error 
and show the tenability of the control sera in the absence of a significant time 
or week component in ail but 2 trials. 
Table 4 
Analysis of variance results obtained for various inter-laboratory serum urea 
surveys 
Control 
serum 
1 
2 
2 
2 
3 
3 
3 
3 
Trial 
6 
7a 
7 b 
8 
9 a 
9 b 
1 0 
1 1 
I 
4 
4 
4 
3 
4 
4 
3 
3 
; 
4 8 
1 2 
12 
2 0 
8 
8 
2 4 
2 4 
l! 
1 
1 
2 
2 
1 
2 
2 
2 
t 
(laboratory) 
29 22 ** 
12 05 ** 
16 13 ** 
23 17 ** 
30 79 * * 
37 02 ** 
64 3 5 * * 
149 39 ** 
F 
(week) 
0 83 
1 60 
1 50 
0 56 
3 17 * 
2 20 
1 42 
0 71 
F 
(interaction) 
_ 
— 
1 16 
2 34 ** 
— 
2 25 * 
1 89 ** 
3 3 3 * * 
* Significant at ρ = 0 95 
* * Significant at ρ = 0 99 
In the trials, where an analysis of variance scheme with replicates was prac­
tised, in 5 out of 8 a significant interaction component was found. In order to 
trace the origin of this observation, the data should be screened for possible 
outliers. If none are found a complex situation exists as mentioned earlier. 
Strictly, from the numerical results of an analysis of variance scheme alone, 
this would be difficult if possible at all. Here, a graphical representation 
of the analysis of variance results could be of help. The procedure may also 
serve to make analysis of variance results more lucid to participants and is 
applicable when not dealing with too large a trial. 
For the scheme with replicates, the procedure is the following 
Denote 
x^ , ,single observation of laboratory ι in week j . 
xb,J ,mean value of laboratory i in week j . 
x¿ ,mean value of laboratory i . 
Xj ,mean value of week j . 
x .overall mean. 
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The total variance of the observations used in the analysis of variance scheme 
with replicates is: 
2 2 7 2 2 
stotal - laboratories + sweeks + interaction + sresidual 
First of all the effect of having collected the data over a prolonged period 
of time is removed and adjusted for the overall mean i.e. 
The variation in the observations 5„ . is thus reduced to a combination of a 
laboratory and interaction contribution apart from the inevitable residual 
error. In a similar way the laboratory effect is removed i.e. 
x'ij " 4,j ~ (5ΐ " 5) (2) 
or together with Eqn. 1 
S
'i,J = %j " (5J " Z) * {*i * ^ 
Now all observations х
г
 - have been compensated for laboratory, week or time 
component. 
_// 
Consequently, with a non-significant interaction variance component, these ж,
 n 
are only subject to random fluctuations. If not, however, the graphical 
representation of the x- • values gives a clear indication whether this 
Ъ
 3 J 
significant contributing factor is either due to one or more outliers, or was 
caused by a systematic component other than a laboratory and week effect. 
Figs. 2 and 3 show the graphical representation of the analysis of variance 
results of trials 2b and 8 (Table 3 and 4). 
Here, although not relevant, as it was not a significant contributing factor, 
the week component is removed in both figures m order to illustrate the whole 
procedure. That it is not a significant contributing factor indeed can be veri­
fied from the graphical representation of the trial results. Within each figure, 
all scales are equal and a reduction with the week component does not lead to 
a reduction of the total variance of the data, according to expectation. Figs. 2 
and 3 show that the greatest variance reduction is achieved by removal of the 
systematic laboratory errors. The origin of the significant interaction 
contribution is also revealed.In Fig. 2 this is shown to result from some 
outlying observations at the beginning and end of the period. Strictly such a 
situation should not have occurred at this stage as before starting the 
analysis, the homogeneity of the sample variances should have been verified. 
However, since no such tests are applicable for cell sizes with j¡ < 3, the 
scheme with replicates offers, by means of the interaction term the possibility 
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hiß 2 Graphical represen ta t ion of the analysis of variance results of survey 2b , summaj i / ed in Table 3 
Along the vertical axis calcium r t su l l s are indicated in mmol / l and the hor izonta l axis r c p r e s m t s the sur 
vcy pt-nod with sampl ing intervals of one week (A) Mean \ a lues of t he labora tor ies ι in w e e k ; xtj for 
i = l — 3 j = 1—20 (B) Mean values of u e i k s J x. for j - I— 20 (c) Results after removal of the week-
c o m p o n e n t , 
c o m p o n e n t , 
according t o Eqn 1 for ι = 1—3 J 
according t o Eqn 2, for ι = 1—3 J 
= 1—20 (D) Results after removal of week/laboratory 
1—20 
big 3 Graphical r eprésen ta t ion of the analysis of variance results of survey θ s u m m a m e d in Table 4 
Along the vertical axis urea results are i n d u a t c d in mmol/1 and the hor i7ontal axis represents the survey 
period with sampling intervals of one week (A) Mean values of the laborator ies ι in week ; дг,^  for ι = 
1—3, J = 1—20 (D) Mean values of weeks j x, for j = 1 —20 (C) Results after removal of the week com­
p o n e n t vjj according t o Eqn 1 for Í = 1—3 j = 1—20 (D) Resul ts after removal of wcrk / l abo ra to ry 
c o m p o n e n t x',', according to Fqn 2 f or J - 1—3 j = 1—20 
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of detecting interfering outliers during the analysis. Fig. 3 illustrates the 
situation where a systematic component is active apart from the laboratory 
contribution. For one of the laboratories we see a decrease of the measurements 
with increasing time. Together with the quantitative results from the analysis 
of variance, this graphical procedure offers a method of tracing the origin of 
certain observations, which cannot be explained from numerical information 
only. 
A disadvantage of the graphical procedure is that it is not clear when dealing 
with a large test set, and also causes a large expansion of the reporting 
system. 
The computations necessary for the graphical representation however do form a 
valuable tool to quantify the "pure" laboratory errors free from other 
contributing factors. Combining this information with a score system, indepen-
dent of the standard deviation, consequently not only forms an objective cri-
terion for judging the "pure" laboratory bias, but also leads to a reporting 
system of a manageable size without loss of information. 
Systematic errors 
The score system is one already used in the national quality control scheme 
in clinical chemistry in The Netherlands (1). In this scheme, trials are 
organized every 2 months whereby participants are provided with 2 control sera 
samples, which are to be analyzed one single time and treated as routine 
samples. 
The statistical analysis consists of a Youden-plot in order to reveal systema-
tic laboratory differences and the scoring system mentioned above. Jansen et 
al. (1) reported the first results based on the scores shown in Table 5. 
The scores of the participants related to these criteria reflect the overall 
laboratory error of each participant, composed of both systematic as well as 
random errors at a fixed time and based on a single observation. 
With the external program (applying the analysis of variance technique), a 
separation of the laboratory error as a performance characteristic of the parti-
cipating laboratories and the random errors of the measurements over a pro-
longed period of time is possible. This is particularly important in view of 
recent reports that intra-laboratory variability can be considerable and may 
obscure systematic method differences (11). 
The procedure starts with the calculations used for the graphical representa-
tion of the analysis of variance results i.e. Eqns. 1 and 2. From these, the 
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Table 5 
Calculation of scores for systematic method errors 
Sodium 
Mean ± 
Mean ± 
Mean ± 
Mean ± 
Mean ± 
Mean + 
and chloride 
1% 
2% 
3% 
4% 
5% 
> 5% 
Inorganic pt 
10 
9 
7 
5 
3 
0 
losphate, urea, 
creatine, cholesterol 
glucose and 
Mean + 
Mean ± 
Mean ì 
Mean ± 
Mean ± 
Mean ± 
2' 
4« 
6s 
8* 
10 = 
> 10' 
total protein 
s: 10 
*: 9 
s: 7 
.: 5 
s: 3 
b: 0 
Potassium 
Mean 
Mean 
Mean 
Mean 
+ 
+ 
+ 
+ > 
2 
5 
7 
7 
5% 
% 
5% 
5% 
10 
8 
6 
0 
Calcium 
Mean ± 
Mean ± 
Mean ± 
Mean + 
Mean + 
Mean ± 
Mean ± 
Urate 
Mean ± 
Mean ± 
Mean ± 
Mean ± 
Mean ± 
Mean ± 
> 
> 
1% 
2% 
3% 
4% 
5% 
7% 
7% 
2' 
10 
9 
8 
7 
5 
2 
0 
: 10 
4%: 9 
6%: 7 
10 = ,: 5 
14%: 3 
14%: 0 
"pure" systematic laboratory error іь calculated from the laboratories average 
value after subtraction of other possibly significant contributing factors. 
Thereafter these are compared and graded according to the criteria of Table 5. 
Since for most components no reference methods are yet available, the overall 
mean value of the participants, calculated from the data from which possible 
significant time and/or interaction components were removed, is used as the 
reference value. This prevents the reference value being affected by bad results 
of one or more participants. In the situation shown in Fig. 3, all the data of 
the laboratory, whose results decreased with increasing time, would be omitted 
when the reference value is calculated. When confronted with outliers (Fig. 2), 
these are removed before establishing the reference value. 
Random errors: meosurability and conLrollability 
"Controlling is intervening m a situation on the basis of measurements". Based 
on this definition, Van der Grinten (2) stated that the three elements 
occuring in this definition may each contain an uncertainty that sets limits 
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to the controlling efficiency i.e.: 
(1) The measurements may be error-prone. 
(2) The interventions may lose part of their effect through overestimation or 
dynamically unfavourable responses of the process. 
(3) The situation is not clear i.e. the static and dynamic process characteris­
tics are insufficiently known. 
Fig. 4 illustrates these three elements for a clinical laboratory. 
The analytical procedure is the process with underlying disturbances г(і), 
which converts a physical or chemical quantity of samples, into a quantity 
representative of these samples, i.e. data. 
The quality control data, sampled at a rate \/Ί&, contain the information about 
the behaviour of the process and this information is assembled in the measuring 
unit M, which on its turn is also error-prone due to measuring errors w(t) . 
z<0 
PATIENT AND QUALITY CONTROL SAMPLES 
»> 
I t 
С ^ M 
τ 
voi 
Fig. 4. Schematic diagram illustrating the analytical procedure as a process 
to be controlled. M, measuring unit; C, controller; Τ , sampling interval; i>(É), 
measuring errors; г(£), disturbances causing the process to run out of control. 
The intervening actions, based on the control data by controller C, want to 
neutralize the effect of the measured discrepancies from a target value. In 
order for these interventions to be appropriate, the measurements must 
approximate to the actual process value as closely as possible. 
In evaluating the efficiency of the controlling system or control loop, shown 
in Fig. 4, both process and control system properties have to be taken into 
' ' 
ANALYTICAL 
PROCEDURE 
i , 
PATIENT AND QUALITY CONTROL DATA 
У 
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account. Van der Grinten (2) defxnes as a measure of the optimum measuring 
efficiency, the measurability m 2; 
m
2
 = ? — or σ| = σ2 . (1 -m 2) σ£ < σ* (4) 
W 
Here σ denotes the variance of C(t), the difference between the measuring 
result and the actual process value at time t and a
w
 is the variance of the 
analytical process. The definition of the measurability according to Eqn. 4 
now quantifies which part of the signal is actually measured under optimum 
conditions. Therefore we only consider the variation in V(t) i.e. w(t) =z(t) -z 
and είί) = Vit) - V. Consequently ω and ε are zero. Systematic errors are not 
included in the considerations because they cannot be influenced statistically. 
In the ideal case m equals 1, i.e. σ
ε
 = 0, the process value is exactly known. 
In the most non-ideal situation m -0 i.e. a7 =0,,, the measuring error is 100%, 
ε
 w 
implying a defective measuring unit. The practical implication of Eqn. 4 is 
that it can be used to judge the performance of various quality control systems 
m clinical chemistry laboratories with regard to their measuring or 
reconstructing efficiency. 
Analogous to the measurability m 2, Van der Grinten (2) defines as a measure of 
the optimum controlling efficiency, the controllability r2• 
,2
 = n
2 
2 
a
w 
(5) 
Here σ is the variance of the controlled process. Eqn. 5 indicates the optimum 
controlling efficiency of a control system with 0 •$ r 4 1. When p 2 = 0 , the 
controlling action has no effect at all, the disturbance suppression is 0% i.e. 
O
e
 = a
w
, whereas when r2 = 1, this is 100%, σ2 = 0, vis. ideal control. Since a 
process can never be controlled to a higher degree than the measuring errors 
ε(ί) allow, 7'2<n2i.e. σ 2 ^ σ 2 . It is obvious that when σ2 = σ2, r2 = m2 . From 
formulae 4 and 5 it follows that the properties of the process and characteris­
tics of the controlling system will determine our ability to measure and control 
the analytical process. Important features are; the analysis time Τ , the sam­
pling frequency 1/У
а
, the duration of the sampling action І'
ті
 the process stan­
dard deviation σ , and the time constant of the process T
w
 which is inversly 
proportional to the velocity of the process fluctuations and the standard devia­
tion of the measuring unit Μ, о The effect of these parameters on m 2 and i"2 
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is dealt with in the paper concerning dynamic deviation control m clinical 
chemistry laboratories based on the time variant behaviour of analytical pro­
cesses (3) . At present we shall assume that m and 2" are known for a given 
situation. Formulae 4 and 5 then allow quantification of the efficiency of the 
controlling actions taken in the process in order to minimize σ
ε
 and σ . It may 
turn out that the effect is quite small. Variation of the parameters mentioned 
above which allow this (i.e. T
a
, Τ , Τ and σ ), consequently creates the pos­
sibility of investigating which alterations would benefit an increase m m 
and r most. Thereafter it can be verified within each laboratory if this 
increase is worth the expense and possible additional workload. Another pos­
sibility is that the efficiency is considered to be sufficient. Application 
of measurability and controllability rules then permit quantification whether 
or not the same efficiency can be achieved with less effort and reduced expense. 
As part of an external quality control program, one could approach the notion 
from the opposite side i.e. set the initial precision requirements for the 
various determinations, thus quantifying σ^, the process variance after a con­
trolling action is performed. Incentives to set these criteria should be that 
they coincide most closely with the clinical objectives. Various recommendations 
have been made (12- 15) . One of the first to balance precision requirements 
against the costs of such measurements to society were Lmdberg and Watson (16), 
who usea a mathematical model of the effect upon the diagnostic process of 
imprecision in measurements and the influence upon these two of importance 
of diagnosis and prevalence of disease. We are currently investigating 
which criteria should be implemented m the external quality control program. 
At present we suggest comparing the process variance of each participant σ , 
with the residual error ö£eslciua;i. i.e. σ^ = cr|.eSx(juai, obtained directly from 
the analysis of variance scheme and often refered to as the survey precision. 
The precision performance of each participant related to ОгестЛпя! i.e. Og, 
then gives each laboratory information about his performance in comparison with 
the group during the trial period. 
2 2 
When ö wia p, the participant fullfils the criteria set by the program for the 
specific determination considered, his precision is considered to be adequate 
and he need take no further action although he must be alert to maintain this 
standard. 
When a laboratory does not meet the requirements, application of measurability 
and controllability rules (Eqns. 4 and 5) offers a means to investigate what 
actions are to be taken to fullfil the precision criteria. 
165 
Implementation of precision criteria, independent of the trial results, is, 
however, to be preferred, since an overall poor trial performance may obscure 
the actual problem. 
It should also be emphasized that even when a laboratory meets these precision 
criteria (set independently of the survey results) this does not necessarily 
have to imply that the optimum control efficiency within each laboratory has 
been achieved, since the purpose of process control is to make the fluctuations 
of a process quantity around its average value as small as possible i.e. 
minimization of 0e. Recent studies (17) indicate that at least some clinical 
laboratory determinations must be made more precise than at present. 
Quality control procedures are never able to improve an analytical method but 
they can be a mechanism to assure that certain standards are warranted in 
clinical chemistry laboratories. 
In older for these quality control systems to supply the information they were 
intended for in clinical chemistry laboratories, analytical procedure or pro-
cess characteristics and control system features will determine our ability 
actually to reconstruct or measure what is happening in that process, and the 
efficiency with which tnese disturbances can be controlled by a controlling 
action. 
Conclusions 
The proposed external quality control program is based on the distribution of 
a control serum among laboratories in such a quantity that it can be used in 
their mtra-laboratory quality control program for several weeks. 
In comparison with the external program at present used by the Dutch Foundation 
on Quality Control in Clinical Chemistry Hospital Laboratories, the proposed 
program has following advantages 
(a) Laboratories are followed during a certain time so that the results are 
less affected by accidental large deviations from a target value which in the 
former program was an often given reason to explain a bad result. 
(b) Systematic laboratory errors are well separated from random errors. 
(c) Possible deterioration of the control serum is revealed. 
(d) The occurrence of interaction components which interfere with the analysis 
of variance scheme is revealed, and outliers or long-term drift in one of the 
laboratories, which have a negative influence on setting the target value of 
the trial, can be removed. 
(e) Incorporation of the b -rule to test the assumption of the gaussian d i s t n -
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bution of the data used in the analysis of variance scheme prevents misinterpre-
tation of the analysis of variance results. When data interfere with this rule, 
a frequency distribution of the data is constructed which can reveal certain 
sources of error. 
(f) Application of measurability and controllability rules allows to quantify 
measuring and controlling efficiency of intra-laboratory quality control systems 
and offers the possibility of indicating which improvement(s) would increase 
the efficiency most, if this efficiency is considered to be insufficient. Details 
are discussed in another paper (3). 
The results of the program are presented to the participants m a format that 
does not overwhelm them with information. Each participant receives a report of 
his own performance during the trial period with regard to systematic and random 
errors. The results of the analysis of variance scheme arc graphically displayed 
to make the numerical results clearer. Each participant can then verify and 
compare his performance with the other participating laboratories. 
Which precision criteria are to be implemented in the program is still a matter 
for discussion. 
Once decided, random errors could be graded according to some kind of scoring 
system. 
This proposal for an external quality control program was presented to the Dutch 
Foundation on Quality Control in Clinical Chemistry Hospital Laboratories and 
accepted. Presently a trial is being organized. 
The intention in the future is not to replace the system already functioning 
m The Netherlands, but to let both external programs operate simultaneously. 
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SUMMARY 
Quality control in clinical chemistry laboratories and the dynamics of 
analytical processes are the elements of the investigation described in this 
thesis. 
The participants in this retrospective investigation were 25 clinical chemistry 
laboratories in the Netherlands, all members of the Foundation on Quality 
Control in Clinical Chemistry Hospital Laboratories. 
The data and results of the investigation pertain to the period 1974 - 1975. 
Intralaboratory quality control and related aspects of each participant 
seperately and of the group, were studied on the basis of the results of an 
inventory inquiry. 
The dynamic behaviour of the analytical processes which were used by the 
participants for the serum calcium and urea determination, is investigated 
by subjecting the routinely generated intralaboratory quality control data of 
each laboratory, to autocorrelation analysis. 
Based on the dynamics of analytical processes, thereafter first incentives are 
given, which ultimately should lead to a dynamic system of process deviation 
control in clinical chemistry laboratories. 
In chapter 1 a general introduction in quality control in clinical chemistry 
is given. The need for, and the various forms of quality control, are discussed. 
The objectives of the investigation and the motives for the chosen design, 
together with the consequences of this design, are dealt with. 
Questionnaire and state of the art of quality control and related aspects in a 
group of clinical chemistry laboratories in the Netherlands in 1974 - 1975, 
are discussed in chapter 2. 
The results of this Inventory inquiry show that 60% of the employed quality 
control sera, were commercially obtained. 40"s were prepared m the laboratories. 
Of the 'commercial·1 sera, 35% was prepared from pooled human sera, 43% from 
pooled horse sera and 22% from pooled bovine sera. 
For the control sera prepared in the laboratories, these figures are respective-
ly 72, 6 and 22%. 
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Most of the participants establish the 'norm'-values for the calcium and the 
urea component in these sera themselves. The procedures therefore used are 
summarized and discussed. 
Some participants however establish these 'norm'-values in cooperation with 
other laboratories and some adopt the 'norm'-values which the firm states for 
the specific analyte in the supplied control serum batch. Approximately 15% 
of the activ analysis capacity of the laboratories for the serum calcium and 
urea determination, is used for the analysis of control specimens. Approximately 
one control specimen is inserted among a series of = 5 - 6 patient specimens. 
This implies that one quality control result is used for the surveillance of 
the analytical process during approximately 1 5 - 3 0 minutes. 
A synopsis of the calibration standards the participants used for establishing 
the calibration curves for the serum calcium and urea determination, is 
contained. 
The results show that the number of calibration standards varies from laboratory 
to laboratory and from determination to determination. Also the range of 
concentration levels used to establish the calibration curve shows remarkable 
discrepancies. 
The implications of the place of calibration standards, quality control and 
patient specimens in an analytical run are dealt with. A summary of the 
composition of these runs in the various laboratories is contained. Quality 
control procedures based on the use of patient specimens as 'daily mean', 
'average of normals' and 'number-plus', are hardly adopted. 
The principle of the reference sample method is used by all participants. 
Not always however were the thereby employed control charts effective in 
detecting an out of control situation of the analytical process. 
Application of several separate control charts instead of a combined chart can 
supply misleading information. An example is shown, illustrating this feature. 
The intervention criteria on the basis of which the participants actually 
perform controlling actions in the analytical process, and the different 
approach towards the use of quality control data by some of the participants 
in this regard, are dealt with. 
Overall conclusion is that considerable time and effort is spent on the 
improvement of the reliability of clinical chemical data. 
Quality control is however not always dealth with in a systematic, effective 
and correct way. 
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In chapter 3 the autocorrelation technique is of concern. 
Arising from a practical situation, the effect of missing values in time series 
on autocorrelation analysis, particularly on the estimation of the time constant 
of a process, is investigated. 
A solution is described to overcome this problem. Monte Carlo simulations are 
performed to test the validity and applicability of the procedure, for various 
time series models. 
The results indicate that in other than extreme situations, the procedure is 
valid and applicable. 
Rounding-off data in time series, with and without missing values, is seen to 
have a negative systematic effect on the estimation of the time constant of a 
first order stationary stochastic process. In extreme situations the time 
constant is severly underestimated. 
The effect of missing values in time series on the standard error of auto-
correlation estimates is investigated for a first order stationary stochastic 
process, and for such process with superimposed error. 
A modified version of Bartlett's formula, with which the standard error of 
autocorrelation estimates is calculated, is seen to be valid for both process 
models. The results of the Monte Carlo simulations show the validity and 
applicability of the modified formula. 
From a theoretical interest but also to help stimulate the use of the auto-
correlation technique in clinical chemistry laboratories, a relationship between 
the autocorrelation and analysis of variance technique, well known in clinical 
chemistry, was looked for. 
For a first order stationary stochastic process this relationship is derived. 
The results of the Monte Carlo simulations show its validity and applicability. 
A practical example is included. 
The definition of the analytical process and the compilation of time series of 
quality control data, in chapter 4, form the basis of the investigation 
concerning dynamics of analytical processes. 
The results, pertaining to the processes which were used by a group of 
clinical chemistry laboratories for the serum calcium and urea determinations 
m 1974 - 1975, are shown. 
The results of the autocorrelation analysis for both determinations, indicate 
that analytical processes exhibit a dynamic or time variant behaviour. 
Various process models are appropriate. In cenerai however, the analytical 
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processes used for the serum calcium and urea determination could be 
represented as first order stationary stochastic processes. 
The consequences of such a dynamic process behaviour for intralaboratory 
quality control and the possibilities of the autocorrelation technique are 
discussed. 
Several suggestions are included, to prevent in future studies, the 
difficulties encountered during this investigation. 
The possibilities to establish a dynamic system of process deviation control 
in clinical chemistry laboratories, on the basis of the time variant behaviour 
of analytical processes, are dealt within chapter 5. 
The measurability and controllability rules of Van der Grinten are interpreted 
for a control loop in which the analytical process is the object which needs 
to be controlled. 
With the emphasis on the possibility of a quality control system to measure the 
events occurring in the analytical process, an example is included. 
The ultimate goal is to establish a dynamic system of process deviation control 
in clinical laboratories. Here first incentives are given. 
In chapter 6, an external quality control program is described which documents 
the routine performance of clinical chemistry laboratories with respect to 
accuracy and precision, and which bears consequences for intralaboratory quality 
control. 
To that purpose, participants are supplied with a large lot of stable control 
serum to be used in their intralaboratory quality control program during a 
prolonged period of time. (2 months) 
The statistical analysis of the submitted data consists of an analysis of 
variance scheme in order to separate the systematic from the random errors. 
Principles of the analysis of variance technique are dealt with. 
A graphical procedure to display its results is shown. Testing procedures to 
justify application of the analysis of variance technique are discussed and 
several features are illustrated. 
Advantages of this program in comparison with the external program presently 
used by the Foundation on Quality Control in Clinical Chemistry Hospital 
Laboratories are discussed. The program, dealt with here, was presented to the 
Foundation and accepted. Several trials have since been organi7ed. 
At present further trials are being prepared. 
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SAMENVATTING 
De kwaliteitsbewaking in klinisch chemische laboratoria en het dynamische ge-
drag van analytische processen, vormen de elementen van het in deze disserta-
tie beschreven onderzoek. 
Deelnemers aan dit retrospectief opgezette onderzoek waren 2 5 klinisch chemische 
laboratoria in Nederland, allen lid van de Stichting Kwaliteitsbewaking Klinisch 
Chemische Ziekenhuislaboratona. 
De gegevens en resultaten van het onderzoek betreffen de periode 1974 - 1975. 
De stand van zaken met betrekking tot de intralaboratonele kwaliteitsbewaking 
en daaraan gerelateerde aspecten van iedere deelnemer afzonderlijk en van de 
groep, is geïnventariseerd en onderzocht door middel van een enquête. 
Het dynamische gedrag van de analytische processen, die door de deelnemers wer-
den ingezet voor de serum calcium en ureum bepaling, is onderzocht door een 
autocorrelatie analyse uit te voeren op de routinematig gegenereerde intralabo-
ratonele kwaliteitskontrole data van ieder laboratorium. 
De basis van het dynamische gedrag van analytische processen wordt vervolgens 
een eerste aanzet gegeven om te komen tot een dynamisch systeem van proces de-
viatiekontrole in klinisch chemische laboratoria. 
In hoofdstuk 1 wordt een algemene inleiding gegeven in de kwaliteitsbewaking 
in de klinische chemie. De noodzaak tot invoering van deze systemen alsmede de 
verschillende vormen van kwaliteitsbewaking worden behandeld. De doelstellingen 
van het onderzoek en de motivering van de gekozen opzet, met de consequenties 
die deze aanpak met zich bracht, worden toegelicht. 
Het enquêteformulier en de stand van zaken met betrekking tot de kwaliteitsbe-
waking en daaraan gerelateerde aspecten in een groep van klinisch chemische la-
boratoria in Nederland worden besproken in hoofdstuk 2. 
De resultaten van dit inventariserende onderzoek tonen aan, dat 60ΐ van de ge­
bruikte kontrole sera commercieel verkregen zijn en 401 in de laboratoria zelf 
zijn bereid. 
Van de 'commerciële' kontrole sera is 35% bereid uit gepoolde humane sera, 43% 
uit paarden sera en 22% uit runder sera. 
Voor de in de laboratoria zelf bereide kontrole sera zijn deze cijfers respec-
tievelijk 72, 6 en 22%. 
Het merendeel van de deelnemers bepaalt de 'norm'-waarden voor de calcium en 
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ureum komponent in de kontrole sera zelf. Een overzicht van de daarvoor gebruik-
te procedures i^ opgenomen. 
De consequenties van verschillende procedures worden belicht. 
Een aantal deelnemers stellen de 'norm'-waarden daarentegen vast in samenwerking 
met andere laboratoria en weer anderen nemen de door de firma bijgeleverde 
'norm'-waarden over. De implicatie van een en ander wordt besproken. 
Ongeveer 15% van de aktieve analysecapaciteit van de laboratoria voor de serum 
calcium en ureum bepalingen wordt gebruikt ten behoeve van de analyse kontrole 
monsters. Gemiddeld wordt 1 kontrole monster ingezet per 5 à 6 patiënten 
monsters. Dit impliceert dat 1 kontrole resultaat het analytische proces gedu-
rende 15 tot 30 minuten bewaakt. 
Met betrekking tot het kalibreren van analysemethoden tonen de resultaten aan 
dat niet alleen het aantal kalibratiestandaarden, met behulp waarvan de kali-
bratiekurve wordt opgesteld, varieert van laboratorium tot laboratorium en van 
bepaling tot bepaling, maar dat ook het bestreken concentratiebereik wisselt. 
De implicaties van deze waarnemingen worden toegelicht. 
De plaatsing van de kalibratiestandaarden en de kontrole sera in een reeks te 
analyseren patiënten monsters en een overzicht van de samenstelling van deze 
reeksen in de verschillende laboratoria ia opgenomen. 
De kwaliteitsbewakings-procedures, gebaseerd op het gebruik van patientenmon-
ster resultaten zoals 'daily mean', 'average of normals' en 'number-plus' wor-
den nauwelijks door de deelnemers gebruikt. 
De gemiddelden kontrole kaart zoals die door Levey en Jennings in de klinische 
chemie werd geïntroduceerd, wordt daarentegen door alle deelnemers gebruikt. 
De effektiv!teit van deze kaart om een ontsporing van het analytische proces 
te onderkennen laat in een aantal gevallen te wensen over. 
Het naast elkaar gebruiken van verschillende kontrole kaarten in plaats van een 
gekombineerde kaart kan soms misleidende informatie verschaffen. 
De interventieknteria op grond waarvan de deelnemers regelende akties in het 
analytische proces plegen uit te voeren en het verschil in benadering ten aan-
zien van de waarde van een kontrolemonster resultaat hierbij, worden aan de 
hand van een drietal voorbeelden getoond. 
Algemene konklusie is dat een niet aanzienlijke hoeveelheid tijd en moeite aan 
de verbetering van de betrouwbaarheid van klinisch chemische analyseresultaten 
wordt besteed. De kwaliteitsbewaking in klinische chemische laboratoria wordt 
echter niet altijd even systematisch, effektief en korrekt aangepakt. 
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In hoofdstuk 3 wordt de autocorrelatie techniek beschreven. 
Vanuit een praktische behoefte, is het effect van missende waarden in tijdreek-
sen op de autocorrelatie analyse, met name op de schatting van de tijdconstante 
van een proces, onderzocht. 
Een praktische oplossing wordt getoond en Monte Carlo simulaties zijn uitgevoerd 
om de betrouwbaarheid en toepasbaarheid van de procedure voor verschillende 
procesmodellen na te gaan. 
De resultaten tonen aan dat, in andere dan extreme situaties, de procedure be-
trouwbaar en toepasbaar is. Verder blijkt dat het afronden van waarnemingen m 
tijdreeksen, zowel met als zonder missende waarden, een systematische onder-
schatting oplevert van de tijdconstante van een proces. In het extreme geval 
worden tijdconstanten ernstig onderschat. 
Het effekt van missende waarden in tijdreeksen op de fout in de autocorrelatie 
schattingen is onderzocht voor een eerste orde stationair stochastisch proces 
en voor een dergelijk proces met daarop gesuperponeerde ruis. 
Een modificeerde versie van Barlett's formule, waarmee de fout in autocorrela-
tie schattingen wordt beschreven, is middels Monte Carlo simulaties voor beide 
modellen getoetst. De resultaten tonen de betrouwbaarheid en toepasbaarheid van 
de gemodificeerde formule aan. 
Vanuit een theoretische interesse en om de introduktie van de autocorrelatie 
techniek in de klinische chemie te entameren, is gezocht naar een verband tus-
sen de autocorrelatie en variantie analyse techniek. Deze laatste techniek ge-
niet in de klinische chemie al enige bekendheid. 
Voor een eerste orde stationair stochastisch proces is deze relatie afgeleid. 
De resultaten van de uitgevoerde Monte Carlo simulaties bevestigen de betrouw-
baarheid en toepasbaarheid van de afgeleide formule. Een praktische toepassing 
wordt getoond. 
De definiëring van het analytische proces en de opbouw van tijdreeksen uit intra-
laboratonele krfaliteitskontrole data in hoofdstuk 4, vormen de basis voor het 
onderzoek naar de dynamische aspekten van analytische processen. 
De resultaten hebben betrekking op de analytische processen die in een aantal 
klinische laboratoria m Nederland in 1974 - 1975 zijn gebruikt voor de serum 
calcium en ureum bepaling. 
De resultaten van de autocorrelatie analyse, voorzover de data dit toelieten, 
wijzen erop dat analytische processen een dynamisch gedrag vertonen. 
Over het algemeen zijn de analytische processen te beschrijven als eerste orde 
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stationair stochastische processen. 
In een aantal gevallen blijken ook andere procesmodellen voor te komen. 
De resultaten worden toegelicht en autocorrelogrammen zijn toegevoegd. 
De consequenties van een dynamisch gedrag van analytische processen op de intra-
laboratonele kwaliteitsbewaking worden besproken. 
Enkele suggesties om de tijdens dit onderzoek tegengekomen moeilijkheden bij 
toekomstig onderzoek te vermijden, worden gegeven. 
De mogelijkheden om op basis van het dynamisch gedrag van analytische proces-
sen te komen tot een systeem van proces deviatie kontrole in klinisch chemische 
laboratoria zijn opgenomen in hoofdstuk 5. 
Hier worden de meet- en regelbaarheidsregels van Van der Grinten voor een regel-
kring waarbij het analytische proces het te regelen objekt is, geïnterpreteerd. 
Met de nadruk op de mogelijkheden van een kwaliteitsbewakmgssysteem om de ge-
beurtenissen die zich in het analytische proces voltrekken te kunnen meten op 
basis van kwaliteitskontrole metingen, wordt een voorbeeld gegeven om de 
toepassing van de/e regels te illustreren. 
Dit gedeelte van het onderzoek heeft tot doel een eerste aanzet te geven tot de 
invoering van een dynamisch systeem van proces deviatie kontrole in klinisch 
chemische laboratoria. 
In hoofdstuk 6 wordt een extern kwaliteitsbewakingsprogramma beschreven dat een 
overzicht geeft van de juistheid en nauwkeurigheid van routinematig uitgevoerde 
klinisch chemische bepalingen, met een koppeling naar de intralaboratoriele 
kwaliteitsbcwakingsprogramma's van ieder deelnemend laboratorium. 
Daartoe worden de deelnemers voorzien van een voldoende hoeveelheid stabiel 
kontrole serum wat zij gedurende een langere periode (2 maanden) in hun 
interne KwaliLeitsbewanngsnrogramma gebruiken. 
De statistische analyse van de ingestuurde data bestaat uit een variantie 
analyse, met behulp waarvan de systematische van de toevallige fouten te schei-
den zijn. De principes van de vanantieanalyse techniek worden toegelicht en een 
grafische procedure om de resultaten weer te geven, wordt getoond. Test proce-
dures om een korrekte toepassing van de variantie analyse te waarborgen worden 
besproken en geïllustreerd. Voordelen van dit programma ten opzichte van het ex-
terne kwaliteitsbewakingsprogramma zoals dat door de Stichting Kwaliteitsbewa-
king Klinisch Chemische Ziekenhuislaboratona nu wordt doorgevoerd, zijn opgenomen. 
Het in dit hoofdstuk beschreven programma is door de Stichting overgenomen en 
enkele enquêtes zijn inmiddels doorgevoerd. 
Verdere enquêtes zijn in voorbereiding. 
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S T E L L I N G E N 
I 
De informatie-opbrengst per eenheid van kosten, zoals gedefinieerd door 
Danzer et al., kan niet voldoen als knterium voor de keuze van een 
analysemethode. 
Danzer, K., and Eckschlager, К., Talanta 25, 725, 1978. 
II 
De weergave van analysevoorschriften d.m.v. flowschema's, zoals voorgesteld 
door Rohleder et al., is geen wezenlijke uitbreiding van het door Malissa et 
al. ontwikkelde Symbolic Synoptic System for Analytical Chemistry (SSSAC) en 
voldoet derhalve niet aan de eisen die aan een dergelijke presentatie gesteld 
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